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esis Summary:
e Retinal Vessel Analyser (RVA) is a commercially available ophthalmoscopic instrument
capable of acquiring vessel diameter ﬂuctuations in real time and in high temporal resolution.
Visual stimulation by means of ﬂickering light is a unique exploration tool of neurovascular
coupling in the human retina. Vessel reactivity as mediated by local vascular endothelial
vasodilators and vasoconstrictors can be assessed non-invasively, in vivo. In brief, the work in
this thesis
• deals with interobserver and intraobserver reproducibility of the ﬂicker responses in
healthy volunteers
• explains the superiority of individually analysed reactivity parameters over vendor-
generated output
• links in static retinal measures with dynamic ones
• highlights practical limitations in the use of the RVA that may undermine its clinical
usefulness
• provides recommendations for standardising measurements in terms of vessel location
and vessel segment length and
• presents three case reports of essential hypertensives in a -year follow-up.
Strict standardisation of measurement procedures is a necessity when utilising the RVA system.
Agreement between research groups on implemented protocols needs to be met, before it could
be considered a clinically useful tool in detecting or predicting microvascular dysfunction.
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. e Heart
.. Cardiac Anatomy and Physiology
e circulatory system of an adult individual contains a volume of approximately  litres of
blood (Rogers, ). e body organ responsible for its circulation to every tissue is the heart.
Anatomically, the heart consists of four muscular chambers; the right and le atria (superiorly)
and the right and le ventricles (inferiorly). ese are pairwise interconnected via two valves;
the tricuspid and the mitral valve respectively. Exteriorly to the heart, these chambers are
connected to the largest blood vessels of the human body; the vena cavæ (the superior and the
inferior) and the aorta. Oxygen-deprived blood is fed to the heart via the vena cavæ, entering
into the right atrium. Blood ﬂow continues through the tricuspid valve into the right ventricle,
while the valve opens and the atrium contracts (atrial systole). In turn, as soon as the right
ventricle ﬁlls with blood, it contracts as well (ventricular systole). At the same time another
valve, the pulmonary valve, opens up to let blood through to the pulmonary arteries to be
pumped into the lungs. In the lungs, carbon dioxide is released and oxygen is absorbed. Now,
oxygen-rich blood returns to the heart via the pulmonary veins and correspondingly passes
through the le atrium, the mitral valve and into the le ventricle. is occurs at the same
time as a new contraction is taking place in the heart’s right atrium-ventricle. e ﬁnal valve
that opens simultaneously with le ventricular contraction is the aortic valve. Here, blood is
pumped into the aorta to be distributed further out towards the body’s organs and tissues.
.. Conduction System
e aforementioned muscle contractions are driven by a series of electrical impulses (action
potentials) generated by a group of specialised cells in the right atrium, the cardiomyocytes.
e tissue that comprises these cells is called the Sinoatrial (SA) node, also known as the
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heart’s “natural pacemaker”. e conduction pathway of the heart is made up of the following
specialised heart tissues: the Atrioventricular (AV) node, the bundle of His, the right and le
bundle branches and the Purkinje ﬁbres, successively. Finally, the actual contraction function
is performed by the contractile cells of the heart. ese provide the necessary kinetic and
potential energy for blood to propagate through the circulatory system.
Cardiac function is altered by neural activation. e heart is innervated by both the
Sympathetic Nervous System (SNS) (adrenergic) and the Parasympathetic Nervous System
(PNS) (cholinergic). e two systems work in tandem; the former is known to be the
accelerator of the heart, whereas the laer serves as the heart’s decelerator. Epinephrine
and norepinephrine are the two main chemical mediators that increase Heart Rate (HR), AV
conduction and contractility, via the SNS. e overall eﬀect of sympathetic contribution is to
increase Cardiac Output (CO), Systemic Vascular Resistance (SVR) and arterial Blood Pressure
(BP). e time necessary for the SNS to actuate these eﬀects is in the order of  seconds
(Cliﬀord et al., ). is compensating mechanism is particularly important during exercise,
emotional stress and haemorrhagic shock. On the other hand, parasympathetic innervation
of the heart is controlled by the vagus nerve. Parasympathetic activity therefore is sometimes
termed vagal activity. In contrast with the SNS, the vagus nerve acts quickly, carrying impulses
that lower HR and decelerate or block AV conduction, via acetylcholine release, within a
second.
. Cardiovascular System
.. Blood Flow
e ﬂow of ﬂuids with viscosity (η) through rigid, cylindric tubes of length (L) and radius (r)
in hydraulic systems obey the Poiseuille-Hagen law (Pournaras et al., ) that expresses the
relation between the ﬂuid ﬂow (Q) and the pressure diﬀerence (or else perfusion pressure) (ΔP):
Q = ΔPπr
􏻀
􏻄ηL =
ΔP
R (.)
e above expression assumes long, straight tubes, a Newtonian ﬂuid and steady, laminar ﬂow
conditions. Despite the fact that these assumptions are not entirely true for the human vascular
system, the ﬂow, pressure and resistance relationships still remain applicable. Hence, in
analogy to electrical circuits and Ohm’s law, the rate of blood ﬂow (Q) is inversely proportional
to vascular resistance (R). From Equation (.):
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R ∝ ηLr 􏻀 (.)
In health, blood viscosity does not ﬂuctuate, assuming constant haematocrit and temperature,
thus it can be considered constant (Klabunde, ). Similarly, vessel length is constant.
erefore, themajor determinant of resistance to blood ﬂow through a blood vessel is its calibre
(diameter is directly proportional to radius), since it is proportional to 􏺽/r 􏻀 (Equation (.)).
is means that a potential halving of blood vessel radius increases resistance -fold and vice
versa. It is evident that subtle vessel calibre ﬂuctuations can yield marked changes in vascular
resistance and consequently in blood ﬂow.
Due to their small diameter (i.e. less than 􏺾􏺼􏺼μm), arterioles are termed resistance vessels and
may regulate local blood ﬂow in their surrounding tissues (Klabunde, ). e extrinsic
regulation is mediated via a twofold pathway; the Autonomic Nervous System (ANS) and
the endocrine system. At rest, arterioles receive a baseline level of autonomic stimulation
which makes them slightly constricted, known as the vascular tone. Vasodilation is reached
by decrease of sympathetic stimulation below baseline levels and vasoconstriction by increase
above the baseline. Other mechanisms controlling vasomotor response, intrinsic to the vessels
this time, take the form ofmetabolic andmyogenic control; the former is incurred bymetabolite
accumulation according to the rate of metabolic activity and the laer by smooth muscle
relaxation or contraction. Metabolic regulation is mainlymediated by vascular endothelial cells
and local neural tissue surrounding the vessels, which release vasoactive molecules. e most
potent vasodilator is known to be Nitric Oxide (NO) and conversely endothelin- is the most
potent vasoconstrictor (Haeﬂiger et al., ). e myogenic responses for blood ﬂow vascular
autoregulation are mediated by pericytes and smooth muscle cells. Myogenic vascular tone is
a function of artery wall stretch and depends on the presence of calcium in the extracellular
space (Bevan et al., ).
.. Arterial Blood Pressure
e arterial vascular network is considered to be physically determined by its elastic char-
acteristics (compliance) and the blood volume circulating in it. e arterial volume in turn
depends on the inﬂow rate from the heart into the arteries (CO) and the outﬂow rate from the
arteries through the resistance vessels (arterioles) into tissues and body organs (Figure .). In
the resting state, these peripheral organs are supplied with blood according to their metabolic
needs. From the law of conservation of mass, given that the vascular system is a closed-loop
circuit, if the heart pumps blood at a higher rate than it is fed through veins, then the arterial
walls need to expand, giving a pressure rise and vice versa.
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Figure .: Primary physiologic factors aﬀecting certain physical factors which, in turn, determine arterial blood
pressure. Adapted from Berne and Levy () (p. )
Arterial BP is the force of blood against artery walls due to the pumping of the heart. BP is
deﬁned by the two extremes of systemic BP, namely systolic and diastolic pressure. Systolic
Blood Pressure (SBP) is the highest measured value obtained during ventricular contraction
(during a heartbeat), whereas Diastolic Blood Pressure (DBP) is the lowest measured value
obtained during ventricular relaxation (between heartbeats). BP is measured in millimeters of
mercury (mmHg). Automatic, digital BP devices using the oscillometric measurement method
are clinically used. Measurement is performed by occluding the artery of an extremity (arm,
wrist, ﬁnger, or leg) with an inﬂatable cuﬀ (Beevers et al., ).
.. Regulation of Blood Pressure
In physiologic conditions, whenever the sympathetic system is activated, the body down-
regulates parasympathetic activity and vice versa. ese two branches of the ANS are
rarely completely activated or deactivated; instead the body adjusts their levels of activation
appropriately to its needs. On that basis, the ANS makes HR adjustments via sensors located
throughout the body. ese sensors include the baroreceptors which exist in all mammalian
arteries and sense the arterial pressure. ey are a type of mechanoreceptor and respond
to arterial wall stretching, in a negative feedback loop fashion. If arterial pressure (mean,
pulse or both, see Section ...) rises abruptly, then vessel walls passively dilate in order
to accommodate this pressure rise. Consequently, the baroreceptors get activated and ﬁre
action potentials to a degree proportional to the change in pressure. e baroreceptor ﬁring
has an inhibitory eﬀect on sympathetic outﬂow and a boosting eﬀect on vagal outﬂow, hence
driving BP down. Also, these autonomic changes cause vasoconstriction (increased SVR) and
decreased CO. e reduction in CO results from both a decreased HR and a reduced force of AV
contraction, dropping arterial BP. e reverse action is taking place in case of a sudden pressure
drop, sustaining arterial BP at normal levels at all times. is is known as the baroreceptor

 Overview of principal literature
reﬂex or simply baroreﬂex, one of the body’smechanisms capable ofmaintaining homoeostasis.
Baroreﬂex sensitivity is now a prognostic factor in cardiology; it is signiﬁcantly altered during
certain disease states (La Rovere et al., ).
... Mean Arterial Blood Pressure and Pulse Pressure
When BP is clinically measured, the systolic and diastolic values are recorded. But two
additional ways of characterizing BP are important to consider. Physiologically, the pressure
that is primarily regulated and considered a beer indicator of perfusion (than SBP) to vital
organs, is the Mean Arterial Blood Pressure (MABP). MABP, measured in mmHg, is the
pressure in the arteries averaged over a single cardiac cycle duration and can be approximated
from the following empirical formula:
MABP ≃ 􏺾􏺿DBP +
􏺽
􏺿SBP (.)
Since the heart spends more time in the relaxing state (diastole) than in the contracting state
(systole), DBP has a greater eﬀect on MABP. For example, if systolic pressure is  mmHg
and diastolic pressure is  mmHg, then MABP is approximately  mmHg using the above
calculation. A MABP of at least  mmHg is necessary to perfuse the coronary arteries,
brain, and kidneys. Factors that determine MABP are CO and SVR, according to the following
relationship (based on Equation (.)) :
MABP ≃ CO ⋅ SVR (.)
As the le ventricle ejects blood into the aorta, the aortic pressure increases. e maximal
change in aortic pressure during systole represents the aortic pulse pressure. Pulse Pressure
(PP) is deﬁned as the diﬀerence between arterial systolic and diastolic pressures. us,
Equation (.) can be rewrien as:
MABP ≃ DBP + 􏺽􏺿PP (.)
Using the same numeric example as previously (SBP/DBP equal to / mmHg) then PP
equals to  mmHg. e rise in aortic pressure from its diastolic to systolic value is determined
by the compliance of the aorta as well as the ventricular Stroke Volume (SV). e stroke volume
is the amount of blood injected into arteries by each heart beat:
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Figure .: Graphical representation of the BP wave. SBP - DBP = PP. e dicrotic notch is caused by the aortic
valve closure. MABP is deﬁned according to Equation (.). Duration of a cardiac cycle is approximately
 msec.
SV = COHR (.)
e greater the stroke volume the heart pumps out, the greater the change in aortic pressure.
Compliance is simply a measure of the capacity of the arterial system to accommodate further
increases in volume (Δvolume / Δpressure). At given stroke volumes, the pressure increase is
determined by the vessel compliance. Flexible arteries that expand easily have high compliance,
contrary to stiﬀ arteries. e aorta’s walls, being the most compliant vessel walls throughout
the arterial system, expand to accommodate the increase in blood volume with ventricular
ejection. e more compliant a vessel, the smaller the pressure change during cardiac cycles
(i.e. smaller PP). Aortic compliance decreases with age or disease (e.g. arteriosclerosis) due
to structural changes, thereby producing age-dependent increases in PP. In general, both an
abnormally high PP and MABP are risk factors for cardiovascular disease (Dart and Kingwell,
).
. Diagnostic Tests and Procedures
.. Ambulatory BP Monitoring
Since BP is depending on factors such as age, gender, time of day (Millar-Craig et al., ), diet,
cardiac cycle (Knudtson et al., ; Chen et al., ), stress and physical activity (Anuradha
et al., ) it is evident that isolated, clinic BP measurements have inherent limitations and
may not be representative of the true BP in many patients. e white-coat eﬀect, referring
to a BP increase occurring at the time of a clinic visit and aenuating soon thereaer, may
be an additional obstacle to true BP assessment (Pickering et al., ). An alternative
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method of measuring BP in clinical practice is self-monitoring or home monitoring. Multiple
measurements at home enable a beer estimate of the average or true pressure, it is cost-
eﬀective and usually eliminates the white-coat eﬀect (Verberk et al., ). Nevertheless, it is
prone to measurement bias due to unreliable procedures when obtaining BP.
Portable BPmonitors that can be ﬁed for durations of  to  hours and can obtain and record
regular BP readings have become widely accepted as a clinically useful tool for diagnosing
and managing Hypertension (HT) (Waeber et al., ). Rather than measuring BP when
patients are remaining under artiﬁcial clinic conditions, BP behaviour is recorded during their
usual daily activities. Ambulatory Blood Pressure Monitoring (ABPM) oﬀers a wealth of BP
related information that no other method can provide. Mapping of diurnal variation of BP,
calculating arterial stiﬀness indices and pinpointing transient BP events would not be achieved
without the advent of ABPM. Measurement frequency during a typical -h period is generally
not recommended to be greater than every  minutes (which could interfere with routine
activities), neither less frequent than every minutes (which could give an inadequate amount
of measurements). Pieces of evidence from cardiovascular event-based, longitudinal studies
have been made available, that ABPM improves cardiovascular risk stratiﬁcation over and
beyond traditional risk factors, including conventional clinic BP measurement (Verdecchia,
).
... Ambulatory Arterial Stiﬀness Index
Another surrogate marker of arterial stiﬀness derived from ABPM that may predict cardiovas-
cular mortality is the Ambulatory Arterial Stiﬀness Index (AASI) (Dolan et al., ). AASI is
derived graphically by ploing DBP against SBP readings from unedited -hour recordings
and obtaining the slope of the regression line. AASI is then calculated as one minus the
regression slope. It is a novel measure which has been shown to be an integrated measure,
which is characteristic for an individual and reﬂects the combined eﬀects of le ventricular
ejection, active and passive components of arterial stiﬀness, and the reﬂection of the arterial
pulse wave (Li et al., ). Prior to the introduction of AASI, researchers were using PP as
a measure of arterial stiﬀness. However, PP only reﬂects a static diﬀerence between systolic
and diastolic pressure and does not exploit the dynamic relation between diastolic and systolic
blood pressure throughout the whole day as AASI does.
.. Electrocardiography
e electrical activity of the heart can be monitored in a non-invasive manner by means of
an electrocardiograph. Changes occurring in the membrane potential of cardiac muscle cells
during consecutive cardiac cycles are added up to produce an Electrocardiogram (ECG). ECG
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recordings provide a plethora of information about cardiac structure and function over time.
It is widely used in clinical practice to diagnose heart disorders including cardiac arrhythmias.
A number of electrodes are aached to the skin at pre-speciﬁed positions sensing the electrical
currents which propagate from the heart’s surrounding tissue to the skin surface. ese weak,
at ﬁrst, electrical currents are transmied to an ECG device, ampliﬁed and transformed into
ECG traces that represent the heart’s systole-diastole cycle. A schematic representation of an
ECG tracing is shown in Figure ..
Cardiac cells at rest are considered polarised. When a stimulus occurs (SA node ﬁring), ions
cross the cell membrane and cause an action potential resulting in atrial contraction. is is
called depolarisation and is represented by the P wave. e electrical impulse arrives at the AV
node where it is delayed by  milliseconds. Albeit minute, this delay is critical: it allows the
atria to fully contract and eject blood into the ventricle. At the same time, it keeps the ventricle
from contracting too quickly, allowing adequate time to complete its ﬁlling phase. On the ECG,
this brief period of no electrical activity is depicted by a straight (isoelectric) line between the
P wave and the beginning of the QRS complex. e impulse is then propagated down to the
ventricle through the bundle of His, right and le bundle branches and Purkinje ﬁbres yielding
ventricular contraction (QRS complex). Finally, the ventricle returns to its relaxed state (T
wave); this is called repolarisation. HR can be determined from the R-R interval, which is the
time between consecutive QRS complexes. Here, the term HR refers to the rate of ventricular
contractions. In some abnormal conditions atrial and ventricular rates diﬀer, so it is important
to distinguish between the two. Atrial HR is determined by measuring the P-P intervals.
Obtaining an ECG waveform is possible by means of one or more leads simultaneously. A
lead provides a view of the heart’s electrical activity between a positive and a negative pole.
Intuitively, these are called bipolar. Connecting these two poles by an imaginary line deﬁnes
the lead’s axis, which refers to the direction of the electrical current ﬂowing through the heart.
e ECG output consists of an upward deﬂection if electrical current is heading towards the (+)
electrode and vice versa. All bipolar leads need a third electrode as well, known as the ground.
is is placed on the sternum bone to prevent electrical interference from reducing the ECG
signal’s quality. Electrode terminals are color-coded for easier identiﬁcation and placement.
Since the heart is a three-dimensional organ and ECG electrodes may only be placed super-
ﬁcially on the skin, there are two diﬀerent planes that electrical activity can be probed from.
ese are the frontal and the horizontal planes. Conventionally, for the frontal plane there are
six limp leads,  bipolar (I, II, III) and  unipolar (avR, avL, avF) and for the horizontal plane
there are six chest (alternatively called precordial) leads, all unipolar (V􏺽 to V􏻂). Diﬀerent
leads provide diﬀerent diagnostic information. Unipolar leads require only one electrode.
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Figure .: Two complete, normal ECG cycles with waves, intervals and segments shown.
Combining more than one lead and omiing others is normal clinical practice on a per patient
basis.
An ECG may be recorded for a short time period (for example,  minutes), so the output can be
manually processed from hard copy printouts of the ECG strip created. Alternatively, longer
recordings ( or  hour) demand digital storage on solid state disks and specialised soware
for analysis and interpretation.
... Ambulatory ECG Monitoring
Norman J. Holter, an American biophysicist, developed the ﬁrst clinical prototype of a portable
ECG recorder in  (Barold, ). Since then, the term Holter monitoring is a synonym of
Ambulatory Electrocardiography (AECG). ere are two types of AECGmonitors. Continuous
ones that typically record for  or  hours and intermient ones that are used for long periods
of time (weeks to months) to provide shorter, intermient recordings on demand (alternatively
termed event recorders).
Ambulatory cardiac monitoring overcomes the limitations of one-oﬀ ECG recordings as it is
designed to identify transient cardiac disturbances occurring throughout the patient’s daily
routine, thus deemed free of bias of a controlled laboratory seing. It also makes possible the
examination of cardiac autonomic function by measuring Heart Rate Variability (HRV) (see
Section ...). According to the Seventh Report of the Joint National Commiee clinical
situations in which AECG monitoring may be useful are white-coat hypertension, evaluation
of nocturnal BP changes and hypotensive symptoms associated with antihypertensive med-
ications or autonomic dysfunction. Modern AECG monitors have an autonomy of storage
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capacity and running time of digitally recording more than . QRS complexes (for a h
period) and at the same time are compact and lightweight to carry on. Modiﬁed three-electrode
bipolar leads have been developed for the case of AECG. Some of these electrode placements
are shown in Figure ..
All modiﬁed bipolar lead placements shown in Figure . have the plus electrode in position
V􏻁. at is, the ﬁh intercostal space at the le anterior axillary line. e Central Back (CB􏻁)
lead has the negative electrode at the right scapula bone. e Central Manubrium (CM􏻁) lead
has the negative lead at the manubrium sterni. Lastly, the CC􏻁 lead has the negative electrode
at the ﬁh intercostal space at the right anterior axillary line (alternatively, this is the V􏻁R
position). Typically, combinations of two or three bipolar leads are used, which amounts to
ﬁve or seven electrodes in total, respectively. Signals are recorded in separate channels per
electrode pair.
e aforementioned modiﬁed ambulatory leads oﬀer maximised P-wave height for the dia-
gnosis of atrial arrhythmias and increased ECG sensitivity for the detection of anterior
myocardial ischaemia. Particularly, a study has exempliﬁed the use of the CM􏻁 lead as being
the most useful one for ambulatory monitoring (yyumi et al., ).
... Heart Rate Variability
e balance between the two reciprocal activities of the ANS (SNS and PNS) is evidenced
in the beat-to-beat changes of the cardiac cycle. HRV is concerned with the oscillation (i.e.
variability) in the interval between consecutive heart beats, which may contain indicators of
current disease, or signs about impending cardiovascular disease. It can be quantitatively and
non-invasively evaluated either by time domain or by frequency domain methods (Malliani,
). Comparisons of the sympatho-vagal balance can be made between pathological and
physiological conditions, diﬀerent types of activity (rest, exercise) and to analyse circadian
rhythms (day-night changes).
Figure .:Modiﬁed three-electrode bipolar lead system: 􏹔􏹓􏻁, 􏹔􏹞􏻁, 􏹔􏹔􏻁. Ground electrode is not shown. LA
stands for Le Arm, RA stands for Right Arm.
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Figure .:e time series of R-R intervals obtained is represented graphically as a tachogram. e horizontal axis
of the diagram indicates the time and the vertical axis shows the RR distance in msec (average of 
seconds). One data line shows the minimum and maximum RR intervals. See also Figure ..
In case of time domain HRV analysis, the so-called Normal-to-Normal (NN) intervals are
determined. ese are all intervals between normal (sinus) beats. Assuming a -hour
AECG recording, the variables that can be calculated to estimate an overall HRV are either
of statistical nature (Table .) or of geometrical nature (Table .). e list of variables
in the aforementioned tables is not exhaustive (Malik et al., ). SDNN estimates (and
similarly other HRV measures) depend on the length of the recording period. As such,
valid comparisons are only to be carried out between values derived from ECG recordings
of comparable durations.
e series of NN intervals can also be ploed accordingly to derive useful clinical correlates.
e geometrical time domain methods are derived from various approaches implemented to
characterize the variability of these plot paerns. To perform such calculations, either the
sample density distribution of NN intervals is constructed (assigning the number of equally
long NN intervals to each value of their duration) or a (D or D) Lorenz/Poincaré plot of
NN intervals (each NN interval is ploed against its next one) (Hnatkova et al., ). Such
geometrical methods require the NN intervals sequence to be appropriately binned on their
time scale to permit the construction of smoothed histograms. e reason that these bins are
Variable Units Description
SDNN msec Standard Deviation of all NN intervals
SDANN msec Standard Deviation of the Averages of NN intervalscalculated over  minutes ECG segments
RMSSD msec (Square) Root of the Mean of the Sum of the Squares ofDiﬀerences between successive NN intervals
Table .: Statistical measures of HRV used in time domain analysis.
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selected to be of approximately  milliseconds (see Table .) is simply because it corresponds
to the typical sampling frequency of commercial AECG monitors ( Hz).
Taking a step further from time domain into frequency domain analysis, spectral information
from an R-R tachogram can be decomposed and periodicities may be identiﬁed. Power spectra
of R-R variability from AECG recorders have been shown to provide markers of sympathetic
and vagal function. In humans, three main spectral components are distinguished in a Power
Spectral Density (PSD) plot (Figure .). eVery Low Frequency (VLF) component (. - .
Hz) that depends primarily on the presence of parasympathetic outﬂow (Taylor et al., ).
e Low Frequency (LF) component (. - . Hz) which is believed to be due to baroreceptor
mediated BP control and relates to both sympathetic and parasympathetic function and the
High Frequency (HF) component (. - . Hz) which is correlated with respiratory driven
vagal input to the SA node, reﬂecting parasympathetic nervous system activity (Kamath and
Fallen, ). Measurement of VLF, LF and HF power components is made in absolute values of
power (msec 􏺾). Alternatively, LF and HF speciﬁcally may also be reported in normalised units
(nu) which represent the relative value of each component in proportion to the total power
minus the VLF component (Pagani et al., ). e LF/HF ratio is an index of sympatho-vagal
balance (Lombardi et al., ). High values for the ratio suggest predominance of sympathetic
nervous activity and vice versa.
In  hour AECG recordings of normal subjects, despite the fact that LF and HF components
account for approximately only % of the total spectral power (see Figure .), these two are the
spectral components mostly referred to in literature. LF and HF can increase under diﬀerent
conditions. In healthy subjects, an increased LF is observed during ° head tilt, standing,
mental stress andmoderate exercise, whereas increased HF is induced by controlled respiration
and cold stimulation of the face (Malik et al., ).
e role of the ANS in essential HT (see Section .) is an important area of investigation. A sig-
niﬁcant amount of studies have investigated the clinical value of HRV in various cardiovascular
Variable Units Description
HRV
triangular
index
n/a
Total number of all NN intervals divided by the maximum
height of the histogram of all NN intervals measured on a
discrete scale of . msec bins (/ sec)
TINN msec
Width of the base of the triangular interpolation (the
minimum square diﬀerence is used to ﬁnd such a triangle)
of the maximum height of the histogram of all NN
intervals
Table .: Geometrical measures of HRV used in time domain analysis.
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Figure .: Power Spectral Density of the tachogram in Figure .. Horizontal axis represents frequency in Hz and
the vertical axis shows the PSD. e input range, total power, LF and HF power components and LF/HF
ratio are displayed, too. e grey vertical lines on the chart mark the VLF, LF and HF components (-.
Hz, .-. Hz, .-. Hz, respectively).
diseases, including HT. Among those studies, an increased LF component during night-time
rest has been found in hypertensives compared to normotensives, accompanied by blunting of
circadian paerns (Guzzei et al., ). Complementary evidence of reduced parasympathetic
cardiac control was found a few years later between a group of hypertensives and both normal
and borderline hypertensive groups (Langewitz et al., ).
.. CardioTens -hour ECG and BP monitoring
CardioTens (Meditech Ltd, Hungary) is a commercially available combined ambulatory BP
and ECG monitor. e device can be used either as an independent ABPM device if only
the BP cuﬀ is aached to it, or as an AECG if only the ECG electrodes are aached or as a
dual recorder incorporating both functions simultaneously. e incorporated ABPM device is
validated by the British Hypertension Society and performs within the recommendations of
the Association for the Advancement of Medical Instrumentation (Barna et al., ). It uses
a proprietary Meditech algorithm for determining BP which is equivalent to that obtained
by a trained observer using the cuﬀ/stethoscope auscultation method Korotkoﬀ phase V,
within the limits prescribed by the American National Standard for Electronic or Automated
Sphygmomanometers (White et al., ). Readings can be taken at frequent, pre-programmed
time intervals.
e AECG part of the device can perform routine AECG registration via two independent
channels, producing an ECG strip with two leads (CM􏻁 and CC􏻁) of  seconds duration
every  minutes, continuously for up to  hours. It features a sampling rate of  Hz,
adequate to precisely locate the peak of QRS complexes, and an analog-to-digital converter
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Figure .: Set-up window of the CardioVisions soware for conﬁrming correct electrode placement and checking
ECG signal in real-time. Channel A (red, white) corresponds to lead 􏹔􏹔􏻁, channel B (yellow, green)
corresponds to 􏹔􏹞􏻁 and N electrode is the ground.
of  bits. PSD processing in CardioVisions uses four-minute Hann-windowed samples. If
the input range is longer than this four-minute unit, PSD is calculated by averaging adjacent,
non-overlapping four-minute samples. Individual spectral components can be automatically
determined, together with their center frequency and associated power, i.e. area.
. Hypertension
.. Deﬁnition and Classiﬁcation of Hypertension
Diagnosis and treatment of hypertension is essentially based on the outcome of casual,
indirect BP readings, although ambulatory or BP recordings at home might eventually become
preferable to minimise the bias of white-coat HT. A systolic and/or diastolic BP measurement
persistently higher than normal values - for a given age group - is deﬁned as HT. According to
the latest and most relevant (for the European population) guidelines jointly published (Mancia
et al., ) by the European Society of Hypertension and the European Society of Cardiology,
normotensives and hypertensives are distinguished as in Table ..
Category Systolic BP (mmHg) Diastolic BP (mmHg)
Optimal < and <
Normal - and/or -
High normal (Pre-Hypertension) - and/or -
Grade  HT (mild) - and/or -
Grade  HT (moderate) - and/or -
Grade  HT (severe) ≥ and/or ≥
Table .: Classiﬁcation of HT based on BP levels in adults (Mancia et al., ). In case of SBP and DBP falling into
diﬀerent categories, the higher value is considered for classiﬁcation.
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HT diagnosed in the vast majority of the population is of an unknown cause (i.e. idiopathic).
is condition is called primary or essential HT. In both developed and developing countries,
essential hypertension aﬀects –% of the adult population, and up to –% of those
beyond their seventh decade of life (Staessen et al., ). HT in the rest of hypertensive
patients, results secondarily from renal disease, endocrine disorders, or other identiﬁable
causes and this type is called secondary hypertension.
Malignant Hypertension (MHT) is the most severe form of HT, and is deﬁned clinically as the
presence of severe hypertension in association with ocular disease (Shantsila et al., ).
.. Management of Hypertension
Guidelines have been published from the World Health Organisation and the International
Society of Hypertension on management of HT (Whitworth, ). More recently, the British
Hypertension Society working party, in light of the latest peer-reviewed publications, has also
published relevant guidelines (Williams et al., ).
Non-pharmacological strategies can reduce BP (Williams et al., ). ese entail reduction of
alcohol consumption, lowering of salt intake, adopting a diet rich in fresh fruits and vegetables
and restriction of caloric intake. Less eﬀective for BP reduction but helpful also towards
reducing cardiovascular risk in general, are regular dynamic exercise and abstaining from
smoking.
Antihypertensive drug treatment diminishes the complications of HT. e three broad classes
of drugs used to treat primary HT are diuretics (to reduce blood volume), vasodilators (to
decrease SVR), and cardioinhibitory drugs (to decrease CO). Irrespective of the mechanisms
that may operate to initiate and sustain HT, its treatment is important because it increases the
risk of further complications such as coronary artery disease, stroke and renal disease.
. Peripheral Circulation
Although the site of routine BP measurement focuses aention on the haemodynamics of large
conduit arteries, namely the brachial artery from the upper arm, it is accepted that HT is
a systemic condition involving the vascular tree as a whole. As such, various non-invasive
clinical tools have been developed to assess microvascular function and structure. Described in
the following sections are two such vascular beds that can be aﬀected by generalised systemic
disturbances or ,in fact, be the ones that undergo pathological changes prior to systemic disease:
the retinal circulation and the nailfold microcirculation.
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. e Eye
e eye is an easily accessible, transparent “window” to peripheral microvasculature that can
be examined non-invasively in vivo. Two vascular beds exist in the posterior eye; the choroidal
(part of the uveal layer) and the retinal. On one hand, retinal blood vessels supply nutrients
and oxygen to the neural retina, namely retinal ganglion cells and their axons, as well as to
the anterior part of the Optic Nerve Head (ONH). On the other hand, the choroidal plexus, is
the most perfused tissue of any other tissue in the body per unit weight (Nickla and Wallman,
). Hence, the maintenance of normal fundus vascular structure and function is of high
importance. In the following sections, retinal circulation features are described along with
current clinical and laboratory investigative techniques on retinal structure and function.
.. Retinal Vasculature
emain vessels of the eye comprise the Central Retinal Artery (CRA) and the Central Retinal
Vein (CRV). ese enter and exit the globe respectively within the ONH, bifurcate at the
optic disk into superior and inferior branches and then further divide into temporal and nasal
branches (Figure .). Mapping the retina into four quadrants yields the respective superior
temporal, superior nasal, inferior temporal and inferior nasal vessel branches. e temporal
parts of these vessel branches form the superior arcade, composed of the superior temporal
artery and vein and the inferior arcade, composed of the inferior temporal artery and vein. In
terms of fundus photography the temporal half of the retina is the target that is documented,
including the ONH and the macula (Figure .). Stokoe and Turner (Stokoe and Turner,
) reported that the temporal side of the fundus contained wider vessels and were more
predictable in their branching than the nasal one, when they were trying to obtain comparable
vessel pairs (arteries and veins) for their study.
Figure .: Normal fundus image of a le eye,
ONH centered, °.
Figure .: Normal fundus image of a right
eye, macula centered, °.
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Whilst termed retinal arteries and veins, retinal vessels aer they bifurcate for the ﬁrst time
distal to the ONH are in fact arterioles and venules respectively, if accurate terminology is
used. Namely, the CRA begins to change markedly in its structure aer passing through the
lamina cribrosa of the sclera, losing a big part of its internal elastic lamina and its muscular
coat (Scheie, ). Aer the ﬁrst bifurcation distal to the ONH, the arterioles and venules have
no elastic lamina and the muscle ﬁbers lose continuity. en, arterioles gradually branch oﬀ to
form smaller arteriole daughter vessels and terminal arterioles, which feed into the capillary
bed as they extend towards the peripheral retina. Pre-capillary arterioles and post-capillary
venules are linked through anastomotic capillaries.
.. Posterior Eye Haemodynamics
Blood circulation of the posterior eye and especially choroidal blood ﬂow depend on perfusion
pressure. Mean Ocular Perfusion Pressure (OPP) driving blood through the eye is the mean
blood pressure in the ophthalmic artery entering the orbit minus the pressure in the veins
returning to the heart. e venous pressure is approximately equal to Intraocular Pressure
(IOP), while there is a pressure drop of a factor of / between the brachial artery and the
ophthalmic artery (Pournaras et al., ), thus:
meanOPP ≃ 􏺾􏺿MABP − IOP (.)
Retinal blood vessels are not innervated; rather their dilation and constriction depend on
autoregulation (Dorion, ). e main regulators of retinal blood ﬂow are the vascular
endothelium cells, the neural and the glial cells. Experimentally, autoregulation of the retinal
microcirculation is assessed by provocation methods, which are extensively described in
Sections ... to ....
e choroid, in contrast, does not exhibit autoregulation of blood ﬂow. is, however,
does not mean that the choroid is a passive, non-reactive vascular region. An intensive
autonomous innervation by the SNS permits central regulation of the choroidal blood ﬂow.
is is important, for example, for protecting the choroid from hyperperfusion in patients with
increased BP.
. alitative Retinal Analysis
e quest for early detection of systemic vascular disease by means of ophthalmologic
examination has surely been long-lasting and is still ongoing. One of the earliest reports
“on ophthalmoscopic evidence of general arterial disease” dates back to  (Gunn, ).
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Markus Gunn ﬁrst precisely deﬁned a number of signs of the retinal vessels that are typical
of retinal arteriosclerosis and demonstrated their close relation to cerebral vascular disease.
Speciﬁcally, these signs have been further investigated by Moore (Moore, ) and comprised
of a) irregularity of the lumen of retinal arteries, b) arterial tortuosity, c) increased arteriolar
light reﬂex, d) loss of arterial wall translucency, e) venular blood ﬂow obstruction where they
are crossed by arteries (this condition was later termed as “arteriovenous nipping”) and )
retinal oedema.
.. e Keith-Wagener-Barker Classiﬁcation
By early ’s, investigators had identiﬁed two distinct types of essential HT; the benign and
the malignant form of the disease. However, it was apparent that this grouping was rather
crude and did not facilitate all cases. In , Keith et al. () aempted to relate retinal
vascular changes to survival rates in the hypertensive population aiming towards increased
accuracy of prognosis in the general population. To avoid descriptive terms that could cause
confusion, they used numbered groups. e so-called Keith-Wagener-Barker classiﬁcation
system appears in Table ..
eir results were based on identifying a combination of structural changes: qualitative retinal
observations and quantitative measurements of peripheral arterioles of the pectoralis major
muscle. e  hypertensive patients included in their study were followed up for a period of
 to  years and were grouped on the basis of the ophthalmoscopic characteristics of each
group (Table .). e resulting survival curves were distinct for each of the four groups
having a gradually increasing steepness from benign to malignant hypertension. Despite the
inherent limitations of their study, described not only by later publications (Chasis, ) but by
the authors themselves too, the Keith-Wagener-Barker classiﬁcation scheme has been widely
adapted (Walsh, ) in prognosticating for survival.
Table .: Keith-Wagener-Barker hypertension classiﬁcation system (Walsh, ).
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. antitative Retinal Analysis
.. Assessing Retinal Structure
Digital retinal images are taken by means of fundus cameras. ese images can be post-
processed in order to yield a breadth of quantitative values towards the ultimate goal of vascular
network characterisation and risk stratiﬁcation. ese quantitative metrics are discussed
below.
... Central Retinal Arteriolar, Venular Equivalent and Arterio-Venous Ratio
earteriole and venulewidths and their ratio have long been regarded as signs of hypertensive
disease (Kagan et al., ). In , Parr and Spears (Parr and Spears, a,b) paved the way
towards the long-sought transition from qualitative and subjective grading of retinal images to
quantitative and objective measurements by summarising the calibre of all retinal arteries as
the equivalent width of the CRA. at way, comparison of the arterial widths of diﬀerent eyes
was made possible, independently of the complexity and paern of branching. ey recruited
normotensive young adults and measured the diameter of all arterioles (parent-daughter pairs)
from the edge of the ONH outward to about °. e rationale behind this zone selection is
that at that distance from the optic disk the retinal arteries and veins are rather arterioles and
venules respectively (i.e. they have lost their internal elastic lamina and their muscle layer
is not continuous (Scheie, )) and according to studies (Parr, ) it has been suggested
that these vessels are more readily aﬀected from pathological conditions, like HT. en,
they investigated the relationship between individual trunk vessels and their corresponding
branches and calculated a model that best ﬁt their experimental data. Next, they conﬁrmed
their model with an independent group of subjects. is empirically derived formula calculated
the width (in μm) of a parent artery from the widths of its two branches:
W􏸀􏸑􏸓􏸄􏸑􏸘 = 􏽮(􏺼.􏻄􏻃W􏺾􏺽 + 􏺽.􏺼􏺽W􏺾􏺾 − 􏺼.􏺾􏺾W􏺽W􏺾 − 􏺽􏺼.􏻃􏻂) (.)
where W􏸀􏸑􏸓􏸄􏸑􏸘 is the parent trunk arteriole diameter, W􏺽 the narrower and W􏺾 the wider
branch. Successive calculations from the outer peripheral retina towards the ONH yielded
a single value of the width of the CRA, the Central Retinal Artery Equivalent (CRAE). is
mathematical relationship compared remarkably beer than both the sum of the widths and
the sum of the squares of the widths of all arteries entering the retina, that since that time had
been used as a measure of the general calibre of these vessels. Aer corroborating the original
Parr formula, Hubbard et al. () adapted this approach to deliver an analogous formula for
venules that calculated the width (in μm) of a parent vein from the widths of its two branches:
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W􏸕􏸄􏸈􏸍 = 􏽮(􏺼.􏻃􏺾W􏺾􏺽 + 􏺼.􏻅􏺽W􏺾􏺾 + 􏻀􏻁􏺼.􏺼􏻁) (.)
where, respectively, W􏸕􏸄􏸈􏸍 is the parent trunk venule diameter, W􏺽 the narrower and W􏺾 the
wider branch. Likewise, the general venular calibre is summarised in a value termed the Central
Retinal Vein Equivalent (CRVE). Hence, the Arterio-Venous Ratio (AVR) could be obtained as
per following equation:
AVR = CRAECRVE (.)
AVR is dimensionless, thus has advantages over absolute vessel width measurements. Apart
from the fact that - by deﬁnition - it represents a generalised vessel calibre, rather than
isolated vessel diameters, it additionally does not require to take into consideration any scaling
diﬀerences between diﬀerent refractive errors of eyes, as these are cancelled out. Correction
for refraction is surely important for quantifying absolute retinal vessel widths without errors,
but this is not the case when using the AVR (Wong et al., ; Paon et al., ).
Hubbard and his colleagues modiﬁed Parr’s methodology in a way to make it more aractive
to use in large population studies, like the Atherosclerosis Risk In Communities (ARIC) study
(Hubbard et al., ) in which they ﬁrst tested its validity and reproducibility. ey ﬁrst
deﬁned a ring-shaped measurement zone, concentric to the optic disk and half to one Disk
Diameter (DD) away from it (Figure .). en, instead of identifying the pairs of every branch
vessel and the corresponding parent trunk as in the Parr method, they arbitrarily matched the
largest vessel with the smallest one, then the next largest with the next smallest and so on,
until all vessels coursing through that measurement zone were accounted for and the central
retinal equivalents (CRAE, CRVE) were calculated and from these, AVR. In case the number of
vessels to be combined is odd, the remaining single vessel is carried on to the next iteration.
A comparison between the modiﬁed ARIC method with the original Parr method showed no
statistically signiﬁcant diﬀerences between AVR values, hence its use was deemed appropriate.
Four years later, Knudtson et al. (), essentially members of the previous ARIC study,
suggested revised formulæ, as well as methodology, for summarising retinal vessel diameters,
proving their superiority over the Parr-Hubbard formulæ and methodology. e major
advantage of the revised formulæ over the previous ones is that they do not contain constant
values, thus can be solved for various measurement units (eg. number of pixels) and are not
constrained for vessel widths in micrometers only, being virtually independent of image scale.
Regarding the methodology, instead of measuring all vessels lying within the measurement
zone, they only include the six largest of them in their formulæ. Investigating the relationship
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Figure .: Concentric AVR measurement rings as deﬁned by the ARIC study (Hubbard et al., ). e grid is
composed of three circles concentric with the ONH: the innermost circumscribing the average optic
disc, the middle one including the area from the disc margin to half DD from the margin and the outer
one including the area from half DD to  DD from the disc margin.
between the number of vessels taken into the measurements and the resulting CRAE and CRVE
they found a strong increasing trend that falsiﬁed the ﬁnal result. erefore, restricting the
measured vessels at six at all times their methodology proved more robust and at the same
time reduced the process time of the calculations. Several studies implemented the use of
these revised formulæ (Taarnhøj et al., ; Cheung et al., ).
Of course, the various approaches of diﬀerent investigators are not ceasing to evolve, complic-
ating the quest for standardisation. Paon et al. (Paon et al., ) proposed another revised
formula that incorporates an asymmetry factor of the retinal arteriolar branching. Various
formulæ for calculating AVR have been tested and compared (Hemminki et al., ) and more
recently newer methods have emerged as well that incorporate extended measurement zones
(Cheung et al., ).
... Vessel Tortuosity Index
In healthy subjects, blood vessels follow a fairly straight course or are only slightly, in an
arc-fashion, curved. One can ﬁnd diﬀerent deﬁnitions of tortuosity indices in the literature
(Kalitzeos et al., ). e most easily implemented and widely used, the tortuosity index, T,
is calculated as the ratio of the actual length of the vessel segment L (arc length) to the straight
line distance between two branching points, D (chord length).
T = LD (.)
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e bending of a vessel inﬂuences its local ﬂow haemodynamics and may result in adverse
clinical consequences. us, quantifying tortuosity could be used as an indicator of retinal
morphological changes, either on a local extent if speciﬁc vessels are chosen or globally if the
total vascular tree is analysed.
Early investigations (Moore, ) on the signs of arteriosclerosis were rather contained in
including tortuosity of the arteries as one of them, because of its wide variability under
physiological conditions and its rare occurrence. Various theories have been described
(Bracher, ) and tube models tested (Kylstra et al., ) to try to elucidate the aetiology
of vessel tortuosity. In vascular disease the vessel wall loses its elasticity and the lumen is
narrowed, impeding blood ﬂow, as previously described (Section ...). As a result of the force
of BP upon a tube which has lost its carrying power, the vessel then becomes tortuous (Bracher,
; Gunn, ). Leatham (Leatham, ) stated that tortuosity of retinal arterioles was not
believed to be a sign of hypertension because it occurred randomly in both aged, normotensives
individuals as well as hypertensives. Adding to the uncertainty of accessing general vessel
tortuosity during ophthalmoscopy, the subjective characterisation such as “not noticeably
tortuous”, “moderately tortuous” and “markedly tortuous”wasmaking its usefulness evenmore
dubious.
Later investigators incorporated manipulation of fundus photographs with the use of bulky,
but quite accurate devices such as proﬁle projectors (Lotmar et al., ). Absolute and relative
measurement of retinal arterial tortuosity was made possible by subdividing a vessel into a
series of circular arcs of individual curvature andmeasuring the chord lengths and arrow height
of these arcs. e sequence of chords is considered to represent the vessel in its “non-twisted”
form. It is easy to understand that such a technique was entirely manual to perform, thus
time-consuming, error-prone and diﬃcult to reproduce. Others (Kylstra et al., ) deﬁned
tortuosity as merely the sum of the height of the arcs that make up the tortuous vessel.
e course of arterioles from projected fundus images on a digitising table was measured from
two normotensive age groups (Williams, ). Measurement of a single arteriole (∼mm long),
representative of all arterioles in the posterior pole region was performed by calculating the
distance of its actual path length and the distance of the line connecting its ﬁrst and last point.
e tortuosity index is the ratio between them as previously mentioned (Equation (.)). An
absolutely straight vessel would have an index of , whereas one that has an actual course %
longer than its straight line course would have a tortuosity of .. Diﬀerences between old and
young age groups were not signiﬁcant and other investigators conﬁrmed the same outcome
(Taarnhøj et al., ), although their methodology diﬀered signiﬁcantly.
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e above deﬁnition of the tortuosity index has been described as unsuitable for its weakness
to distinguish between vessels with equal path lengths and diﬀerent degree of bending, so a
number of novel indices have been proposed (Azegrouz et al., ; Dougherty and Varro, ;
Hart et al., ). Advances in computer-assisted methods (Wallace, ; Cheung et al., ;
Dougherty et al., ) have pushed current methodologies forward and qualitative studies are
currently an exception to the rule (Taarnhøj et al., ).
... Bifurcation Angles and Junction Exponents
A vessel branching can be described geometrically in terms of its junction exponent, x, and its
bifurcation angle ω, which is the angle between two daughter vessels. e junction exponent
provides an index of the relative widths of the parent d􏺼 and daughter d􏺽, d􏺾 vessels through
the equation:
d􏸗􏺼 = d􏸗􏺽 + d􏸗􏺾 (.)
where d􏺽 is the wider branch and d􏺾 the narrower one. It has been suggested that, in an
“ideal” vascular network, there is an optimal way that vessels at bifurcation junctions can be
interconnected, in order for fastest transport of blood to be achieved for the least amount of
biological work (Murray, ). In other words, it is implied that deviations from optimal
vascular architecture may be associated with vascular damage. ese theoretical, optimal
values were calculated to be x = 􏺿 and ω̂ ≃ 􏻃􏻁°, so Equation (.) is wrien:
d􏺿􏺼 = d􏺿􏺽 + d􏺿􏺾 (.)
Assumptions made when deriving Equation (.) include laminar blood ﬂow and constant
blood viscosity. Comparison of experimental results to theoretical values have followed,
although in scarce numbers. Zamir and colleagues (Zamir et al., ) introduced two non-
dimensional parameters in order to make comparisons of relative diameters of branches rather
than absolute diameters: the area ratio β and the asymmetry ratio α; in that way diﬀerences
of magniﬁcation between images was not an issue. Even so, results followed the trend of the
theoretical values, but scaered signiﬁcantly.
Few studies have considered comparing healthy subjects with hypertensives. Average bifurc-
ation angles from both normotensives and hypertensives varied considerably from theoretical
values (Stanton et al., ), but at the same time the sample size was small and only arteries
were measured. Bifurcation angle values declined with increasing age. Regarding junction
exponents, both groups had similar values, declined with age and were always smaller than the
theoretical value of . Another study’s results (Houben et al., ), followed an almost identical
trend for arterial bifurcation angles between hypertensives and normals showing signiﬁcant
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diﬀerences. eir aempt to measure vein bifurcation angles as well, yielded insigniﬁcant
diﬀerences.
In a rather small sample, the eﬀect of oxygen and carbon dioxide inhalation was tested in
normotensives and hypertensives (Chapman et al., ). Neither bifurcation angles, nor
junction exponents diﬀered signiﬁcantly between the two BP groups and parent arteriolar
diameters were comparable. Hypertensive patients had a less marked arteriolar constriction
when breathing oxygen than controls and breathing carbon dioxide resulted in increased
arteriolar diameters in healthy subjects, but not in the hypertensive group. No alterations
in junction exponents in either groups were noted.
Comparison of branching angles between individuals with atherosclerosis and healthy subjects
showed no signiﬁcant diﬀerence (Chapman et al., ). Instead of using junction exponents,
the same group introduced a novel optimality parameter that performed beer in terms of
reliability and showed signiﬁcant diﬀerence between the two groups. Recently, another study
(Wi et al., ) proposed a parameter referred to as optimality ratio, that appears promising.
... Length-to-Diameter Ratio
e Length-to-Diameter Ratio (LDR) is another structural, dimensionless quantity that may
describe the retinal vascular bed. As the name suggests, it is deﬁned as the ratio of the length
of a vessel, between two branching points, to its diameter over that segment (King et al., ).
Its clinical usefulness has not been extensively assessed as yet (Chapman et al., ; Hughes
et al., ).
.. Assessing Retinal Vessel Dynamics
All structural parameters described in the previous sections are extracted from measurements
based on static fundus images which essentially are a snapshot of the constantly changing
retinal circulation. e opportunity to monitor microvasculature over a period of time might
elucidate more complex functional principles.
... Retinal Vessel Analyser
e Retinal Vessel Analyser (RVA) is a commercially available (Imedos Systems, Germany)
ophthalmoscopic instrument capable of acquiring vessel diameter ﬂuctuations in real time.
ese diameter changes happen physiologically due to the pulsatile nature of blood ﬂow and
additionally may be altered by means of external provocation. RVA comprises a mydriatic
fundus camera, a Charged-Coupled Device (CCD) video camera and a personal computer that
uses dedicated soware to control and adjust the measurement parameters. Versatility is a
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key aspect of RVA, being easily extendible with a ﬂicker module for vascular reactivity testing
(Section ...), an oxygen module for Oxygen Saturation (OSat) mapping (Section ..), an
electrocardiograph or a BP monitoring interface for synchronisation with the cardiac cycle
(Blum et al., ) andwith a video recorder for oﬄine post-processing of the recorded sessions.
At the system’s heart is a Carl Zeiss FF􏻀􏻁􏺼􏸏􏸋􏸔􏸒 mydriatic fundus camera capable of acquiring
both full color and red-free (- nm) retinal images °, ° or ° wide. Still images
can be recorded at a resolution of × pixels, while video sequences are displayed at
a lower resolution of × pixels. To achieve an optimum contrast for visualisation of the
retinal blood vessels a special green ﬁlter is intercepted in the illumination pathway of the
fundus camera. us, green light enters the subject’s eye via its pharmacologically dilated
pupil. Since, retinal blood vessels containing haemoglobin have diﬀerent absorption spectra
from the surrounding tissue, the integrated vessel tracker registers with the red blood cells
column and follows it throughout the course of timemaking both temporal and spatial diameter
analysis possible. Consequently, a data matrix of vessels’ diameters is obtained at the end
of a measuring session. Temporal resolution of the RVA system is  msec (i.e.  diameter
readings per second), while spatially it assesses one mean diameter value every  Measuring
Units (MU); where one MU corresponds to one micron for the standard Gullstrand eye and
assuming relaxed accommodation. Calculation of relative values, for example baseline versus
stimulation values, minimises the inﬂuence of deviation of individual eyes from the Gullstrand
eye model, as well as from optical errors.
Although subject compliance is crucial for taking quality measurements, small eye and/or
head movements, as well as transient shadows or reﬂections are unavoidable. To overcome
these practical issues, the RVA encompasses adaptive algorithms that can compensate for a
reasonable amount of such disturbances (Muench et al., ). e view obtained from the
fundus camera is simultaneously acquired from the -CCD video camera (JVC, KY-FBU),
displayed on the computer’s monitor and optionally recorded on video tape at the same time.
Regarding continuous baseline vessel diameter recordings, short term and day to day repro-
ducibility of the RVA system have been found to be higher for veins than arteries for a ﬁve
minute long measurement session (Polak et al., ). Nevertheless, short term reproducibility
was reported to be excellent with Intraclass Correlation Coeﬃcient (ICC) values of .
for veins and . for arteries and slightly lower for day to day sessions (. and .,
respectively). Similarly high reproducibility values for baseline (i.e. constant illumination)
diameter measurements have been reported a few years later as well (Pache et al., ).
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... Flier Provocation
Contrary to extraocular blood vessels, intraocular retinal vessels are not innervated (Brown and
Jampol, ), thus depend on local autoregulatory factors for actively regulating blood ﬂow
(see Section ..). e autoregulation mechanism, that maintains constant blood ﬂow despite
changes in arterial perfusion pressure or metabolic demands of the surrounding tissue, is an
undoubtful and well documented phenomenon (Johnson, ). Retinal vessels are capable
of responding to such changes by either vasodilation or vasoconstriction, accordingly (see
Section ..). Despite the complex association between endothelial function and Cardio-
Vascular Disease (CVD) progress (Luscher, ), impaired retinal vascular reactivity has been
described in a number of pathological conditions; hypertension amongst them (Panza et al.,
; Delles et al., ).
Following animal studies, Formaz and collaborators (Formaz et al., ) proved an increase in
retinal vessel diameters induced by diﬀuse luminance ﬂicker illumination in the human retina.
Since then, many studies have exploited retinal ﬂicker provocation as a tool to assess vascular
reactivity in health and disease (Heitmar and Summers, ). Interrupting the illumination
path of the RVA system with an optoelectronic shuer, light is modulated with a rectangular
bright-dark (on/o) wave to produce a ﬂicker stimulus over the entire ° angle ﬁeld of the
camera. is ﬂicker stimulus has a . Hz frequency, well within the range of frequencies (-
 Hz) where the human visual system’s sensitivity for luminance ﬂicker is at its maximum
(Lee et al., ). For a PAL standard CCD video camera of a frame rate of  Hz, every other
frame is a dark image, thus halving the amount of collected data points during the ﬂicker cycles.
Across literature there are reports of various ﬂicker protocols being implemented. Prior
to the adaptation of the embedded RVA ﬂicker module, research groups used their own
implementations of external ﬂicker stimuli (Polak et al., ). ese used not only diﬀerent
ﬂicker frequencies ( Hz), but also diﬀerent baseline/ﬂicker durations and amount of ﬂicker
repeats. Since , the standard and most widely used ﬂicker protocol is the one shown in
Figure ., using the . Hz ﬂicker frequency. Starting oﬀ with a baseline of  seconds, the
ﬁrst ﬂicker period of  seconds starts. e paern of  seconds of recovery (i.e. baseline
illumination) and  seconds of ﬂicker is then repeated two times and the measurement
concludes at the  seconds mark, or put diﬀerently, in ﬁve minutes and ﬁy seconds.
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Figure .: Schematic representation of the standard ﬂicker measurement protocol.
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For practical reasons of avoiding artiﬁcially variable baseline vessel diameters, it is common
practice to discard the ﬁrst  seconds of every measurement session from subsequent analysis.
A typical response of a pair of retinal vessels to the RVA ﬂicker session is shown in Figure ..
Arteries and veins follow distinct reaction paths, owing to the functional and structural
diﬀerences between each vessel type. For the artery, with each ﬂicker initiation the vessel
responds with vasodilatition, relying on the principles of neurovascular coupling (Riva et al.,
). Aer ﬂicker cessation, artery diameter decreases below baseline values (reactive
constriction) and returns to the range of initial diameter values approximately - seconds
post ﬂicker cessation. Essentially, the choice of  seconds ﬂicker duration and  seconds
of recovery time thereaer is empirically based on a compromise between gaining a marked
vessel response and allowing enough time to vessels for their diameters to return back to initial
values (Nagel et al., ). Veins, on the other hand, do not undergo a constriction phase as
arteries do and additionally show a sustained vasodilation phase, characteristic of their larger
vessel compliance and their nature of being reservoir vessels.
... Dynamic Response Analysis
Analysis of the retinal arteriolar and venular responses similar to the one in Figure . can
be performed either by utilising the RVA soware-generated output or by independently
processing raw data. e RVA soware summarises the three ﬂicker provocations into one
average and reports the following four parameters: A􏸌􏸀􏸗, A􏸌􏸈􏸍, A􏸏􏸄􏸀􏸊 (maximum arterial
dilation, constriction and diﬀerence between the two, respectively) and V􏸌􏸀􏸗 (maximum
venular dilation). For statistical purposes, these responses are calculated from an arbitrarily
chosen time window, that encompasses  seconds:  seconds before ﬂicker cessation and
 seconds aer (Kotliar et al., ). en, the soware automatically generates a report,
classifying the vessel responses according to values from Table ., as “normal”, “narrowed”,
“unremarkable” or “undetectable” reaction.
Arteries Normal Mean Normal Standard Deviation (SD)
A􏸌􏸀􏸗 (%) . ±.
A􏸌􏸈􏸍 (%) -. ±.
A􏸏􏸄􏸀􏸊 (%) . ±
Veins
V􏸌􏸀􏸗 (%) . ±.
Table .: Classiﬁcation scheme of vessel response to ﬂicker used by the in-built RVA soware. Based on these
values (Nagel et al., ), RVA generates a report of a “normal”, “narrowed”, “unremarkable” or
“undetectable” reaction.
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Figure .: A typical, normal arterial (red) and venular (blue) response from ﬂicker provocation following the
standard protocol shown in Figure .. Doed vertical lines indicate the presence of the ﬂicker
stimulus. e ﬁrst  seconds have been discarded prior to ploing the graphs.
In terms of analysing raw data output independently of the RVA soware, there are various
approaches as well as measurement parameters calculated. e basic distinction between
approaches is choosing to report on an averaged response across all three (or as many as
possible) ﬂicker repeats or choosing to analyse them separately. Irrespectively of that choice,
the parameters used to characterise an arteriolar and venular response to ﬂicker provocation
are the following:
• Baseline Diameter Fluctuation (BDF), the maximum amplitude (peak-to-peak) for arteri-
oles and venules,  seconds prior to (each) ﬂicker start
• Maximum Dilation (MD), the maximum -second diameter for arterioles and venules,
within  seconds aer (each) ﬂicker start
• Maximum Constriction (MC), the minimum -second diameter for arterioles, within 
seconds aer (each) ﬂicker start
• Dilation Amplitude (DA), the diﬀerence between MD and MC for arterioles
• Baseline-Corrected Flicker Response (bFR), the diﬀerence between DA and BDF for
arterioles (Nagel et al., )
• Reaction Time (RT), the time needed (in seconds) to reach MD for arterioles and venules
• Constriction Time (CT), the time needed (in seconds) to reach MC for arterioles
• ΔD, the diﬀerence between MD and the -second vessel diameter prior to ﬂicker start
for arterioles or venules (a measure of vessel dilatory capacity) (Heitmar et al., )
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• Average Peak Ratio (APR), the ratio of DA over BDF for arterioles (a measure of vessel
elasticity) (Heitmar et al., a)
All diameter values are reported as a % change (i.e. normalised) to the initial (i.e. prior to the
ﬁrst ﬂicker) mean baseline diameter. Similarly to the MD and MC parameters, others have
deﬁned a  seconds time window (calculating the median), i.e.  seconds before and  seconds
aer the time point of the maximum/minimum dilation/constriction diameter and have termed
it “meanmaximal dilation/constriction”, respectively (Kotliar et al., b). Also, the area under
the reaction curve during baseline and during/aer ﬂicker has been calculated, essentially
providing an average diameter (Gugleta et al., ).
... Other External Provocations
e ﬁrst report on the results of external provocation with the RVA system by means of
isometric exercise was performed in  (Blum et al., ) on  healthy volunteers with
encouraging results for the feasibility of retinal functional assessment. Other techniques that
temporarily alter retinal blood ﬂow to assess vascular reactivity include the use of an oculo-
oscillo dynamograph (Nagel and Vilser, ; Kotliar et al., ) and gas mixtures inhalation
(Blum et al., ; Kiss et al., ; Resch et al., ; Wimpissinger et al., ; Jean-Louis
et al., ). A combination of stimulation techniques is also possible; performing an isometric
exercise (Bek et al., ; Jensen et al., ) or temporarily elevating IOP by means of an
episcleral suction cup (Garhöfer et al., ) and at the same time stimulating the retina with
ﬂickering light.
.. Retinal Oximetry
Measurement of retinal oxygen consumptionmay provide important clinical information about
the metabolic state of the retina. Diﬀerences between the oxygen delivered to the retina via
arterioles and drained away from it via venules can be quantiﬁed, if the total OSat in these
vessels is measured. Such information can be used to complement our understanding on retinal
function in health and disease.
Dual-wavelength oximetry uses digitally recorded retinal images obtained simultaneously at
two distinct wavelengths to determine retinal vessel OSat. A dual band-pass ﬁlter at a sensitive
( nm) and a non-sensitive ( nm, isosbestic) wavelength is replacing the optoelectronic
shuer in the previously described RVA camera system (Section ...). Oxyhemoglobin
(HbO􏺾) and deoxyhemoglobin (Hb) absorb light equally at the isosbestic wavelength, whereas
there is a considerable absorbance variation at the sensitive wavelength. Since it is practically
impossible to measure neither transmiance nor absorption of light in the retina, in order

 Overview of principal literature
to determine OSat, reﬂection must be exploited instead. us, Optical Density (OD) can be
calculated based on the retinal reﬂectance of the retinal vessels (I􏸈􏸍􏸓) and that of the surrounding
tissue (I􏸄􏸗􏸓), measured as grayscale pixel values:
OD = logI􏸄􏸗􏸓I􏸈􏸍􏸓
(.)
e Optical Density Ratio (ODR) is the ratio between the ODs of the two sampled wavelengths,
which has been found to be linearly related to OSat aer compensation for vessel diameter and
fundus pigmentation (Hammer et al., ). Reliability and reproducibility of the technique has
been recently evaluated in healthy volunteers with promising results (Lasta et al., ; Man
et al., ).
.. Visual Field Testing
Visual Field (VF) testing (or else perimetry) is an additional ancillary test for following func-
tional changes of many retinal diseases, alongside its frequent use in glaucoma management
and in diagnosis of neurological disorders. Static automated perimetry is the most common
method of clinical VF testing. It involves determining the dimmest stimulus that can be seen at
a series of pre-determined test point locations. e Humphrey Field Analyser II (Carl Zeiss
Meditec, Germany) is an advanced, commercially available perimeter intended to identify
visual ﬁeld defects. It incorporates widely accepted testing algorithms, especially the Swedish
Interactive resholding Algorithm (SITA), which oﬀer very high accuracy and a relatively
short test time. e test of choice for examining the central visual ﬁeld is the - SITA
Standard paern which comprises  test point locations covering the central ° ﬁeld with
a grid of points ° apart. Two quantitative global indices that summarise visual ﬁeld status
are the mean deviation and the paern standard deviation, both measured in decibels. e
former shows how much, on average, the whole ﬁeld deviates from normal while the laer
reﬂects irregularities in the ﬁeld, such as those caused by localised defects. ese can be used
in research to sort eyes into groups of varying disease states.
. Nailfold Capillaroscopy
Structural evaluation of the morphology, distribution and number of capillaries is deemed
necessary to investigate microvessel rarefaction at a peripheral level. Capillary rarefaction
occurs in many tissues in patients with essential HT and has been shown to contribute to
an increased peripheral vascular resistance (Serne et al., ). It is yet unknown whether
abnormalities in these vessels are a cause or consequence of elevated BP (Noon et al., ).
Rarefaction may be caused by a structural (anatomic) lack of capillaries, functional non-
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perfusion, or both. Conjuctival (Harper et al., ) and nailfold (Noon et al., ; Antonios
et al., ) capillary density have been found signiﬁcantly smaller in hypertensives than in
normotensives. Common techniques used to assess cutaneous microvascular function include
capillaroscopy, venous occlusion plethysmography, and laser Doppler anemometry (Yvonne-
Tee et al., ).
e nailfold plexus is one of only a few locations on the human body where capillaries advance
close enough to the skin surface to become easily detectable in vivo. ey lie in hairpin-like
loops parallel to the skin surface. Each loop consist of an arterial and a venous limb. Using
laser Doppler anemometry blood cell velocities can be measured within single skin capillaries,
not only from the nailfold area, but also in the sublingual and lip skin. Of course, the nailfold
area causes no discomfort to the patient and is easier to minimise involuntary movements, thus
it is the preferred microvascular sampling site.
.. Measurement Principle
When a narrow beam of laser light is focused onto an arterial or venous limb of a capillary
loop, a fraction of the laser light is backscaered by red blood cells, shiing the frequency
of light according to the Doppler eﬀect. e frequency shi is directly proportional to the
speed of the blood column. Impaired haemodynamic paerns and functional activity of the
nailfold capillaries have been reported aer topical temporary cooling of the area. e test is
being performed by rapidly decompressing CO􏺾 and directing it to the ﬁngertip by means of a
tube. e nailfold capillaries are being observed and blood velocity is recorded before, during
and aer the cooling phase. Flow stop is deﬁned as velocity below . mm/sec for longer
than  seconds (Mahler et al., ). Prolonged stop of ﬂow, a condition termed vasospasm,
characterised hypertensives contrary to normotensives in a study (Gasser and Bühler, ).
is ﬁnding has been interpreted as a reduced functional reserve at a capillary level in HT.
.. CapiScope Capillaroscopy System
e CAM Laser Doppler Capillary Anemometer (KK Technology, England) is a commercially
available video capillaroscopy system that can measure blood cell velocity (Stücker et al., ).
It uses a low power, near-infrared ( nm) laser for detecting the necessary Doppler shi. e
use of this wavelength has several advantages: it exhibits a deeper penetration depth, the
measurement is less aﬀected by the oxygenation of blood and it is also less dependent on skin
color, as melanin has a low absorption in the near-infrared. Actual sample depth is typically
less than 􏺽􏺼􏺼μm. e laser beam is focused via the objective down to a  microns diameter
spot in the centre of the ﬁeld of view. Illumination is provided by  LEDs emiing green light
( nm) to maximize the contrast between the erythrocytes and the surrounding tissue. A
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CCD camera (Model XC-CE, Sony, Japan) needs to be focused so that the object plane and
the laser focal point match to get a clear view. e camera output is fed to a computer monitor.
e CAM system provides an approximately× magniﬁed image of the nailfold plexus with
a resolution of × pixels. e device can be positioned appropriately onto the limb of a
capillary loop using an XYZ micropositioner stage. e laser beam is reﬂected by blood cells
at the focal point moving parallel to the tissue surface. is gives the laser light a Doppler shi
directly proportional to the velocity of the reﬂecting blood cells. Acoustic feedback control
with sound from the Doppler shi provides real time audible cues via the computer speakers
during the entire measurement. is allows the operator to obtain the point of maximum signal
strength more readily. e Doppler shied laser signal is collected by the objective and internal
optoelectronics and processed in real time by means of the accompanied CapiScope soware
producing a velocity trace (in absolute units of mm/s). is system can be used to measure
velocities ranging from . to . mm/s. e velocity trace can be saved along with an image
or video sequence of the capillary being measured, onto the hard drive of the computer, for
oﬄine post-processing.
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Retinal Vessel Analyser: Reproducibility
. Baground
During the early years of introduction of the RVA (Chapter ) into the scientiﬁc seing, it
was merely used to observe and record retinal vessel diameters under constant illumination
(baseline conditions) over time. A few studies, as mentioned in Section ..., have reported on
the device’s reproducibility and sensitivity under such conditions with excellent results. How-
ever, with the introduction of ﬂicker stimulation and the possibility to probe retinal reactivity,
a completely diﬀerent regime of measurements (dynamic reaction) was characterising RVA’s
main function. Unfortunately, subsequent studies utilising ﬂicker measurements described the
accuracy of the system by referring to the reproducibility and sensitivity of the non-relevant
early studies.
Studies actually reporting on reproducibility of the ﬂicker responses are either irrelevant to
the current hardware and protocol or incomplete. An early study reported Coeﬃcient of
Variation (CV) values of % but it was unclearwhether this was for arteries, veins, or combined
(Polak et al., ). A later study reported CV values of .% for arteries and .% for
veins (Garhöfer et al., ). However, both studies at that time were using a prototype RVA
system and a ﬂicker frequency of  Hz. Nagel et al. (a) were the ﬁrst to report short-
term ( hour) and long-term ( month) variability of ﬂicker responses but had the following
limitations: they measured only one parameter (maximum vessel dilation), they did not state
how they deﬁned that parameter and also they averaged responses over the three ﬂicker cycles
within each session. Reproducibility of the values calculated with the inbuilt RVA analysis have
been reported in healthy Asian individuals (Nguyen et al., ) using non-standard measures
(Pearson correlation coeﬃcients). e only report - using the current RVA system and the
current protocol - on CV values among both baseline and reaction diameters has been published
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only recently, with low CV values for MD and MC and moderate CV values for RT (Heitmar
et al., ).
.. Motivation and Resear Rationale
e RVA in its current implementation is a fairly new research tool in retinal functional
assessment since it was introduced no earlier than  (Nagel et al., a). A few years
later, several experts in the ﬁeld published a feature review on the RVA and its applicability,
highlighting several “unresolved open questions” (Garhöfer et al., ). e insuﬃciency of
reproducibility data of ﬂicker responses was the main one.
e nature of such measurements, being related to microvasculature haemodynamics, is
inherently variable. us, protocols should be strictly adhered to and standardisation pro-
cedures should always be meticulously observed. Otherwise, external factors might mask or
exaggerate the true ﬂicker responses. On that basis, detailed reproducibility analysis by means
of the ICC is performed: comparisons between examiners are reported for the ﬁrst time and
the intraobserver (or else intersession) reproducibility analysis from Heitmar et al. () is
expanded upon with a greater amount of parameters tested across arteries and veins on a
ﬂicker per ﬂicker breakdown, as well as on averaged ﬂicker cycles.
Lastly, the vendor-generated ﬂicker-reaction report classiﬁes responses according to an ob-
solete ﬂicker protocol (Nagel et al., ) and its inbuilt parameters are deﬁned on a rather
narrow time window of  seconds ( seconds prior to ﬂicker cessation and  seconds aer)
(Section ...). Recent studies utilising diﬀerent parameter deﬁnitions (Heitmar et al., )
have reported values of maximum dilation and/or constriction to be occurring outside this time
frame, thus rendering the appropriateness of the RVA-generated parameters ambivalent. us,
comparison between the inbuilt and independent analysis output is being performed.
.. Aims
e aims of this study were the following:
• to quantify and test the interobserver and intraobserver reproducibility of the RVA
system for the independently analysed dynamic retinal vessel reactivity parameters
(BDF, DA, MD, MC, bFR, ΔD, APR, RT, CT) on a per ﬂicker analysis.
• to quantify and test the reproducibility of the inbuilt soware-generated parameters of
A􏸌􏸀􏸗,A􏸌􏸈􏸍,A􏸏􏸄􏸀􏸊 and V􏸌􏸀􏸗 and to compare them with their counterparts: arterial MD,
MC, DA and venular MD, respectively.
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• to quantify the static retinal vessel parameters of tortuosity, branching angles and AVR
as processed from fundus photos obtained with the same RVA system.
. Subjects and Methods
.. Interobserver Reproducibility
Measurements were performed by two Examiners for  healthy volunteers ( males,  females)
under identical conditions. Both Examiners had comparable experience with the RVA device
and adhered to the detailed protocol described in Section ... e sequence of data collection
between Examiner  and Examiner  was arbitrarily selected. A break of at least ﬁve minutes
was allowed between the two sessions per subject. All measurements took place within 
months.
.. Intraobserver Reproducibility
Measurements were performed by a single examiner for  healthy volunteers ( males,
 females) on two occasions under identical conditions. All measurements adhered to the
detailed protocol described in Section ...
.. Standardisations Applied
e vessel length selection was governed by each individual’s angioarchitecture, but was
always kept as long as possible. Nevertheless, when selecting vessel segments for a meas-
urement in real time, no two pairs can be selected to be precisely equally long. us, in
order to standardise comparisons and to eliminate potential inﬂuence of the segment length
measured between examiners (interobserver reproducibility study) as well as between sessions
(intraobserver reproducibility study) the following procedure was followed: for every pair of
vessel segments that underwent comparison, the longer one was truncated to exactly the same
length as the shorter one. is was possible by processing the raw data matrix output of the
RVA. Moreover, for the repeated measurement throughout the intraobserver reproducibility
study, the repetition feature of the soware was used, which automatically measures exactly
the same location as in the previous one. In some cases this was not possible due to registration
issues, but the location was manually matched as closely as possible.
.. Inclusion and Exclusion Criteria
All participants conformed with the following criteria:
• aged at least  years old
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• had no history of systemic disease or any current relevant manifestation
• were medication-free
• had clear optical media
• had no history of epilepsy
ey were given a minimum of  hours to decide on their participation and to ask any
questions, aer receiving a wrien description of the study protocol. e tenets of the
Declaration of Helsinki were observed, and institutional review board approval was granted.
Wrien informed consent was obtained from every participant prior to the measurements.
.. Study Protocol
At least  hours prior to their morning visits, participants were asked to abstain from smoking,
from consuming products containing alcohol or caﬀeine, as well as from taking up any sort of
considerable physical activity, whereas they were instructed not to fast. Room temperature
was maintained constant during all measurements (- ℃).
... Intraocular Pressure Measurement
Non-contact tonometry was performed to assess IOP by means of a validated (Ogbuehi and
Almubrad, ) device (Pulsair EasyEye, Keeler Ltd., UK). ree readings were obtained from
each eye and the average value was recorded.
... Blood Pressure and Pulse Assessment
All participants remained seated for at least  minutes to ensure stable haemodynamic
conditions prior to the start of the examination. BP was measured from the brachial artery of
the forearm using a validated (Rogoza et al., ), automated oscillometric digital BP monitor
(UA-, A&D Instruments Ltd., UK). ree consecutive readings of SBP, DBP and HR were
recorded. MABP was calculated as previously deﬁned (Equation (.)).
... Retinal Vessel Functional Assessment
Details on the measuring principle of the RVA have been described earlier (Section ...).
One arbitrarily selected eye was examined. One drop of Tropicamide (% w/v, Bausch & Lomb,
UK) was instilled to achieve pupil dilation necessary for geing unobstructed view of the
posterior pole. As soon as full pupil dilationwas reached, the dynamic retinal vessel assessment
commenced. e fellow eye was covered to achieve good ﬁxation. During the examination,
subjects were encouraged to blink normally (to maintain a suﬃciently wet cornea) and to
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maintain steady ﬁxation at the internal target, the tip of a needle. is was placed accordingly
in order to position the desired vessel segments centrally as viewed on the computer monitor.
e measurement location selected was - DD away from the ONH (Garhöfer et al., )
(Figure .). First, the arterial vessel segment was selected, then the venular one and as soon
as the soware registered successfully the corresponding positions the measurement session
started automatically. In case the contrast between the vessels and the background tissue was
not adequate, or other degradations aﬀecting video quality appeared, the measurement was
aborted and restarted. e standard ﬂicker protocol of  seconds baseline,  seconds ﬂicker
and  seconds of recovery was applied (Figure .). e soware used throughout the data
capturing sessions was the vendor-supplied Retinal Vessel Analyser (V...).
... Retinal Vessel Structural Assessment
Following the RVA assessment, the camera was set to take monochromatic and color fundus
images from the same, previously dilated eye. e vendor-supplied soware - Visualis
(V...) - was used for capturing the fundus photos. A series of images were obtained
as follows:
• for AVR calculation: one monochromatic image with the ONH centered at ° and one
color RGB image (for reference)
• for tortuosity and branching angles: onemonochromatic imagewith themacula centered
at ° that included the superotemporal and inferotemporal quadrants
e desired topology was achieved by instructing the subject to follow a blinking red ﬁxation
Light-emiing Diode (LED) light with the fellow, unobstructed eye. e images were digitally
stored in Tagged Image File Format (TIFF) format (lossless) for subsequent analysis.
Figure .: Typical measurement location. Leer A in the red circle represents the arterial vessel segment and leer
V in the blue circle represents the venular vessel segment.
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For the AVR measurement, the vendor-supplied soware was used for analysis, namely
VesselMap  (V...). e CRAE and the CRVE were semi-automatically obtained from
each subject according to the ARIC protocol (Hubbard et al., ). e quotient of these values
was automatically calculated to derive AVR. At least four arteries and four veins were selected
for the AVR measurement, depending on individual angioarchitecture. Whenever images were
captured on two occasions, average AVR values were calculated (Figure .).
For the measurement of branching angles (Figure .) and tortuosity values (Figure .) ImageJ
(Version .v) (Abramoﬀ et al., ) was used onmonochromatic fundus images for increased
contrast and, hence, greater accuracy. First and second order major bifurcations of one
representative artery and one representative veinwere selected distal to the ONH for branching
angles and the vessel segment linking those two bifurcations deﬁned the location of tortuosity
measurements. e line coursing through the vessels measured the arc length, whereas the
straight line corresponded to the chord length. e ratio of the two equalled the tortuosity
index. All bifurcation angle and arc/chord length measurements were repeated three times
and their averages went into subsequent analyses.
.. Outcome Measures
.. Dynamic Parameters
e following parameters (as deﬁned in Section ...) were measured and compared (between
examiners and between sessions, for inter- and intraobserver reproducibility respectively) for
all three ﬂicker cycles (henceforth designated with numbers ,  and ) by means of raw
RVA output data processing: BDF, bFR, MD, MC, DA, RT, CT, ΔD and APR. Absolute
arteriolar and venular diameters were recorded in MU and compared across Examiners and
across measurement sessions. Also, the RVA generated parameters of A􏸌􏸀􏸗, A􏸌􏸈􏸍, A􏸏􏸄􏸀􏸊 and
Figure .:Measurement of AVR of a right eye bymanually selecting arteries (red) and veins (blue) coursing through
the outer ring (le). Measurement of AVR of the same eye from a subsequent visit (right). See also
Figure . on page .
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Figure .: Illustration of bifurcation angles measurement using ImageJ. Values reported are in degrees. e angle
marked in green represents the proximal measurement site and the angle marked in yellow represents
the distal measurement site. e two bifurcation angles deﬁne the vessel segment taken for tortuosity
measurements (see Figure .).
Figure .: Illustration of tortuosity measurement using ImageJ, of the same vesssel segment as in Figure .. Values
reported are dimensionless. e yellow line marks the arc length and the green line marks the chord
length.
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V􏸌􏸀􏸗 are reported and compared to their counterparts: arterial MD, MC, DA and venular MD,
respectively.
.. Static Parameters
CRAE, CRVE and corresponding AVR values, tortuosity indices (see Equation (.)) and
bifurcation angles for both arteries and veins are reported according to the previously described
protocols (Section ...) for the intraobserver cohort (n=) only (Table .).
.. Statistics and Data Analysis
SPSS (Version . Chicago, SPSS Inc.) was used for statistical analysis and Graphpad Prism
(Version .) for ploing purposes. Normality tests were performed on all continuous data
by means of the Shapiro-Wilk test, to determine distribution. In case of normal distributions,
data are expressed as means (SD) and groups are compared by Student’s paired t-tests. Non-
normally distributed data are expressed as medians (Inter-artile Range (IQR)), compared
by the Mann-Whitney U test. IQR is calculated as the diﬀerence between the third and
ﬁrst quartiles. For multiple comparisons across the three ﬂicker cycles, the non-parametric
Friedman test was performed. Forward stepwise multiple linear regression analysis was used
to test if any of the static or dynamic variables signiﬁcantly predicted maximum dilation
responses. For all calculations, a P value of < . was considered signiﬁcant. Reproducibility
was tested by means of the ICC (Shrout and Fleiss, ). Box-and-whiskers plots shown
indicate the median and the IQR, whereas whiskers are drawn down to the 􏻁􏸓􏸇 percentile and
up to the 􏻅􏻁􏸓􏸇. Points below and above the whiskers are drawn as black ﬁlled dots, indicating
outliers, where applicable.
. Results
.. Interobserver Reproducibility
... Subjects
Characteristics of the participants (n=) for the interobserver reproducibility part of this study
are shown in Table .. Mean (±SD) age of the healthy volunteers cohort was  (±􏻃) years old.
... Retinal Vessels’ Absolute Diameters
e retinal arteriolar and venular absolute diameter values followed a normal distribution.
Hence, values are expressed as means (SD). No statistically signiﬁcant diﬀerence was found
between Examiners of the absolute arterioles and venules diameters that each one selected for
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Subject Age Gender IOP SBP DBP MABP HR(years) (mmHg) (mmHg) (mmHg) (mmHg) (pulses/min)
  f     
  m     
  f     
  f     
  m     
  m     
  f     
  f     
  f     
  f     
  f     
  m     
  m     
Table .: Demographics and baseline characteristics of subjects (n=) included in the interobserver study.
Subjects are sorted by age in ascending order. For acronyms, see page .
the assessment of the retinal microvascular reactivity to ﬂicker light. P values are shown in
Table ..
... Inbuilt Dynamic Flier Response Analysis
e parametersA􏸌􏸀􏸗,A􏸌􏸈􏸍,A􏸏􏸄􏸀􏸊 for arterioles andV􏸌􏸀􏸗 for venules generated from the RVA
soware (averaged across all three ﬂicker cycles) are shown in Table . per Examiner. Since
these values followed a normal distribution, a parametric Student’s t-test was performed to
check for diﬀerences.
... Independent Dynamic Flier Response Analysis
All dynamic response parameters tested for interobserver reproducibility were not normally
distributed. us, values shown are medians (IQR). Statistical signiﬁcance was sought using
the Mann-Whitney U test. Box-and-whisker diagrams were ploed for BDF, MD, MC, DA,
bFR, ΔD, APR, RT and CT for arteries (Figures . to .) and for BDF, MD, ΔD and RT for
veins (Figures . to .) for all three ﬂickers. e diﬀerence of MC of arterioles of the second
and third ﬂicker cycles between examiners was statistically signiﬁcant (p=. and p=.,
respectively). Statistically signiﬁcant diﬀerence was also found between the MD response of
arteries during the last (third) ﬂicker (p=.) (Table .).
e time points of maximum dilation and maximum constriction for arteries (RT, CT) and
for maximum dilation for veins (RT) are shown in Table .. Comparisons across Examiners
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Subject Examiner  Examiner  Examiner  Examiner Arteriolar Diameter (MU) Venular Diameter (MU)
 . . . .
 . . . .
  . . .
 . . . .
 . . . .
 . . . 
 . . . .
 . . . .
 . .  .
 . . . .
 . . . .
 . . . .
 . . . .
Mean (SD) . (.) . (.) . (.) . (.)
ICC . .
p value . .
Table .: Comparison of absolute arteriolar and venular diameters between Examiners. MU stands for
Measurement Units. Student’s paired t-tests were performed.
revealed a diﬀerence only for the arterial RT during the second ﬂicker cycle (p=.). Across
ﬂicker cycles within Examiners, no statistically signiﬁcant diﬀerences were found. Finally,
non-parametric comparisons using the Mann Whitney U test between arterial and venular RT
revealed diﬀerences only for Examiner  (ﬂickers  and ), with the veins needing longer time
to reach maximum dilation compared to their arterial counterparts.
... Comparison Between Inbuilt and Independent Analysis
To compare the inbuilt RVA soware analysis with the one independently calculated from
raw data, the three ﬂicker responses as per Table . were averaged. en, the two were
Parameter (%) Examiner  Examiner  ICC p value
A􏸌􏸀􏸗 . (.) . (.) . .
A􏸌􏸈􏸍 -. (.) -. (.) . .
A􏸏􏸄􏸀􏸊 . (.) . (.) . .
V􏸌􏸀􏸗 . (.) . (.) . .
Table .: Inbuilt RVA dynamic ﬂicker response parameters compared between examiners (n=). Values are
expressed as means (SD) % change to baseline diameter. Student’s paired t-tests were performed. For
deﬁnitions, see Section ... on page .

 Retinal Vessel Analyser: Reproducibility
Parameter Examiner  Examiner  ICC p valueArterioles (across Examiners)
BDF (%) . (.) . (.) . .
BDF (%)  (.) . (.) . .
BDF (%) . (.) . (.) . .
Friedman test (within Examiner) . .
MD (%) . (.) . (.) . .
MD (%) . (.)  (.) . .
MD (%) . (.) . (.) . .
Friedman test (within Examiner) . .
MC (%) . (.) . (.) . .
MC (%) . (.) . (.) -. .
MC (%) . (.) . (.) -. .
Friedman test (within Examiner) . .
DA (%) . () . (.) . .
DA (%) . (.) . (.) . .
DA (%) . (.) . (.) . .
Friedman test (within Examiner) . .
bFR (%) . () . () . .
bFR (%) . (.) . (.) . .
bFR (%) . (.) . (.) . .
Friedman test (within Examiner) . .
ΔD (%) . (.) . (.) . .
ΔD (%) . (.) . (.) . .
ΔD (%) . (.) . (.) . .
Friedman test (within Examiner) . .
APR . (.) . (.) . .
APR . () . (.) . .
APR . () . () . .
Friedman test (within Examiner) . .
Venules
BDF (%) . (.)  (.) . .
BDF (%) . (.) . (.) . .
BDF (%) . (.) . (.) . .
Friedman test (within Examiner) . .
MD (%) . (.) . (.) . .
MD (%)  (.)  (.) . .
MD (%)  (.)  (.) . .
Friedman test (within Examiner) . .
ΔD (%) . (.) . (.) . .
ΔD (%) . (.) . (.) . .
ΔD (%) . (.) . (.) . .
Friedman test (within Examiner) . .
Table .: Independently analysed RVA dynamic ﬂicker response parameters compared between examiners
(n=). Values are expressed as medians (IQR). Mann Whitney U tests were performed for across
Examiners comparisons and Friedman tests were performed for within Examiner comparisons. Statistical
signiﬁcance is denoted in bold. For acronyms, see page .

 Retinal Vessel Analyser: Reproducibility
Boxplot 1 E1 E2 Boxplot 2
0
5
10
B
D
F1
%
D
ia
m
et
er
C
ha
ng
e
Boxplot 1 E1 E2 Boxplot 2
0
5
10
B
D
F2
%
D
ia
m
et
er
C
ha
ng
e
Boxplot 1 E1 E2 Boxplot 2
0
5
10
B
D
F3
%
D
ia
m
et
er
C
ha
ng
e
Boxplot 1 E1 E2 Boxplot 2
90
95
100
M
C
1
%
R
el
at
iv
e
D
ia
m
et
er
Boxplot 1 E1 E2 Boxplot 2
90
95
100
M
C
2
%
R
el
at
iv
e
D
ia
m
et
er
Boxplot 1 E1 E2 Boxplot 2
90
95
100
M
C
3
%
R
el
at
iv
e
D
ia
m
et
er
Boxplot 1 E1 E2 Boxplot 2
100
105
110
115
M
D
1
%
R
el
at
iv
e
D
ia
m
et
er
Boxplot 1 E1 E2 Boxplot 2
100
105
110
115
M
D
2
%
R
el
at
iv
e
D
ia
m
et
er
Boxplot 1 E1 E2 Boxplot 2
100
105
110
115
M
D
3
%
R
el
at
iv
e
D
ia
m
et
er
Boxplot 1 E1 E2 Boxplot 2
5
10
15
D
A
1
%
D
ia
m
et
er
C
ha
ng
e
Boxplot 1 E1 E2 Boxplot 2
5
10
15
D
A
2
%
D
ia
m
et
er
C
ha
ng
e
Boxplot 1 E1 E2 Boxplot 2
5
10
15
D
A
3
%
D
ia
m
et
er
C
ha
ng
e
Boxplot 1 E1 E2 Boxplot 2
0
5
10
bF
R
1
%
D
ia
m
et
er
C
ha
ng
e
Boxplot 1 E1 E2 Boxplot 2
0
5
10
bF
R
2
%
D
ia
m
et
er
C
ha
ng
e
Boxplot 1 E1 E2 Boxplot 2
0
5
10
bF
R
3
%
D
ia
m
et
er
C
ha
ng
e
Boxplot 1 E1 E2 Boxplot 2
0
5
10
15
D
el
ta
D
1
Boxplot 1 E1 E2 Boxplot 2
0
5
10
15
D
el
ta
D
2
Boxplot 1 E1 E2 Boxplot 2
0
5
10
15
D
el
ta
D
3
Boxplot 1 E1 E2 Boxplot 2
0
2
4
6
8
A
PR
1
Boxplot 1 E1 E2 Boxplot 2
0
2
4
6
8
A
PR
2
Boxplot 1 E1 E2 Boxplot 2
0
2
4
6
8
A
PR
3
Figure .: Combined box-and-whisker and “Examiner  - Examiner ” comparison scaerplots (joined with
straight lines) showing arteriolar diameter ﬂuctuation and ﬂicker responses (n=) across all three
ﬂickers. See Table . for numerical values. For acronyms, see page .

 Retinal Vessel Analyser: Reproducibility
Parameter Examiner  Examiner  ICC p valueArterioles (across Examiners)
RT (seconds)  ()  () . .
RT (seconds)  ()  (.)† . .
RT (seconds)  ()  (.)‡ . .
Friedman test (within Examiner) . .
CT (seconds)  ()  (.) -. .
CT (seconds)  ()  () -. .
CT (seconds)  (.)  () . .
Friedman test (within Examiner) . .
Venules
RT (seconds)  (.)  (.) . .
RT (seconds)  ()  (.)† . .
RT (seconds)  ()  ()‡ -. .
Friedman test (within Examiner) . .
Table .: Independently analysed RVA dynamic response parameters (n=) compared between examiners. Values
are expressed as medians (IQR). Mann Whitney U tests were performed for across Examiners and
across vessel type (arteries-veins) comparisons and Friedman tests were performed for within Examiner
comparisons. † signiﬁes borderline statistically signiﬁcant diﬀerence (p=.) between arteries and veins
for ﬂicker . ‡ signiﬁes statistically signiﬁcant diﬀerence (p=.) between arteries and veins for ﬂicker
. For acronyms, see page .
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Figure .: Combined box-and-whisker and “Examiner  - Examiner ” comparison scaerplots (joined with
straight lines) showing arteriolar reaction and constriction times (n=) across all three ﬂickers. See
Table . for numerical values. For acronyms, see page .
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 Retinal Vessel Analyser: Reproducibility
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Figure .: Combined box-and-whisker and “Examiner  - Examiner ” comparison scaerplots (joined with
straight lines) showing venular diameter ﬂuctuation and ﬂicker responses (n=) across all three ﬂickers.
See Table . for numerical values. For acronyms, see page .
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Figure .: Combined box-and-whisker and “Examiner  - Examiner ” comparison scaerplots (joined with
straight lines) showing venular reaction times (n=) across all three ﬂickers. See Table . for numerical
values. For acronyms, see page .

 Retinal Vessel Analyser: Reproducibility
compared using a parametric Student’s t-test and the results are shown in Table .. For
Examiner , all arterial parameters calculated by means of the vendor-supplied RVA soware
were signiﬁcantly underestimated, compared to the respective independently analysed ones.
e statistical signiﬁcance of venular maximal dilation response was borderline (p=.). For
Examiner , maximal arterial constriction (p<.) and arterial dilation amplitude (p=.)
were found to be signiﬁcantly diﬀerent between the two.
... Averaged Flier Responses
All previously calculated parameters were tested for reproducibility on a per ﬂicker basis. Since
the majority of research groups are performing averaging across the three ﬂicker cycles, we
are also presenting reproducibility results of all previously calculated parameters, this time
with averaged values, collapsing data across all ﬂicker repetitions (Tables . to .). Averaged
values followed a normal distribution, hence parametric tests were performed to check for
diﬀerences.
.. Intraobserver Reproducibility
... Subjects
Baseline characteristics of the participants (n=) for the intraobserver reproducibility part of
this study are shown in Table .. Mean (±SD) age of the healthy volunteers cohort was  (±􏻅)
years old.
Parameter (%) Examiner  p value Examiner  p value
A􏸌􏸀􏸗 . (.) . . (.) .MD (arteries) . (.) . (.)
A􏸌􏸈􏸍 -. (.) <. -. (.) <.MC -. (.) -. (.)
A􏸏􏸄􏸀􏸊 . (.) <. . (.) .DA . (.) . (.)
V􏸌􏸀􏸗 . (.) . . (.) .MD (veins) . () . (.)
Table .: Comparison (n=) between inbuilt (see Table .) and independent ﬂicker analysis (see Table .). Values
are expressed as means (SD) % change to baseline diameter. Student’s paired t-tests were performed.
Statistical signiﬁcance is denoted in bold. For deﬁnitions, see Section ... on page .

 Retinal Vessel Analyser: Reproducibility
Parameter Examiner  Examiner  ICC p valueArterioles
BDF (%) . () . (.) . .
MD (%) . (.) . (.) . .
MC (%) . (.) . (.) -. .
DA (%) . (.) . (.) . .
bFR (%) . (.) . (.) . .
ΔD (%) . (.)  (.) . .
APR . (.) . (.) . .
Venules
BDF (%) . (.) . (.) . .
MD (%) . (.) . (.) . .
ΔD (%) . (.) . (.) . .
Table .: Independently analysed RVA dynamic ﬂicker response parameters (n=) compared between measure-
ment sessions, averaged across all three ﬂicker cycles. Values are expressed as means (SD). Student’s
paired t-tests were performed. Statistical signiﬁcance is denoted in bold. For acronyms, see page .
Parameter Examiner  Examiner  ICC p valueArterioles (across Examiners)
RT (seconds)  ()  () . .
CT (seconds)  ()  () . .
Venules
RT (seconds)  ()  () -. .
Table .: Independently analysed RVA dynamic response parameters (n=) compared between examiners,
averaged across all three ﬂicker cycles. Values are expressed as means (SD). Student’s paired t-tests
were performed. Statistical signiﬁcance is denoted in bold. For acronyms, see page .
Parameter Measurement  Measurement  p value
IOP (mmHg)  ()  () .
SBP (mmHg)  ()  () .
DBP (mmHg)  ()  () .
MABP (mmHg)  ()  () .
HR (pulses/min)  ()  () .
Table .: Baseline characteristics of subjects (n=) participating in the intraobserver study. Values are expressed
as means (SD). Student’s paired t-tests were performed. For acronyms, see page .

 Retinal Vessel Analyser: Reproducibility
... Retinal Absolute Diameters
Comparing the absolute arteriolar diameter betweenmeasurement sessions revealed no statist-
ically signiﬁcant diﬀerence. On the other hand, absolute venular diameters were signiﬁcantly
diﬀerent. Nevertheless, ICC values for both vessel types showed excellent reproducibility (See
Table .).
Vessel Type Measurement  Measurement  ICC p-value
Arteries (MU)  ()  () . .
Veins (MU)  ()  () . .
Table .: Comparison of absolute arteriolar and venular diameters (n=) between the twomeasurement sessions.
Values are expressed as means (SD). Student’s paired t-tests were performed. Statistical signiﬁcance is
denoted in bold.
... Inbuilt Dynamic Flier Response Analysis
e parametersA􏸌􏸀􏸗,A􏸌􏸈􏸍,A􏸏􏸄􏸀􏸊 for arterioles andV􏸌􏸀􏸗 for venules generated from the RVA
soware (averaged across all three ﬂicker cycles) are shown in Table . for eachmeasurement
session. Non-parametric Mann Whitney U tests for signiﬁcance testing were performed, since
values failed to indicate normal distributions.
... Independent Dynamic Flier Response Analysis
Similarly to the interobserver analysis, all dynamic response parameters tested for intraob-
server reproducibility were not normally distributed. us, values shown are medians
(IQR). Statistical signiﬁcance was checked using the Mann-Whitney U test. Box-and-whisker
diagrams were ploed for BDF, MD, MC, DA, bFR,ΔD, APR, RT and CT for arteries (Figures .
to .) and for BDF, MD, ΔD and RT for veins (Figures . to .) for all three ﬂickers.
Outliers are shown with black ﬁlled dots, where applicable.
Parameter (%) Measurement  Measurement  ICC p value
A􏸌􏸀􏸗 . (.) . (.) . .
A􏸌􏸈􏸍 -. (.) -. (.) . .
A􏸏􏸄􏸀􏸊 . (.) . (.) . .
V􏸌􏸀􏸗 . (.) . () . .
Table .: Inbuilt RVA dynamic ﬂicker response parameters compared between measurement sessions (n=).
Values are expressed as medians (IQR) % change to baseline diameter. Mann Whitney U tests were
performed for across measurements comparisons. For deﬁnitions, see Section ... on page .

 Retinal Vessel Analyser: Reproducibility
Parameter Measurement  Measurement  ICC p valueArterioles
BDF (%) . (.) . (.) . .
BDF (%) . (.)  (.) . .
BDF (%) . (.) . (.) . .
Friedman test . .
MD (%) . (.) . (.) . .
MD (%) . (.) . (.) . .
MD (%) . (.) . (.) . .
Friedman test . .
MC (%) . (.) . (.) . .
MC (%)  (.) . (.) . .
MC (%) . (.) . (.) . .
Friedman test . .
DA (%) . (.) . (.) . .
DA (%)  (.)  (.) . .
DA (%)  (.)  (.) . .
Friedman test . .
bFR (%)  (.) . () . .
bFR (%) . (.) . (.) . .
bFR (%) . () . () . .
Friedman test . .
ΔD (%) . (.) . () . .
ΔD (%) . (.) . (.) . .
ΔD (%) . (.) . (.) . .
Friedman test . .
APR . () . (.) . .
APR . (.)  (.) . .
APR . (.) . (.) . .
Friedman test . .
Venules
BDF (%) . (.) . (.) . .
BDF (%) . (.) . (.) . .
BDF (%) . (.) . (.) . .
Friedman test . .
MD (%) . (.) . (.) . .
MD (%) . (.) . (.) . .
MD (%)  (.)  (.) . .
Friedman test . .
ΔD (%) . (.) . (.) . .
ΔD (%) . (.) . (.) . .
ΔD (%) . (.) . (.) . .
Friedman test . .
Table .: Independently analysed RVA dynamic ﬂicker response parameters (n=) compared between
measurement sessions. Values are expressed as medians (IQR). Mann Whitney U tests were performed
for across measurements comparisons and Friedman tests were performed for within measurements
comparisons. For acronyms, see page .

 Retinal Vessel Analyser: Reproducibility
Parameter Measurement  Measurement  ICC p valueArterioles
RT (seconds)  ()†  ()¶ . .
RT (seconds)  ()‡  () -. .
RT (seconds)  ()§  () . .
Friedman test . .
CT (seconds)  ()  () . .
CT (seconds)  ()  () . .
CT (seconds)  ()  () -. .
Friedman test . .
Venules
RT (seconds)  ()†  ()¶ . .
RT (seconds)  ()‡  () . .
RT (seconds)  ()§  () . .
Friedman test . .
Table .: Independently analysed RVA dynamic response parameters (n=) compared between measurement
sessions. Values are expressed as medians (IQR). Mann Whitney U tests were performed for across
measurements and across vessel type (arteries-veins) comparisons and Friedman tests were performed
for within measurements comparisons. † signiﬁes statistically signiﬁcant diﬀerence (p=.) between
arteries and veins for ﬂicker , measurement . ‡ signiﬁes statistically signiﬁcant diﬀerence (p<.)
between arteries and veins for ﬂicker , measurement . § signiﬁes statistically signiﬁcant diﬀerence
(p=.) between arteries and veins for ﬂicker , measurement . ¶ signiﬁes statistically signiﬁcant
diﬀerence (p=.) between arteries and veins for ﬂicker , measurement . For acronyms, see page
.

 Retinal Vessel Analyser: Reproducibility
Boxplot 1 M1 M2 Boxplot 2
0
5
10
15
20
25
B
D
F1
%
D
ia
m
et
er
C
ha
ng
e
Boxplot 1 M1 M2 Boxplot 2
0
5
10
15
20
25
B
D
F2
%
D
ia
m
et
er
C
ha
ng
e
Boxplot 1 M1 M2 Boxplot 2
0
5
10
15
20
25
B
D
F3
%
D
ia
m
et
er
C
ha
ng
e
Boxplot 1 M1 M2 Boxplot 2
90
100
110
M
C
1
%
R
el
at
iv
e
D
ia
m
et
er
Boxplot 1 M1 M2 Boxplot 2
90
100
110
M
C
2
%
R
el
at
iv
e
D
ia
m
et
er
Boxplot 1 M1 M2 Boxplot 2
90
100
110
M
C
3
%
R
el
at
iv
e
D
ia
m
et
er
Boxplot 1 M1 M2 Boxplot 2
100
110
120
130
M
D
1
%
R
el
at
iv
e
D
ia
m
et
er
Boxplot 1 M1 M2 Boxplot 2
100
110
120
130
M
D
2
%
R
el
at
iv
e
D
ia
m
et
er
Boxplot 1 M1 M2 Boxplot 2
100
110
120
130
M
D
3
%
R
el
at
iv
e
D
ia
m
et
er
Boxplot 1 M1 M2 Boxplot 2
0
5
10
15
20
D
A
1
%
D
ia
m
et
er
C
ha
ng
e
Boxplot 1 M1 M2 Boxplot 2
0
5
10
15
20
D
A
2
%
D
ia
m
et
er
C
ha
ng
e
Boxplot 1 M1 M2 Boxplot 2
0
5
10
15
20
D
A
3
%
D
ia
m
et
er
C
ha
ng
e
Boxplot 1 M1 M2 Boxplot 2
-5
0
5
10
bF
R
1
%
D
ia
m
et
er
C
ha
ng
e
Boxplot 1 M1 M2 Boxplot 2
-5
0
5
10
bF
R
2
%
D
ia
m
et
er
C
ha
ng
e
Boxplot 1 M1 M2 Boxplot 2
-5
0
5
10
bF
R
3
%
D
ia
m
et
er
C
ha
ng
e
Boxplot 1 M1 M2 Boxplot 2
0
5
10
15
20
D
el
ta
D
1
Boxplot 1 M1 M2 Boxplot 2
0
5
10
15
20
D
el
ta
D
2
Boxplot 1 M1 M2 Boxplot 2
0
5
10
15
20
D
el
ta
D
3
Boxplot 1 M1 M2 Boxplot 2
0
2
4
6
8
A
PR
1
Boxplot 1 M1 M2 Boxplot 2
0
2
4
6
8
A
PR
2
Boxplot 1 M1 M2 Boxplot 2
0
2
4
6
8
A
PR
3
Figure .: Combined box-and-whisker and “Measurement  - Measurement ” comparison scaerplots (joined
with straight lines) showing arteriolar diameter ﬂuctuation and responses (n=) across all three ﬂickers.
Outliers are depicted as dots. See Table . for numerical values. For acronyms, see page .
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Figure .: Combined box-and-whisker and “Measurement  - Measurement ” comparison scaerplots (joined
with straight lines) showing arteriolar reaction and constriction times (n=) across all three ﬂickers.
Outliers are depicted as dots. See Table . for numerical values. For acronyms, see page .
... Comparison Between Inbuilt and Independent Analysis
To compare the inbuilt RVA soware analysis with the one independently calculated from raw
data, the three ﬂicker responses as per Table . were averaged. en, the two were compared
using a parametric t-test. Results are shown in Table .. For both measurement sessions,
all arterial and venular parameters calculated by means of the vendor-supplied RVA soware
were underestimated, compared to the respective independently analysed ones. All except one
(maximum dilation for measurement session ) reached statistical signiﬁcance (p=.).
Parameter (%) Measurement  p value Measurement  p value
A􏸌􏸀􏸗 . (.) . . () .MD (arteries) . (.) . (.)
A􏸌􏸈􏸍 -. (.) <. -. (.) <.MC -. (.) -. (.)
A􏸏􏸄􏸀􏸊 . (.) <. . (.) <.DA . (.) . (.)
V􏸌􏸀􏸗 . (.) <. . (.) <.MD (veins) . (.) . (.)
Table .: Comparison (n=) between inbuilt (see Table .) and independent ﬂicker analysis (see Table .).
Values are expressed as means (SD) % change to baseline diameter. Student’s paired t-tests were
performed. Statistical signiﬁcance is denoted in bold. For deﬁnitions, see Section ... on page .
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Figure .: Combined box-and-whisker and “Measurement  - Measurement ” comparison scaerplots (joined
with straight lines) showing venular diameter ﬂuctuation and responses (n=) across all three ﬂickers.
Outliers are depicted as dots. See Table . for numerical values. For acronyms, see page .
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Figure .: Combined box-and-whisker and “Measurement  - Measurement ” comparison scaerplots (joined
with straight lines) showing venular reaction times (n=) across all three ﬂickers. Outliers are depicted
as dots. See Table . for numerical values. For acronyms, see page .
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... Averaged Flier Responses
Similarly with results from the interobserver reproducibility analysis, since the majority of
research groups are performing averaging across the three ﬂicker cycles, we are also presenting
reproducibility results of all previously calculated parameters, this time with averaged values,
collapsing data across all ﬂicker repetitions (Tables . to .). Averaged values followed a
normal distribution, hence parametric tests were performed to check for diﬀerences.
... Static Retinal Vessel Parameters
CRAE, CRVE, AVR, tortuosity indices and branching angles values are shown in Table ..
... Multiple Regression Analysis
Forward stepwise multiple regression analysis was used to test if any of the static and
dynamic parameters (averaged across ﬂicker cycles) or any of the measured baseline vessel
diameters and IOP or BP values signiﬁcantly predicted MD (separately for arteries/veins
and measurement sessions). For arteries, the dependent variable was arterial MD and the
independent variables that were tested whether they predicted MD responses were: absolute
arteriolar diameter, IOP, MABP, CRAE, arterial tortuosity, proximal and distal arteriolar
bifurcation angles, BDF, bFR, MC, DA, ΔD, APR, RT and CT. For veins, the dependent variable
was venular MD and the independent variables that were tested whether they predicted MD
responses were: absolute venular diameter, CRVE, venular tortuosity, proximal and distal
venular bifurcation angles, BDF, ΔD, and RT.
For measurement , the results of the regression for arterial MD indicated that three predictors
explained .% of the variance ofMD (R􏺾=., F(,)=, p<.). ese were DA (β=,
p<.), MC (β=., p<.) and CT (β=-., p=.). For measurement , the results of
the regression for arterial MD indicated four predictors that could explain .% of the variance
of MD (R􏺾=., F(,)=, p<.). ese were ΔD (β=., p=.), bFR (β=.,
p<.), MC (β=., p<.) and BDF (β=., p<.).
For measurement , the results of the regression for venular MD indicated that two predictors
explained .% of the variance of MD (R􏺾=., F(,)=., p<.). ese were ΔD
(β=., p<.) and BDF (β=., p<.). For measurement , the results of the regression
for venular MD indicated that the same two predictors explained % of the variance of
MD (R􏺾=., F(,)=., p<.). ese were ΔD (β=., p<.) and BDF (β=.,
p<.).
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Parameter Measurement  Measurement  ICC p valueArterioles
BDF (%) . (.)  (.) . .
MD (%) . (.) . (.) . .
MC (%) . (.) . (.) . .
DA (%) . (.) . (.) . .
bFR (%) . (.) . (.) . .
ΔD (%) . (.)  (.) . .
APR  (.)  (.) . .
Venules
BDF (%) . (.) . (.) . .
MD (%) . (.) . (.) . .
ΔD (%) . (.) . (.) . .
Table .: Independently analysed RVA dynamic ﬂicker response parameters (n=) compared between
measurement sessions, averaged across all three ﬂicker cycles. Values are expressed as means (SD).
Student’s paired t-tests were performed. For acronyms, see page .
Parameter Measurement  Measurement  ICC p valueArterioles
RT (seconds)  ()  () -. .
CT (seconds)  ()  () -. .
Venules
RT (seconds)  ()  () . .
Table .: Independently analysed RVA dynamic response parameters (n=) compared between examiners,
averaged across all three ﬂicker cycles. Values are expressed as means (SD). Student’s paired t-tests
were performed. For acronyms, see page .
Parameter Arteries Veins
CRAE (μm)  () N/A
CRVE (μm) N/A  ()
AVR . (.)
Branching Angle  (proximal) (degrees) . () . ()
Branching Angle  (distal) (degrees) . () . ()
Tortuosity Index . (.) . (.)
Table .: Static retinal vessel parameters of the healthy, intraobserver cohort (n=). Values are expressed as
means (SD). For acronyms, see page .
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Lastly, the test of whether arteriolar MD, MABP and IOP predicted the extent of venular MD
reached no signiﬁcance for both measurement sessions.
. Discussion
.. Interobserver Reproducibility Study
e eﬀect of the strict standardisation procedures during data collection by means of the RVA
system is reﬂected through the high ICC values of absolute arterial and venular diameters
selected by the two Examiners (Table .). ese conﬁrm that both Examiners selected the
same vessel segment. Hence, vessel reaction to ﬂicker stimulation is highly unlikely to be
confounded by any (potential) inﬂuence on initial absolute vessel diameter.
e inbuilt RVA dynamic response parameters, averaged across all three ﬂicker cycles, exhibit
excellent reproducibility across Examiners. As mentioned in Section ..., these values are
calculated from an arbitrarily chosen time window, that encompasses  seconds:  seconds
before ﬂicker cessation and  seconds aer. is means, that the maximal dilation and
constriction are “expected” to take place within a ﬁxed time frame, for each ﬂicker cycle: -
seconds aer ﬂicker initiation. Recently, this assumption has proven problematic, as reaction
times can vary outside this  seconds time frame (Heitmar et al., ). In line with Heitmar
and colleagues, when comparing the two diﬀerent analyses, statistically signiﬁcant diﬀerences
were found for arterial MD and MC when compared with their counterparts (A􏸌􏸀􏸗 and A􏸌􏸈􏸍
respectively) (see Table .). erefore, independently analysing raw RVA data and reporting
the maximal dilation and constriction values from a wider time window of  seconds (aer
ﬂicker initiation) eliminates the underestimation or overestimation of ﬂicker responses.
Interobserver reproducibility of the independently analysed parameters generally showed
moderate ICC values, similarly for both arteries and veins (Table .). Only the DA parameter,
relevant to arteries, showed excellent reproducibility results across all three ﬂicker cycles.
ese results might be explained by two factors: the relatively small sample size per Examiner
(n=) and the inherently variable nature of retinal haemodynamics. Regarding comparisons
across the three ﬂicker cycles within Examiners, the non-parametric Friedman test revealed no
statistically signiﬁcant diﬀerences. is result gives support to the notion that no comparable
diﬀerences exist within a single measurement across the three ﬂicker repeats, therefore
averaging values would make analysis less complicated without sacriﬁcing information.
Reaction and constriction times for arteries and veins showed moderate reproducibility
between Examiners, whereas values did not diﬀer across the three ﬂicker cycles within
Examiners. Interestingly, for Examiner , veins needed signiﬁcantly longer time than arteries
to reach maximum dilation (Table .). is was the case for two out of three ﬂicker cycles.
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A similar “delay” of approximately - seconds of the venous reaction has been previously
reported for healthy subjects (Heitmar et al., , b; Lanzl et al., ; Kotliar et al., b)
in line to this ﬁnding. e fact that this ﬁnding was not evident for measurements taken from
Examiner , might be explained from the relatively small sample size (n=, i.e. low statistical
power). Performing an a priori power analysis for a two-tailed Wilcoxon signed-rank test
(matched pairs) at an alpha level (α) of . by means of the G*Power soware (version ..)
(Faul et al., ), revealed that a sample size (n) of  would be required for a large eﬀect size
(.) with % statistical power, whereas for a medium eﬀect size (.) the sample size would
have to be increased to . Nevertheless, the range of values for reaction and constriction times
reported here, are in very good agreement to the ones obtained from a sample of healthy South
Asians and White Europeans (comparable to the sample characteristics of this study) (Patel
et al., ). e majority of within ﬂicker and across Examiners comparisons did not reveal
statistically signiﬁcant diﬀerences, with the exception of arterial RT of the second ﬂicker cycle.
is, in conjunction with the results mentioned above, might be proof that diﬀerent Examiners
with similar experience may yield comparable results using the RVA system.
.. Intraobserver Reproducibility Study
Having a considerably larger sample size of healthy volunteers (n= versus n=) for
the intraobserver reproducibility study, it was possible to overcome the limitations of the
interobserver reproducibility study. e baseline characteristics of this cohort (Table .)
conﬁrm the healthy status of the participants and that these adhered to the inclusion and
exclusion criteria. Contrary to the comparison between Examiners, when all measurements
took place on the same day, in this part of the study, measurements took place either on
the same day or on a separate visit. Hence, it is important, that prior to both measurements,
IOP and BP values showed no signiﬁcant diﬀerences between the two measurement sessions,
rendering all subsequent comparisons relevant.
Although, both arterial and venular absolute diameters between measurement sessions had
highly reproducible values (shown by ICC values of more than .), the diameter of the
selected venular segment was (on average)  microns narrower during the repeat measurement
(Table .). is diﬀerence might have arisen from measurements that took place on separate
days, when the repetition feature of the soware could not be utilised and manual matching
of the vessel segment was performed. Nevertheless, it has been reported that “baseline vessel
diameter does not inﬂuence relative magnitude of the ﬂicker response” (Gugleta et al., ).
Assuming that this diameter diﬀerence was a deﬁning factor in terms of ﬂicker response, one
would expect to ﬁnd a signiﬁcant diﬀerence in the venular maximum dilation values. In fact,
when the two measurement sessions were compared, this was not the case, neither with the
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V􏸌􏸀􏸗 parameter (Table .), nor with the MD parameter (Table .). Results, thus, are in line
with previous ﬁndings (not inﬂuenced by baseline vessel diameter diﬀerences).
Similarly to the previous sub-study, the inbuilt RVA dynamic response parameters, averaged
across all three ﬂicker cycles, exhibit high reproducibility across measurement sessions. e
maximum arterial constriction (A􏸌􏸈􏸍) is an exception, with a low ICC value of . (Table .).
ough, as previously mentioned, the validity of the soware-generated parameters is more
important in this case, rather than how much reproducible they are. As such, comparisons
performed between the independently analysed reaction parameters and their counterparts re-
vealed an even stronger diﬀerence (compared to the interobserver study) for bothmeasurement
sessions (Table .). Namely, the inbuilt analysis consistently underestimated all responses,
conﬁrming to a greater extent the same ﬁnding as in the smaller cohort of  participants.
Regarding reproducibility of the independently analysed dynamic responses, of note is the
excellent consistence of values relating to venular parameters (BDF, MD and ΔD) throughout
the ﬂicker cycles (Table .) between measurements. On the other hand, arterial parameters
show moderate reproducibility in general compared to veins. is could be explained by
considering some imaging aspects during data capturing: veins appear darker than arteries
and thus exhibit higher contrast to their background. is, in turn, makes veins less susceptible
to erroneous diameter estimations and vice versa. Comparisons within measurement sessions,
across ﬂicker repeats did not reveal statistically signiﬁcant diﬀerences, with one exception:
maximum venular dilation (for measurement ) showed an increasing trend from ﬂicker to
ﬂicker (p=.).
How do the main outcome measures of this thesis (Table .) compare to the ones found in
literature? Since there are few studies that have dealt exclusively with healthy volunteers, to
answer this question, one must refer to publications including healthy populations as controls,
compared across various pathological states. Arterial BDF and bFR have been reported once on
a per ﬂicker basis (Heitmar et al., ) in literature. Values ﬂuctuate approximately % lower
than the ones in the aforementioned study for the former, but are comparable for the laer.
ere are no reports on venular BDF on a per ﬂicker breakdown, to compare these ﬁndings to.
On averaged venular BDF values, Patel et al. () report slightly higher values. Arterial and
venularMDvalues are comparablewith the ones reported by several studies (Nagel et al., a;
Mandecka et al., ; Lasta et al., ), though these studies have averaged responses across
ﬂicker cycles. Approximately % lower maximal dilation and % larger maximal constriction
was found among subjects - for all ﬂickers - compared to the  normals (of an older age group)
included in Heitmar et al. (b). is translates in a comparable arterial DA, despite the age
diﬀerence. e study (Heitmar et al., ) that introduced retinal arteriolar elasticity (deﬁned
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as APR) showed similar values to the ones reported here. e index ΔD representing arterial
and venular dilatory capacity shows comparable values between vessel types.
e ﬁndings of delayed venular RT compared to arterial RT in the interobserver study, were
conﬁrmed with greater power in the intraobserver study. When reaction times of arteries
and veins where compared, values from all ﬂicker cycles within the ﬁrst measurement session
reached statistical signiﬁcance, whereas one cycle did so for the secondmeasurement (the trend
that venules took longer to reach maximum dilation, remained though) (Table .). Also it is
important to note that both reaction and constriction times have low ICC values, indicating
a large ﬂuctuation between sessions and making it debatable whether they are meaningful
to calculate. No signiﬁcant diﬀerences were found within measurement sessions. Looking
at reaction time values, it is evident that arteries may reach maximum dilation (on average)
outside the - seconds window (for instance on the th second). is is essentially the
source of underestimation when using the inbuilt RVA parameters. It is even more pronounced
when calculating the maximum constriction, as constriction times are well outside this range
(ranges of - seconds). Venular reaction times (on average) fall within the - seconds
window, but not all individual values do so, thus rendering comparisons between the two
analyses statistically signiﬁcant (Table .). e values reported here are comparable with
several other studies (Patel et al., ; Heitmar et al., , b) highlighting the importance
and beneﬁts of standardisation when comparisons across studies are to be performed.
Regression analysis did not reveal any relationship between static (baseline diameters, CRAE,
CRVE, tortuosity index, bifurcation angles) and dynamic (MD) parameters, neither in arteries
nor in veins. MABP did not predict arteriolar MD in any of the regression models, conﬁrming
other studies (Heitmar et al., ; Garhöfer et al., ). Interestingly, the two measurement
sessions did not “agree” in which predictors could explain the variance of arterial MD. is
is one more indicator of low agreement among arteriolar calculated parameters. e only
common predictor was arteriolar MC, which shows a positive correlation with arteriolar
MD. In other words, arteries responding to ﬂicker with large dilation responses exhibit large
constriction phases aer ﬂicker cessation. Conversely, for veins the two predictors (BDF and
ΔD) explained the variance of MD consistently throughout the two measurement sessions. By
deﬁnition, ΔD is a measure of a vessel’s dilatory capacity, which explains its relation to MD
as shown by the regression analysis results. Of note is that venular BDF, which represents
the diameter ﬂuctuation during baseline illumination, can predict MD variation during ﬂicker
stimulation. Spontaneous retinal venous pulsation is a well known observation occurring in
the proximity of the ONH (Jacks andMiller, ). is might contribute to venous BDF despite
the considerable distance of the measured vessel segment from the edge of the ONH. Results
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support the notion that large baseline ﬂuctuations lead to large dilation responses during ﬂicker
stimulation.
. Conclusions
Despite the innovation the RVA system has brought into the ﬁeld of non-invasive retinal
function assessment, research groups do not follow standardised analysis procedures yet and
sometimes fail to extensively describe their implemented methods and protocols. Reprodu-
cibility of the ﬂicker responses strongly depends on measuring conditions (Seifertl and Vilser,
). ese should be carefully replicated as carefully as possible, when comparisons are to
be made between healthy participants and various disease populations, to ensure the validity
of the measurements.
Herewith, results are presented of interobserver and intraobserver reproducibility of a series of
parameters that exist to describe the arterial and venular compliance before, during and aer
ﬂicker provocation. Despite the strict standardisations applied throughout, ICC values are low
to moderate for arteries, whereas for veins are moderate to high. Reproducibility is helpful
to examine when there is no satisfactory standard against which to compare the validity of a
measurement. Studies from other research groups are warranted to compare these results to.
In CVD the delicate balance between vasodilators and vasoconstrictors is disturbed leading to
what is commonly referred to as endothelial dysfunction (Nadar et al., ). Hence, accurate
assessment of vascular function has been investigated as a potential prognostic marker and as a
possible therapeutic target. Currently, the golden standard to assess endothelial (dys)function
in a non-invasive manner and on a macrovascular level is Flow-Mediated Dilation (FMD).
Evaluation of FMD in the brachial artery is performed by means of high-resolution ultrasound
recording the physiological response of increased blood ﬂow, following distal forearm induced
ischemia. A recent, multi-center reproducibility study has demonstrated that adherence to
a rigorous protocol and adequate operator skills improve the reliability of the technique
(Ghiadoni et al., ). Short-term CVs were ranging from .% to .%, whereas long-
term CVs were ranging from .% to .%. Flicker-induced vessel responses were weakly
correlated to brachial FMD indicating the absence of a direct analogy between the two vascular
beds and possibly between the two mechanisms involved (Pemp et al., ).
Current studies employing the RVA system to assess endothelial function are pursuing
to explore potential ﬂicker response diﬀerences between health and disease. Since these
comparisons are naturally cross-sectional, the applicability of the RVA is currently limited to
screening or stratiﬁcation purposes. Lack of longitudinal studies is preventing researchers to
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draw conclusions on the progression of the associations reported. Such studies are needed to
explore whether the RVA can be used as a diagnostic tool in the future.
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Chapter 
Location and Length Inﬂuence on Vessel Reactivity
. Baground
Documents provided by the manufacturer of the RVA system (Imedos AG) describe certain
technical limitations as well as certain standardisation procedures which should be followed
by end-users. More speciﬁcally, on selecting the measurement location and vessel segment’s
length, the following are advised:
• Measurement location should be at least . DD away from the ONH.
• Vessel segment’s length should have a maximum length of  DD, but generally recom-
mended to be kept as long as possible.
• Due to resolution limitations, measurement of vessels with luminal diameter smaller
than 􏻅􏺼μm “may be diﬃcult”.
e measurement setup procedure encompasses the following steps. Initially, the camera’s
objective is adjusted centrally to the dilated pupil to an appropriate distance in order to obtain
a uniformly illuminated fundus image on the computer’s screen. en, focus is adjusted to get
a sharp image. e ﬁxation needle needs to be placed accordingly so as the subject is able to
clearly observe it and at the same time the vessels of interest are central to the image view.
e end-user ﬁnally places the measurement window on the desired area. An instance of the
measuring window is shown in Figure .. e pair of red lines superimposed on an arteriole
and a venule indicate the measurement location and length.
How do the aforementioned manufacturer guidelines translate into numerical values? Typic-
ally, in a healthy eye, arterioles’ diameters are ranging from  μm to  μm, whereas venules’
diameters from  μm to  μm, within a range of - DD from the edge of the ONH. Hence,
there is a substantial range of vessel diameters (i.e. diﬀerent locations) that can be measured.
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Regarding vessel’s length, theoretically, the maximum length, that the red lines in Figure .
can be extended to, is  pixels (personal communication). Using the Carl Zeiss FF􏻀􏻁􏺼􏸏􏸋􏸔􏸒
fundus camera at the ° angle image ﬁeld, these correspond to  MU or else to  μm for
Gullstrand’s normal eye (. MU per pixel). Practically, this maximum value cannot possibly
be achieved, since the soware’s algorithm truncates parts of the selection edges, even under
ideal conditions. For example, the maximum length that could possibly be selected using a
stationary straight target (for testing purposes) yielded a value of  MU.
.. Motivation and Resear Rationale
In addition to the lack of standardisation on dilatory parameter calculations (Chapter ),
currently there is no standardisation regarding the location and the length of the vessel
segments selected for retinal endothelial functional assessment bymeans of the RVA. Although
the majority of research groups appear to sample the retina within - DDs away from the
ONH, many others arbitrarily select within a wide range of - DDs (Nagel et al., a,b;
Frederiksen et al., ; Bek et al., ; Mehlsen et al., ). Furthermore, even though the
majority of researchers report the location they measured at, they do so without applying any
standardisation, but base their selection on visual estimations only. Some do not deﬁne their
selection at all (Blum et al., ; Rueddel et al., ).
Similarly for the length of the chosen vessel segments, many studies do not disclose any
information (Rickenbacher et al., ; Reimann et al., ; Pemp et al., ; Lo et al., ;
Lasta et al., ), whereas some that do so, report values as long as  μm (Mandecka et al.,
; Nguyen et al., ; Dawczynski et al., ; Mandecka et al., ) that by deﬁnition
cannot be true (longer than the theoretical upper limit of  μm). Moreover, no study reports
numerical values of absolute vessel segment lengths, despite the fact that this information
can be easily extracted from the supplied soware. Instead, the values that are reported are
qualitative approximations. Also, it is questionable whether values reported are valid, because
ﬁnding a long straight vessel segment (of an extent of  μm) on all measured retinas in a
study is improbable.
Understandingly, both vessel location and length selection are governed by individual angioar-
chitecture. But within the ° angle image ﬁeld, retinal blood vessels vary structurally and
functionally, as a function of size and location. e use of relative (to the baseline) diameter
values to ﬂicker reaction helps to overcome vessel size diﬀerences, but vessel dilation and/or
constrictionmight be inﬂuenced by locality and/or the extent of segmentsmeasured. Herewith,
it is investigated whether these two variables - location and length - aﬀect the measuring
outcomes.
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Figure .: RVA’s measuring window. e four blue circles at each corner aid the repositioning of the ﬁxation
needle (shown at right) for repeated measurements. Here, the superotemporal fundus area of a le eye
is shown.
. Subjects and Methods
Measurements were performed by a single examiner for  healthy volunteers ( males, 
females) in one unselected eye. e same inclusion and exclusion criteria as previously listed
(Section ..), applied.
.. Data Collection
e same protocol was followed as in Section ... using three ﬂicker cycles as in Figure ..
For every given RVA measurement session, vessel diameters of one pair (arteriole-venule)
of operator-selected vessel segments (within an area of - DD) were recorded across space
and time, in real time. ese sessions were recorded on S-VHS tapes. is allowed us to
replay sessions oﬄine and select two additional measurement locations (- DD and - DD)
as per Figure .. Measurement rings as the ones shown in Figure . were superimposed on
each measurement window according to every individuals’ DD to improve standardisation and
achieve perfect measurement location accuracy. e use of relative distances to the ONH to
describe retinal locations is a standard procedure, as for AVR measurements, for instance. e
choice of  DD wide rings, on one hand serves for easy comparisons among diﬀerent groups
(because this is what most groups report) and on the other hand satisﬁes the manufacturer’s
recommendation for taking vessel segments of a maximum of  DD length. Despite the fact
that the length of each vessel segment was arbitrarily selected (within the limits of each ring)
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prior to the commencement of the measurement session, this was later standardised across
subjects, as detailed in the next Section.
.. Data Processing
Data were analysed independently of the vendor-supplied soware. Custom-built scripts were
used to process raw data output from the RVA soware in a versatile way. ese scripts were
wrien by Dr. Robert J. Summers. Excel data matrices containing both the artery and vein
ﬂicker reaction across space (one diameter recording every  MU, extending to a variable
amount of columns, depending on segment length) and time ( diameter recordings per
second, for  seconds equalling to a total maximum of  rows of diameter data) were
split into two Comma-separated Values (CSV) ﬁles using a bash script, by means of the xlscsv
and csplit utilities. Further awk scripts:
• removed any potential outliers (eliminating irregularly high or low values due to e.g.
blinks), data outside ±􏺾 SDs from the mean, similarly to others (Jensen et al., )
• ﬁlled in any potential missing data blocks, using linear interpolation, in line with Kotliar
et al. (a)
• binned values over  second intervals (each containing  data points), in line with Nagel
et al. (); Gugleta et al. ()
• normalised vessel diameter values to the mean of the  seconds of baseline diameter
values, in line with Polak et al. (); Kotliar et al. ()
... Analysis per Location
Further to the real-time recordings of one arteriole and one venule within the area of -
DD (designated as Segment ) distal to the ONH, two additional pairs of vessel segments
were measured oﬄine from the video tape recordings. ese were within a range of - DD
(designated as Segment ) and - DD (designated as Segment ) distal to the ONH. Hence,
a total of  arteriolar vessel segments and  venular segments went into the analysis. To
eliminate any potential bias of vessel length selection, an equally long vessel segment (
MU, corresponding to  columns of data), was processed for all segments across subjects with
the aid of the aforementioned scripts. Absolute arteriolar and venular diameters were recorded
in MU and compared across measurement locations.
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Figure .: Illustration of measured locations in relation to the distance from the ONH. e segment taken out from
the area of - DD distal to the ONH is designated as Segment , from the area of - DD as Segment 
and from the area of - DD as Segment .
... Analysis per Segment’s Length
For the purpose of comparing vessel diameter’s ﬂicker responses of diﬀerent lengths all
vessel segment pairs measured from the - DD area were re-analysed. During that re-
analysis, instead of truncating the vessel lengths to  MU, their full length was utilised
as initially selected during the real-time measurement session. Depending on individual
angioarchitecture, these lengths ranged from  MU to  MU for arteries and from  MU
to  MU for veins. Detailed breakdown on a per individual basis is shown in the Results
section (Table .). e diameter recordings during ﬂicker stimulation of these longer segments
went into a comparison with the previously standardised lengths of  MU.
.. Data and Statistical Analysis
SPSS (Version . Chicago, SPSS Inc.) was used for statistical analysis and for ploing
purposes. Normality tests were performed on all continuous data bymeans of the Shapiro-Wilk
test, to determine distribution. For the case of absolute vessel diameters, values were normally
distributed, thus one-way Analysis of Variance (ANOVA) was used with the measurement
location as the categorical independent variable and vessel diameter as the continuous variable.
For all other outcome parameters calculated, which were non-normally distributed, Kruskal-
Wallis H tests were performed, with the measurement location as the grouping variable. For

 Location and Length Inﬂuence on Vessel Reactivity
all calculations, a P value of < . was considered signiﬁcant. Associations of the outcome
parameters (where applicable) with vessel diameter and MABP were examined by means of
linear regression analysis. Finally, a graphical representation for comparing long and short
segments was used by ploing the diﬀerence of the vessel diameter ﬂicker response of each of
the longest vessel segments minus their  MU long counterparts.
. Results
.. Baseline Characteristics
Data from  healthy volunteers ( males,  females) were analysed and included in this
study. Values of baseline parameters (vessel diameters across all measured segments, age, SBP,
DBP, MABP, HR and IOP) are shown in Table .. A one-way ANOVA was used to test for
vessel diameters diﬀerences among the three measurement locations. Values did not diﬀer
signiﬁcantly across the three measurement locations, neither for arterioles (F (, ) = ., p
= .), nor for venules (F (, ) = ., p = .).
.. Comparison Across Vessel Segments
e following parameters (as deﬁned in Section ...) were calculated and compared (across
three measurement locations) for all three ﬂicker cycles by means of raw RVA output data
processing: BDF, bFR, MD, MC, DA, RT, CT, ΔD and APR. Kruskal-Wallis H tests showed no
statistically signiﬁcant diﬀerences across any of the RVA dynamic ﬂicker responses between
the three measurement locations: neither in a ﬂicker per ﬂicker analysis (Table .), nor when
all ﬂicker cycles were averaged together (Table .).
Parameters Segment  Segment  Segment  p-value(- DD) (- DD) (- DD)
Arteriolar Diameters (MU)  ()  ()  () .
Venular Diameters (MU)  ()  ()  () .
Age (years)  ()
SBP (mmHg)  ()
DBP (mmHg)  ()
MABP (mmHg)  ()
HR (pulses/min)  ()
IOP (mmHg)  ()
Table .: Absolute arteriolar and venular diameters (n=) across three measurement locations and baseline
characteristics of the cohort. Values are expressed as means (SD). For acronyms, see page .
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Parameter
Arterioles
p valueSegment  Segment  Segment 
(- DD) (- DD) (- DD)
BDF (%) . (.) . (.) . (.) .
BDF (%) . (.) . (.) . (.) .
BDF (%) . (.) . (.) . (.) .
MD (%) . (.) . (.) . (.) .
MD (%) . (.) . (.) . (.) .
MD (%) . (.)  (.) . (.) .
MC (%) . (.)  (.)  (.) .
MC (%) . (.) . (.) . (.) .
MC (%)  (.) . (.)  (.) .
DA (%) . (.) . (.) . (.) .
DA (%) . (.) . (.) . (.) .
DA (%) . (.) . (.) . (.) .
bFR (%) . (.) . (.)  (.) .
bFR (%) . (.) . (.) . (.) .
bFR (%) . (.) . (.) . (.) .
ΔD (%) . (.) . (.) . (.) .
ΔD (%) . (.) . (.) . (.) .
ΔD (%) . (.) . (.) . (.) .
APR . (.) . (.) . (.) .
APR . (.) . (.) . (.) .
APR . (.) . (.) . (.) .
Venules
BDF (%) . (.) . () . (.) .
BDF (%) . (.) . (.) . (.) .
BDF (%) . (.) . (.) . (.) .
MD (%) . (.) . (.) . (.) .
MD (%) . (.)  () . (.) .
MD (%) . (.) . () . (.) .
ΔD (%) . (.) . (.) . (.) .
ΔD (%) . (.) . (.) . (.) .
ΔD (%) . () . (.) . (.) .
Table .: RVA dynamic ﬂicker response parameters across three fundus locations (n=) in a ﬂicker by ﬂicker
analysis. Values are expressed as medians (IQR). Kruskal-Wallis H tests were performed for comparisons
across measurement locations. For acronyms, see page .
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Arteriolar reaction times showed a trend of slower reaction (time needed to reach maximum
dilation) for larger vessels (closer to the ONH) compared to smaller ones (further away from the
ONH). is was the case when individual ﬂicker analysis was performed (Table .) and when
ﬂickers where averaged (Table .). A Kruskal-Wallis test revealed that this trend reached
statistical signiﬁcance in the case of averaged ﬂickers (Table .): there was a statistically
signiﬁcant diﬀerence between the diﬀerent measurement locations (H(,n=) = ., p =
.), with a mean rank of . seconds for Segment , . seconds for Segment  and
. seconds for Segment . A post-hoc test using Dunn’s multiple comparisons showed
a signiﬁcant diﬀerence in arteriolar reaction times between Segment  and Segment  (p =
.). Segment  compared to Segment  followed a similar trend, however failed to reach
statistical signiﬁcance (p = .).
Since the previous non-parametric Kruskal-Wallis H tests showed no signiﬁcant diﬀerences
across the three measurement locations for all outcome parameters (as shown in Table .),
all measurement sites (n=) were pooled together for linear regression analysis. Exploring
potential associations of the outcome parameters with absolute vessel diameters did not
show statistically signiﬁcant correlations. For example, neither absolute arteriolar diameter
(r=-., p=.), nor absolute venular diameter (r=-., p=.) correlated with maximum
arteriolar and venular dilation, respectively. On the contrary, there was a signiﬁcant positive
correlation between MABP of subjects and arteriolar diameter response induced by ﬂickering
light (r=., p=.; Figure .).
.. Flier Responses Variability as a Function of Location
To assess whether the measurement location inﬂuences the variability of the outcome meas-
ures, coeﬃcients of variation were calculated across all three ﬂicker cycles and then averaged
across participants (n=). Results for both arterioles and venules are summarised in Table ..
.. Comparison Between Segment Lengths
Output from continuous diameter recordings as per the standard ﬂicker protocol were extracted
from the same vessel selection, twice: once for the longest possible selection and a second
time from the truncation of this long segment to a  MU long segment. e point by
point subtraction of each diameter value derived from the long and short segments are ploed
in Figure . for arteries and Figure . for veins, for all subjects (n=). e analysis was
constrained only within a - DD range from the edge of the ONH (i.e. only “Segments ” were
analysed).

 Location and Length Inﬂuence on Vessel Reactivity
Parameter
Arterioles
p valueSegment  Segment  Segment 
(- DD) (- DD) (- DD)
RT (seconds)  ()  ()  () .
RT (seconds)  ()  ()  () .
RT (seconds)  ()  ()  () .
CT (seconds)  ()  ()  () .
CT (seconds)  ()  ()  () .
CT (seconds)  ()  ()  () .
Venules
RT (seconds)  ()  ()  () .
RT (seconds)  ()  ()  () .
RT (seconds)  ()  ()  () .
Table .: RVA dynamic ﬂicker reaction and constriction times across three fundus locations (n=) in a ﬂicker
by ﬂicker analysis. Values are expressed as medians (IQR). Kruskal-Wallis H tests were performed for
comparisons across measurement locations. For acronyms, see page .
Parameter
Arterioles
p valueSegment  Segment  Segment 
(- DD) (- DD) (- DD)
BDF (%) . (.) . (.) . (.) .
MD (%) . (.)  (.) . (.) .
MC (%) . (.)  () . (.) .
DA (%) . (.) . (.) . (.) .
bFR (%) . (.) . (.) . (.) .
ΔD (%) . () . (.) . () .
APR . (.) . (.) . (.) .
Venules
BDF (%) . (.) . (.) . (.) .
MD (%) . (.) . (.) . (.) .
ΔD (%) . (.)  (.) . (.) .
Table .: RVA dynamic ﬂicker response parameters across three fundus locations (n=), averaged across three
ﬂicker cycles. Values are expressed as medians (IQR). Kruskal-Wallis H tests were performed for
comparisons across measurement locations. For acronyms, see page .

 Location and Length Inﬂuence on Vessel Reactivity
Parameter
Arterioles
p valueSegment  Segment  Segment 
(- DD) (- DD) (- DD)
RT (seconds)  ()†  ()†  () .
CT (seconds)  ()  ()  () .
Venules
RT (seconds)  ()  ()  () .
Table .: RVAdynamic ﬂicker reaction and constriction times across three fundus locations (n=), averaged across
three ﬂicker cycles. Values are expressed as medians (IQR). Kruskal-Wallis H tests were performed
for comparisons across measurement locations. Statistical signiﬁcance is denoted in bold. † signiﬁes
post-hoc test’s statistically signiﬁcant diﬀerences between Segment  and Segment  (p = .). For
acronyms, see page .
Figure .: Correlation between the maximum arteriolar dilation response and MABP for all segments () of all
subjects (n=). e solid line corresponds to the regression line and the dashed line corresponds to the
% conﬁdence interval. Segment  corresponds to an area of - DD, Segment  to an area of - DD
and Segment  to an area of - DD distal to the ONH.

 Location and Length Inﬂuence on Vessel Reactivity
Parameter
Arterioles
Segment  Segment  Segment 
(- DD) (- DD) (- DD)
BDF .% .% .%
MD .% .% .%
MC .% .% .%
DA .% .% .%
bFR .% .% .%
ΔD .% .% .%
APR .% .% .%
RT .% .% .%
CT .% .% .%
Venules
BDF .% .% .%
MD .% .% .%
ΔD .% .% .%
RT .% .% .%
Table .:Mean coeﬃcients of variation across ﬂicker cycles as a function of location for each outcome parameter.
Smallest variability per parameter is highlighted in bold. For acronyms, see page .
Subjects
Arteries Veins
Short Long Diﬀerence Short Long Diﬀerence
MU MU MU MU MU MU
      
      
      
      
      
      
      
      
      
      
      
Table .: Vessel segments lengths that went into the comparison. e extent of the long segments was only
restricted by individual angioarchitecture (selection was always kept as long as possible). e extent
of the short segments was truncated to an arbitrary length of  MU in order to compare two distinctly
diﬀerent lengths.

 Location and Length Inﬂuence on Vessel Reactivity
To quantify the graphical representation of the diﬀerences as shown in Figures . to .,
the area under the curve (positive deviation from zero), the area above the curve (negative
deviation from zero) and their sums (total deviation from zero) were calculated (Table .) for
arteries and veins individually per subject. Since the subtraction was (arbitrarily) calculated
as the long segment minus the short one, larger positive deviations from zero compared to
their negative counterparts means that longer segments showed higher amount of dilation
(on average, across the  seconds) compared to the shorter segments and vice versa. For
arteries, the best agreement (i.e. total deviation values closer to zero) between the two lengths
selections is found for Subjects ,  and . For veins, the best agreement between the two
lengths selections is found for Subjects ,  and . is leaves the majority of participants ( out
of ) with considerable deviations from the theoretical value of zero, indicating an inﬂuence
of vessel segment’s length on diameter recordings.
No correlation was found (neither for arteries, nor for veins) between the absolute length
diﬀerence between the long and the short vessel segments (Table .) and the induced total
deviation from zero (Table .).
. Discussion
.. Measurement Location Considerations
Retinal vessels have varying structural and functional properties as they extend along space.
Smooth muscle cells provide structural support to the vasculature and mediate the myogenic
mechanism for vascular autoregulation of blood ﬂow. As shown by electron microscopy, the
arterial wall consists of ﬁve to seven layers of smooth muscle cells (tunica media) near the
optic disk (Pournaras et al., ). Towards the equator, these decrease to two or three layers.
An additional variable parameter when examining diﬀerent locations along the retina is vessel
branching. Depending on individual angioarchitecture an arteriole belonging to the area of -
DD away from the edge of the ONH may belong to a third order bifurcation, since it is quite
common for feeding arterioles to branch oﬀ towards the macula in the area prior to that (-
DD). Consequently, there is a pressure drop between arterioles of diﬀering branching order,
which may aﬀect the potential of each vessel segment to dilate, accordingly (Gaﬁychuk and
Lubashevsky, ). is is corroborated from the fact that axial velocity of red blood cells in
the major retinal arteries and veins of normal human and primate monkey eyes has been found
to increase linearly with vessel diameter by means of bidirectional laser Doppler velocimetry
(Pournaras et al., ).
Regarding functional heterogeneity along the retinal microvasculature structural diﬀerences
on a cellular level in endothelial cells have been identiﬁed in the pig retina in vitro by means of

 Location and Length Inﬂuence on Vessel Reactivity
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Figure .: Plots of the ﬂicker response diﬀerence between the longest possible segment measured and a truncated
shorter segment of  MU for all subjects for arteries. Vessel segments belonged to an area of - DD
distal to the ONH.

 Location and Length Inﬂuence on Vessel Reactivity
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Figure .: Plots of the ﬂicker response diﬀerence between the longest possible segment measured and a truncated
shorter segment of  MU for all subjects for veins. Vessel segments belonged to an area of - DD
distal to the ONH.

 Location and Length Inﬂuence on Vessel Reactivity
Subjects
Arteries Veins
Deviation from zero
Positive Negative Total Positive Negative Total
 . . . . . .
 . . . . . .
 . .  .  .
 .  . . . .
 . . . . . .
 . . .   
 . . .  . .
 . . . . . .
  . . . . .
 .  . . . 
 .  . . . .
Table .: Values of positive, negative and total deviation from the theoretical value of zero, if the long and short
segments had no inﬂuence on output of diameter recordings for arteries (Figure .) and veins (Figure .).
Essentially, positive values represent the area under the curve, negative values the area above the curve
and total deviation their sum.
confocal microscopy (Yu et al., ). e distribution of F-actin, endothelial cell size and shape,
nucleus size, shape and position within the cell were determined as a function of location along
the vascular tree.
Exploration of retinal vascular reactivity over a range of locations is not a recent concept.
Despite the lack of cuing edge technology at the time, Lanigan et al. () demonstrated the
variability of retinal vessel responses at  diﬀerent sites using isometric muscle contractions
as a stimulus. Responses diﬀered by at least % in various arteriolar sites and at least % in
various venular sites.
Prior to the incorporation of the embedded ﬂicker module in the RVA at a ﬂicker frequency
of . Hz, ﬂicker stimulation was achieved using an external lamp, which shone light onto a
rotating sector disc (Polak et al., ). In their study, their main motivation was to investigate
the optimisation of the diameter response in terms of diﬀerent ﬂicker frequencies (- Hz).
At the same time though, they measured oﬄine multiple locations using the video recordings:
a major vessel trunk proximally (- DD), the same major vessel trunk distally (- DD) and
a distal branch. Using two diﬀerent ﬂicker frequencies ( and  Hz), they found comparable
diameter ﬂicker responses for arteries across all locations. In retinal veins, the response in
branches (i.e. the smaller venules) had a tendency to be higher, but this eﬀect was not signiﬁcant
for their healthy cohort of nine subjects. Results in this work, although, not directly comparable
due the protocol diﬀerences, are in agreement, since no diﬀerences were found in arteriolar or
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venular responses across the three diﬀerent locations. ey also observed negative correlation
between baseline diameters and maximum dilation values in veins, but not in arteries. Here,
results showed a similar negative trend, but this was very weak and did not reach statistical
signiﬁcance.
In a sample of  healthy, non-vasospastic females, Gugleta and colleagues found no signiﬁcant
diﬀerences in maximum dilation amplitude between proximal (- DD) and distal (- DD)
retinal vessels (arteries and veins), with the three ﬂicker cycles being analysed separately
(Gugleta et al., ). Similarly to the results reported in this thesis, they reported no inﬂuence
of the measurement site on vessel responses.
Another study investigated the inﬂuence of measurement location in  healthy males in
arterial diameter response by means of the RVA (Jeppesen et al., ). eir participants were
subjected to isometric exercise, which induced an increase to systemic BP, while arteriolar
diameters were continuously recorded. While this was a completely diﬀerent experimental
protocol (pressure autoregulation) compared to that of ﬂicker stimulation (metabolic autore-
gulation), which induces arterial contraction instead of dilation, it is of interest to note their
ﬁndings: distal retinal arterioles (of smaller calibre) contracted signiﬁcantly more than their
proximal counterparts.
A recent study investigated diﬀerences in the response of arterioles supplying two diﬀerent
areas; the macular and the peripheral retina (Jensen et al., ). ey applied three diﬀerent
provocation protocols: isometric exercise, ﬂickering light and a combination of the two. With
ﬂickering light alone, no diﬀerences were observed between the response in macular and
peripheral arterioles within their  healthy subjects.
e ﬁndings in this thesis extend current knowledge and certain methodological standardisa-
tions are proposed. To implement the location-dependent comparisons, measurement rings
analogous to the concept of AVR measurement rings (Figure .) were introduced. In this
way, the three measurement sites are fully standardised across subjects, rather than using
visual judgement to describe the approximate measurement location as the case is with current
studies. For instance, Gugleta et al. () clearly show an example of vessel location selection
to belong to an area of - DD, but it is not clear whether this location was kept for all of
their subjects, since they mention that “vascular geometry governed the exact location of the
measurement”. Moreover, spliing the areas in  DD wide rings (- DD, - DD and - DD)
fulﬁls the manufacturer’s recommendation to obtain vessel segments of a maximum length of
 DD.
e main outcome parameter, maximum arteriolar and venular dilation in response to ﬂicker-
ing light, did not diﬀer signiﬁcantly across the three measuring sites. is was the case both for
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individual ﬂicker analysis and for averaged ﬂicker responses. e same applied for BDF, MC,
DA, bFR, ΔD, APR and CT. Statistically, this is a direct implication that one could select any
measurement location within a  DD radius from the edge of the ONHwithout this having any
impact on outcome parameters. e only outcome parameter that is an exception, according
to results herein, is arteriolar reaction time between Segment  and . When the three reaction
times were averaged, proximal arterioles were slower to reach maximum dilation compared to
their immediate neighbouring arterioles. ere are no other studies to have measured within
a - DD area and to report reaction time values to compare this ﬁnding to.
Present data lend further support to previous observations (Polak et al., ; Nagel et al.,
) that baseline absolute vessel diameters do not correlate with relative amplitude of ﬂicker
response, as conﬁrmed by linear regression analysis, pooling all  vessel segments together.
Also, a positive correlation between MABP and maximum arteriolar dilation was found. A
 mmHg diﬀerence in MABP showed approximately a % diﬀerence in maximum arteriolar
dilation induced by ﬂicker provocation (within a range of normal BP values). Of course,
correlation does not imply causation and since there are no relevant data in literature to
compare this ﬁnding to, no further assumptions can be made at this point. A comparison
between  normotensives with MABP of  mmHg and  hypertensives with MABP of
 mmHg, showed an inverse relationship of diminishing maximum arteriolar dilation (.%
versus .%, respectively), but used a longer protocol of  ﬂicker repeats (Nagel et al., ).
Despite the aforementioned structural and functional heterogeneities along the retinal mi-
crovasculature, measurements of vascular reactivity in three distinct locations in arterioles
and venules did not diﬀer. ere could be various reasons for that. First, the vessels’
characteristics may not vary enough within - DD for the RVA’s resolving capabilities to
be able to capture these diﬀering vessel properties. Second, retinal diameters are inherently
ﬂuctuating even under constant illumination during the cardiac cycle. Reliable detection of
small diameter changes (.%) was only possible by taking fundus photographs synchronised
to an electrocardiograph, while othermethods either failed to detect changes or were unreliable
(Dumskyj et al., ). As the pulse wave travels along the microvasculature, ﬂicker initiation
may coincide with the crest, the trough or anywhere in between of the wave at a given
vessel segment. erefore, responses may be blunted or augmented accordingly, masking any
potential diﬀerences across diﬀerent measuring locations. Lastly, the sample size might not
suﬃce to detect signiﬁcant diﬀerences. By all means, further studies on this topic arewarranted
to explore the inﬂuence of measurement location on retinal vessel reactivity bymeans of ﬂicker
stimulation.
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.. Measurement Length Considerations
Selecting the extent of the measuring vessel segment using the RVA system is primarily
governed by individual angioarchitecture. Tortuous retinal vessels, bifurcations and closely
situated arteries and veins are segments that cannot be considered for inclusion. Given that the
soware’s algorithm automatically truncates parts of the segment selection in case of quality
issues (for instance, low contrast between vessels and surrounding tissue), end-users should
always aempt to select segments that are as long as possible.
For the ﬁrst time, results on the eﬀect of diﬀerent vessel segment lengths on ﬂicker provocation
diameter recordings of both arterioles and venules are reported. So far, a large body from the
RVA-related publications has given lile or no aention to systematic reporting of the extent of
their vessel selection. From the analysis in this thesis, it is evident that for the majority of cases
( out of  for arteries and  out of  for veins) the measurement length is a factor that induces
variability to the ﬁnal outcome. For both arteries and veins, there was substantial variability in
the diameter responses when two distinctly diﬀerent in length vessel segments were compared.
is implies that including additional (or less) “information” from adjacent locations, yields a
diﬀerent diameter recording. One could argue that ﬂuctuations are a consequence of noise or
insuﬃcient measurement quality (for instance, due to low contrast). However, this is highly
unlikely, since all recordings were carefully selected prior to inclusion in this analysis. As a
maer of fact, this is the reason for the relatively small sample size: only measurements with
even illumination across the full ° ﬁeld and high quality recordings could be fully analysed
up to the - DD measurement ring. is was achieved by extracting the brightness course
graphs by means of the vendor-supplied soware and validating that ﬂuctuations were kept
to a minimum along the measurement duration. It is also known, that optical distortions may
add up to errors of measuring sensitivity up to % if the measuring location is located near
the margins of the image area (Seifertl and Vilser, ). Hence, for added conﬁdence, only
vessel segments belonging to the central - DD measurement ring were included into the
analysis. Another interesting observation is that in the case of veins (speciﬁcally for Subjects 
and ) the long segment selections exhibit consistently higher amounts of dilation (since the
subtraction of long minus short selections are above zero) due to ﬂickering light (time ranges
of -, - and - seconds) by a factor of - MU.
Nevertheless, the implications of this novel ﬁnding do not necessarily have a negative impact to
the reliability of the RVA system, if certain standardisations are enforced. Firstly, all relevant
studies should be reporting the actual measurement location and the exact vessel length of
their analysis. Unfortunately, a considerable amount of publications so far have not disclosed
any such information. Secondly, comparisons within subjects (for example, from multiple
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visit measurements) should always be made with equally long segment selections. Of course,
this is practically not feasible to achieve in real time, but truncating oﬄine vessel segments
accordingly, prior to data analysis, can be easily accomplished.
. Conclusions
e vulnerability of the retina to vascular related diseases and the substantial reliance on
local regulation of the retinal vasculature renders an improved understanding of such local
regulatory mechanisms of signiﬁcant clinical importance. Multi-segment analysis may indeed
show comparable responses in healthy volunteers, but this may not be the case in various
retinal manifestations of systemic disease, including diabetic retinopathy, glaucoma and
hypertensive retinopathy.
Standardisation of measurement conditions is a necessity when utilising the RVA system. e
magnitude of the induced responses by means of retinal ﬂicker provocation is small and many
factors can potentially suppress or augment those responses. Both measurement location and
the extend of the vessel segment sampled should be taken into account to be able to control
for these factors and should always be reported in future publications. Agreement between
research groups on standardisation protocols needs to be reached, before the RVA can be
considered clinically useful in detecting or predicting vascular dysfunction.
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Chapter 
Essential Hypertension: Case Reports
. Introduction and Motivation
Imaging the retinal microvasculature oﬀers a surrogate view of systemic vascular health,
allowing non-invasive and longitudinal assessment of vascular pathology. In order to discuss
the strengths and weaknesses of utilising the RVA system to assess metabolic autoregulation
in the retina in treated essential hypertensives three essential hypertensives were invited
that were previously ( years ago) subjected to the protocol detailed below, as a follow-up,
longitudinal, small case report study.
. Ethical Approval
e study adhered to the tenets of the declaration of Helsinki and the protocol was peer
reviewed from Aston University as well as undergone through a separate second peer review
by the Aston Optometry and Audiology Research Ethics Commiee, which subsequently
approved it. Furthermore, this study has undergone R&D and NHS ethics review prior to its
commencement (Research Ethics Commiee Reference: /EM/).
. Methods and Subjects
One previously diagnosed and two newly diagnosed essential hypertensives had been initially
examined as part of a research study in  and returned for a follow-up examination in .
Both the initial and the follow-up assessments were split into two research appointments, held
on two consecutive days as follows.
.. Day  - Ambulatory BP and ECG Monitoring
Participants were invited to aend their ﬁrst research appointment aer fasting frommidnight
of the preceding day. A  hour BP and ECGmonitor (Cardiotens, Meditech, PMS Instruments,
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UK) was ﬁed to assess both systemic circulation and autonomic function. BP measurements
were obtained every  minutes during the day period and every  minutes during the night
period. Given - for instance - a typical  hour sleep period the total number of BPmeasurements
obtained amounted to . Patients recorded a standardised patient diary on the monitoring
day with information on their daily routine, physical activities undertaken and time and type
of antihypertensive medication taken. en, subjects were dismissed.
... Outcome Measures
At completion of the  hour period the BP and ECG monitor was removed. Data were
downloaded onto a personal computer and were analysed using the vendor-supplied soware,
namely CardioVisions (Version ..). Outcome variables were SBP, DBP, HR, LF, HF, HRV
triangular index, each for day, night and  hour periods.
.. Day  - Eye examinations
e following day, patients returned for their second research appointment. At least  hours
prior to their morning visits, participants were asked to abstain from smoking, from consuming
products containing alcohol or caﬀeine, as well as from taking up any sort of considerable
physical activity, whereas they were instructed not to fast. Room temperature was maintained
constant during all measurements (- ℃). Only right eyes were tested.
... Intraocular Pressure Measurement
Non-contact tonometry was performed to assess IOP by means of a validated (Ogbuehi and
Almubrad, ) device (Pulsair EasyEye, Keeler Ltd., UK). ree consecutive readings were
obtained from the experimental eye and the average value was recorded.
... Retinal Functional Analysis
Details on the RVA measuring principle have been extensively described (Section ...). One
drop of Tropicamide (% w/v, Bausch & Lomb, UK) was instilled to achieve pupil dilation
necessary for geing unobstructed view of the posterior pole. As soon as full pupil dilation
was reached, the dynamic retinal vessel assessment commenced. One retinal arteriole and one
retinal venule from the superotemporal fundus area - DD away from the edge of the ONH
were examined.
... Outcome Measures
e following parameters (as deﬁned in Section ...) were obtained (from both initial and
follow-up sessions) averaged across the three ﬂicker cycles by means of raw RVA output data
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processing: BDF, bFR, MD, MC, DA, RT, CT, ΔD and APR. Absolute arteriolar and venular
diameters were recorded in MU.
.. Data Analysis
Longitudinal results are reported per individual. Due to the nature of the study (case report)
no statistical analyses have been performed. For visualisation of the RVA diameter recordings,
graphs were ploed comparing initial and follow-up measurements.
. Results
.. Sample
ree male Caucasians, non-smokers, essential hypertensives took part in this case reports
series. JW had been previously diagnosed prior to the initial examination (treatment with
combination of beta-blockers and Angiotensin Converting Enzyme (ACE) inhibitors). JH was
diagnosed shortly aer the initial examination and had been under treatment (ACE inhibitors)
ever since the follow-up examination. TR was undiagnosed at the time point of the initial
examination and was under treatment for a few months only (ACE inhibitors and Latanoprost)
prior to the follow-up visit. At the time point of their initial visit JH was , JW was  and TR
was  years old.
.. hr BP and ECG Monitoring
Values of  hour BP monitoring parameters and frequency-domain HRV parameters from 
hour ECG monitoring are shown in Table .. For the case of JH, sympatho-vagal balance as
deﬁned by the LF/HF ratio (for both day and night) has dropped, between the two time points,
to values signifying equal sympathetic and parasympathetic activity. is was mediated from
a combined drop in LF and increase in HF components. SBP and DBP values have dropped
substantially, whereas HR has remained stable. Day time BP values for JW and TR have largely
remained stable. Conversely, improvement on BP values due to antihypertensive medication is
clearly visible in the night time values which have been lowered. Regarding frequency domain
HRV parameters, the younger subject of the three (JW) shows directly opposite sympatho-
vagal activity when compared to the older subject (JH) (approximately two decades of age
diﬀerence). No speciﬁc paern of sympatho-vagal changes is observed in the case of TR.
.. Retinal Functional Assessment
Averaged values across the three ﬂicker provocation cycles were calculated and reported in
Table .. Both arteriolar and venular MD dropped between the two time points for JH
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Parameter JH,  JW,  TR, Initial Follow-up Initial Follow-up Initial Follow-up
SBP/DBP day (mmHg) / / / / / /
SBP/DBP night (mmHg) / / / / / /
SBP/DBP h (mmHg) / / / / / /
HR day      
HR night      
HR h      
LF day (NU)      
LF night (NU)      
HF day (NU)      
HF night (NU)      
LF/HF day (NU) . . . . . 
LF/HF night (NU) . . . . . .
Day/night LF (NU)      
Day/night HF (NU)      
Day/night LF/HF (NU) . . . . . .
HRV TI      
Table .: BP, HR and frequency-domain HRV parameters for the initial and follow-up examinations of the three
hypertensives. Noted years of age for each participant are at the time point of their initial visit. Follow-up
period was ﬁve years. TI, Triangular Index; NU, Normalised Units.
and JW, contrary to TR who showed increased arteriolar reactivity in both vessels. Despite
the increased reactivity for the case of TR, arteriolar dilatory capacity as described by DA
shows similar values across the two visits. is is corroborated by the arteriolar MC values.
Apparently, antihypertensive medication across all subjects has a positive eﬀect in arteriolar
RT. Arteries take substantially less time to reachmaximumdilation, although the value reached
is lower for the cases of JH and JW (. MU and . MU, respectively).
Graphical representations of the diameter responses induced by ﬂickering light by means of
the RVA for the three hypertensives are shown in Figures . to .. Arteries and veins are
ploed separately for easier comparisons between the initial and follow-up examinations.
. Discussion
In both hospitalised and non-hospitalised subjects electrocardiograms were recorded for 
hours and the main ﬁnding was that in both groups the markers of sympathetic and vagal
regulation of HR underwent circadian changes (Furlan et al., ). Namely sympathetic
predominance (LF component) was apparent during the day and vagal predominance (HF
component) during the night. For  out of  instances this was true for subjects in this study
as well (day LF higher than night LF and night HF higher than day HF, Table .). A more
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Figure .: Retinal vascular reactivity by means of the RVA across a  year period for Subject JH. Green lines
represent the follow-up measurement.
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Figure .: Retinal vascular reactivity by means of the RVA across a  year period for Subject JW. Green lines
represent the follow-up measurement.
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Figure .: Retinal vascular reactivity by means of the RVA across a  year period for Subject TR. Green lines
represent the follow-up measurement.
Parameter JH,  JW,  TR, Initial Follow-up Initial Follow-up Initial Follow-up
Arteries
BDF (%) . (.) . (.) . (.) . (.) . () . (.)
MD (%) . (.) . (.) . (.) . (.) . () . (.)
MC (%) . (.) . () . (.) . (.) . ()  (.)
DA (%) . (.) . (.) . (.) . (.) . (.) . (.)
bFR (%) . (.) . (.) . () . (.) . (.) . ()
ΔD (%) . (.) . (.) . (.)  (.) . (.) . (.)
APR . (.)  (.)  (.) . (.) . (.) . (.)
RT (s)  (.)  (.)  (.)  ()  (.)  (.)
CT (s)  (.)  (.)  (.)  (.)  ()  (.)
Veins
BDF (%) . (.)  (.) . (.) . (.) . (.) . (.)
MD (%) . (.) . (.) . () . (.) . (.) . (.)
ΔD (%) . (.)  (.) . (.) . (.) . (.) . (.)
RT (s)  (.)  (.)  (.)  (.)  (.)  (.)
Table .: RVA dynamic ﬂicker response parameters and reaction times, averaged across all three ﬂicker cycles.
Noted years of age for each participant are at the time point of their initial visit. Follow-up period was
ﬁve years. Values are expressed as means (SD). For acronyms, see page .

 Essential Hypertension: Case Reports
recent study reported signiﬁcant alterations in markers of SA regulation (increased LF and
reduced HF) both in pre-hypertensives and to a larger extent in hypertensives (Lucini et al.,
). Also, they noted that “hypertensive autonomic dysregulation was particularly apparent
in the youngest group”.
As it can be seen from the limited amount of data of this small case report study, the interactions
between factors, such as, disease onset and duration, treatment type and duration, age and
others are creating a highly diverse clinical picture. An additional limitation of the case
reports presented here is the long follow-up period of  years with no in between repeat visits.
Although data shown here include a temporal element, more frequent examinations should
ideally be performed (e.g. on a yearly basis). Similar studies to the concept of Nagel et al.
(b) but with suﬃciently large sample sizes and well stratiﬁed hypertensive groups would
enable fruitful comparisons across varying pathological and physiological states. Nevertheless,
the combination of macrovascular with microvascular information is the necessary step for the
ultimate goal for risk stratiﬁcation or treatment monitoring.
Each year CVD causes more than . million deaths in Europe, accounting for nearly half of
all deaths (%) (Allender et al., ). Major advances in prevention have led to improved
hypertension-related mortality and morbidity ﬁgures over the last three decades; nevertheless
essential hypertension is still the most prevalent among cardiovascular disorders. e
pathophysiology of essential hypertension involves a multitude of factors, including the
central nervous system, endocrine factors, the large arteries and the microcirculation. Large
scale population-based studies pioneered in identifying the relationships between impaired
microvascular perfusion, autoregulation or structure and subsequent target organ damage.
e limitation of such studies is that they are cross-sectional in nature. is allows only
assumptions to be made on the time course of the various disease manifestations: does
microvascular damage precede CVD or vice versa, or is it a complex two-way interaction?
No single modality is able to give deﬁnitive answers. e techniques as well as the strategies
for investigating microcirculatory function have evolved almost exponentially over the last 
years. e RVA technology is deﬁnitely a piece of the puzzle. It may serve as a complementary
research tool to help answer unresolved questions in both physiologic and pathological
conditions. Existing data demonstrate that visual stimulation is a powerful modulator of
retinal and optic nerve blood ﬂow. Much work has been accomplished thus far in exploring
neurovascular/neurometabolic coupling in the human retina but there are still many open
questions that remain to be elucidated. Technical limitations in imaging methods of low spatial
and temporal resolution can now be overcomemaking the reliable tracking of retinal capillaries
feasible (Bedggood and Metha, ).

Bibliography
Abramoﬀ, M., Magalhaes, P., and Ram, S. (). Image processing with ImageJ. Biophotonics
international, ():–.
Allender, S., Scarborough, P., Peto, V., Rayner, M., Leal, J., Luengo-Fernandez, R., and Gray, A.
(). European cardiovascular disease statistics. European Heart Network London.
Antonios, T. F. T., Singer, D. R. J., Markandu, N. D., Mortimer, P. S., andMacGregor, G. A. ().
Structural Skin Capillary Rarefaction in Essential Hypertension. Hypertension, ():–
.
Anuradha, S., Healy, G. N., Dunstan, D. W., Klein, R., Klein, B. E., Cotch, M. F., Wong, T. Y.,
and Owen, N. (). Physical Activity, Television Viewing Time, and Retinal Microvascular
Caliber. American Journal of Epidemiology, ():–.
Azegrouz, H., Trucco, E., Dhillon, B., MacGillivray, T., and MacCormick, I. (). ickness
dependent tortuosity estimation for retinal blood vessels. In Engineering in Medicine and
Biology Society, . EMBS ’. th Annual International Conference of the IEEE, volume ,
pages  – .
Barna, I., Keszei, A., and Dunai, A. (). Evaluation of Meditech ABPM- ambulatory blood
pressure measuring device according to the British Hypertension Society protocol. Blood
Press Monitoring, ():–.
Barold, S. (). Norman J. “Je” Holter–“Father” of Ambulatory ECG Monitoring. Journal of
Interventional Cardiac Electrophysiology, ():–.
Bedggood, P. and Metha, A. (). Direct visualization and characterization of erythrocyte
ﬂow in human retinal capillaries. Biomed. Opt. Express, ():–.
Beevers, G., Lip, G. Y., and O’Brien, E. (). Blood pressure measurement: Part I—
Sphygmomanometry: factors common to all techniques. BMJ, ():–.
Bek, T., Hajari, J., and Jeppesen, P. (). Interaction between ﬂicker-induced vasodilatation
and pressure autoregulation in early retinopathy of type  diabetes. Graefe’s Archive for

Bibliography
Clinical and Experimental Ophthalmology, ():–.
Berne, R. M. and Levy, M. N. (). Cardiovascular Physiology. Mosby, th edition.
Bevan, J. A., Bevan, R. D., Hwa, J. J., Owen, M. P., and Tayo, F. M. (). Calcium Regulation
in Vascular Smooth Muscle: Is ere a Paern to Its Variability Within the Arterial Tree?
Journal of Cardiovascular Pharmacology, :S–S.
Blum, M., Bachmann, K., Wintzer, D., Riemer, T., Vilser, W., and Strobel, J. (). Noninvasive
measurement of the Bayliss eﬀect in retinal autoregulation. Graefe’s Archive for Clinical and
Experimental Ophthalmology, ():–.
Blum, M., Kloos, C., Günther, S., Hunger-Dathe, W., and Müller, U. (). Improved metabolic
control results in beer myogenic response of retinal arterioles in patients with diabetes
mellitus type . Ophthalmologica, ():–.
Blum, M., Scherf, C., Bachmann, K., and Strobel, J. (). Alterskorrelierte Kontraktilität
retinaler Arteriolen bei Sauerstoﬀatmung. Der Ophthalmologe, :–.
Bracher, D. (). Changes in peripapillary tortuosity of the central retinal arteries in
newborns. Graefe’s Archive for Clinical and Experimental Ophthalmology, :–.
Brown, S. M. and Jampol, L. M. (). New Concepts of Regulation of Retinal Vessel Tone.
Arch Ophthalmol, ():–.
Chapman, N., Dell’omo, G., Sartini, M. S., Wi, N., Hughes, A., om, S., and Pedrinelli,
R. (). Peripheral vascular disease is associated with abnormal arteriolar diameter
relationships at bifurcations in the human retina. Clin. Sci., ():–.
Chapman, N., Haimes, G., Stanton, A. V., om, S. A., and Hughes, A. D. (). Acute eﬀects
of oxygen and carbon dioxide on retinal vascular network geometry in hypertensive and
normotensive subjects. Clin. Sci., ():–.
Chasis, H. (). Appreciation of the Keith, Wagener, and Barker classiﬁcation of hypertensive
disease. e American Journal of the Medical Sciences, ():.
Chen, H., Patel, V., Wiek, J., Rassam, S., and Kohner, E. (). Vessel diameter changes during
the cardiac cycle. Eye (London, England), :–.
Cheung, C. Y., Hsu, W., Lee, M. L., Wang, J. J., Mitchell, P., Lau, Q. P., Hamzah, H., Ho, M., and
Wong, T. Y. (). A New Method to Measure Peripheral Retinal Vascular Caliber over an
Extended Area. Microcirculation, ():–.
Cliﬀord, G. D., Azuaje, F., and McSharry, P. (). Advanced Methods And Tools for ECG Data
Analysis. Artech House, Inc.

Bibliography
Dart, A. M. and Kingwell, B. A. (). Pulse pressure—a review of mechanisms and clinical
relevance. Journal of the American College of Cardiology, ():–.
Dawczynski, J., Mandecka, A., Blum, M., Müller, U. A., Ach, T., and Strobel, J. ().
Endotheliale Dysfunktion zentraler Netzhautgeäße als Prognoseparameter der diabetischen
Retinopathie? Klin Monatsbl Augenheilkd, ():–.
Delles, C., Michelson, G., Harazny, J., Oehmer, S., Hilgers, K. F., and Schmieder, R. E. ().
Impaired Endothelial Function of the Retinal Vasculature in Hypertensive Patients. Stroke,
():–.
Dolan, E., Li, Y., ijs, L., McCormack, P., Staessen, J. A., O’Brien, E., and Stanton, A. ().
Ambulatory arterial stiﬀness index: rationale and methodology. Blood Pressure Monitoring,
():–.
Dorion, T. (). Manual of ocular fundus examination. Buerworth-Heinemann.
Dougherty, G., Johnson, M., and Wiers, M. (). Measurement of retinal vascular tortuosity
and its application to retinal pathologies. Medical and Biological Engineering and Computing,
():–.
Dougherty, G. and Varro, J. (). A quantitative index for the measurement of the tortuosity
of blood vessels. Medical Engineering & Physics, (): – .
Dumskyj, M. J., Aldington, S. J., Doré, C. J., and Kohner, E. M. (). e accurate assessment
of changes in retinal vessel diameter using multiple frame electrocardiograph synchronised
fundus photography. Current Eye Research, ():–.
Faul, F., Erdfelder, E., Lang, A.-G., and Buchner, A. (). G*power : a ﬂexible statistical power
analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods,
():–.
Formaz, F., Riva, C., and Geiser, M. (). Diﬀuse luminance ﬂicker increases retinal vessel
diameter in humans. Current Eye Research, ():–.
Frederiksen, C., Jeppesen, P., Knudsen, S., Poulsen, P., Mogensen, C., and Bek, T. (). e
blood pressure-induced diameter response of retinal arterioles decreases with increasing
diabetic maculopathy. Graefe’s Archive for Clinical and Experimental Ophthalmology,
():–.
Furlan, R., Guzzei, S., Crivellaro, W., Dassi, S., Tinelli, M., Baselli, G., Cerui, S., Lombardi, F.,
Pagani, M., and Malliani, A. (). Continuous -hour assessment of the neural regulation
of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation, ():–
.

Bibliography
Gaﬁychuk, V. V. and Lubashevsky, I. A. (). On the Principles of the Vascular Network
Branching. Journal of eoretical Biology, (): – .
Garhöfer, G., Bek, T., Boehm, A. G., Gherghel, D., Grunwald, J., Jeppesen, P., Kergoat, H., Kotliar,
K., Lanzl, I., Lovasik, J. V., Nagel, E., Vilser, W., Orgul, S., and Schmeerer, L. (). Use of the
retinal vessel analyzer in ocular blood ﬂow research. Acta Ophthalmologica, ():–.
Garhöfer, G., Resch, H., Weigert, G., Lung, S., Simader, C., and Schmeerer, L. (). Short-
Term Increase of Intraocular Pressure Does Not Alter the Response of Retinal and Optic
Nerve Head Blood Flow to Flicker Stimulation. Investigative Ophthalmology & Visual Science,
():–.
Garhöfer, G., Zawinka, C., Huemer, K.-H., Schmeerer, L., and Dorner, G. T. (). Flicker
Light–Induced Vasodilatation in the Human Retina: Eﬀect of Lactate and Changes in Mean
Arterial Pressure. Investigative Ophthalmology & Visual Science, ():–.
Gasser, P. and Bühler, F. R. (). Nailfold microcirculation in normotensive and essential
hypertensive subjects, as assessed by video-microscopy. Journal of Hypertension, ():–
.
Ghiadoni, L., Faita, F., Salvei, M., Cordiano, C., Biggi, A., Puato, M., Di Monaco, A., De Siati,
L., Volpe, M., Ambrosio, G., Gemignani, V., Muiesan, M. L., Taddei, S., Lanza, G. A., and
Cosentino, F. (). Assessment of ﬂow-mediated dilation reproducibility: a nationwide
multicenter study. Journal of Hypertension, ():–.
Gugleta, K., Kochkorov, A., Katamay, R., Zawinka, C., Flammer, J., and Orgul, S. (). Analysis
of Retinal Vasodilation aer Flicker Light Stimulation in Relation to Vasospastic Propensity.
Investigative Ophthalmology & Visual Science, ():–.
Gugleta, K., Kochkorov, A., Waldmann, N., Polunina, A., Katamay, R., Flammer, J., and Orgul, S.
(). Dynamics of retinal vessel response to ﬂicker light in glaucoma patients and ocular
hypertensives. Graefe’s Archive for Clinical and Experimental Ophthalmology, ():–.
Gugleta, K., Waldmann, N., Polunina, A., Kochkorov, A., Katamay, R., Flammer, J., and Orgul,
S. (). Retinal neurovascular coupling in patients with glaucoma and ocular hypertension
and its association with the level of glaucomatous damage. Graefe’s Archive for Clinical and
Experimental Ophthalmology, :–.
Gunn, M. (). On ophthalmoscopic evidence of general arterial disease. Trans Ophthalmol
Soc UK, :–.
Guzzei, S., Dassi, S., Pecis, M., Casat, R., Masu, A. M., Longoni, P., Tinelli, M., Cerui, S.,
Pagani, M., and Malliani, A. (). Altered paern of circadian neural control of heart

Bibliography
period in mild hypertension. Journal of Hypertension, ():–.
Haeﬂiger, I., Flammer, J., and Luscher, T. (). Heterogeneity of endothelium-dependent
regulation in ophthalmic and ciliary arteries. Investigative Ophthalmology & Visual Science,
():–.
Hammer, M., Vilser, W., Riemer, T., and Schweitzer, D. (). Retinal vessel oximetry-
calibration, compensation for vessel diameter and fundus pigmentation, and reproducibility.
Journal of Biomedical Optics, ():–––.
Harper, R. N., Moore, M. A., Marr, M. C., Was, L. E., and Hutchins, P. M. (). Arteriolar
rarefaction in the conjunctiva of human essential hypertensives. Microvascular Research,
():–.
Hart, W. E., Goldbaum, M., Côté, B., Kube, P., and Nelson, M. R. (). Measurement and
classiﬁcation of retinal vascular tortuosity. International Journal of Medical Informatics, (-
): – .
Heitmar, R., Blann, A., Cubbidge, R. P., Lip, G., and Gherghel, D. (). Continuous retinal
vessel diameter measurements - the future of retinal vessel assessment? Investigative
Ophthalmology & Visual Science, ():–.
Heitmar, R., Blann, A., Cubbidge, R. P., Lip, G., and Gherghel, D. (a). Author Response: Can
Vascular Function Be Assessed by the Interpretation of Retinal Vascular Diameter Changes?
Investigative Ophthalmology & Visual Science, ():–.
Heitmar, R., Cubbidge, R. P., Lip, G. Y. H., Gherghel, D., and Blann, A. D. (b). Altered
Blood Vessel Responses in the Eye and Finger in Coronary Artery Disease. Investigative
Ophthalmology & Visual Science, ():–.
Heitmar, R. and Summers, R. (). Assessing vascular function using dynamic retinal
diameter measurements: A new insight on the endothelium. rombosis and Haemostasis,
():–.
Hemminki, V., Kähönen, M., Tuomisto, M., Turjanmaa, V., and Uusitalo, H. ().
Determination of retinal blood vessel diameters and arteriovenous ratios in systemic
hypertension: comparison of diﬀerent calculation formulae. Graefe’s Archive for Clinical
and Experimental Ophthalmology, :–.
Hnatkova, K., Copie, X., Staunton, A., andMalik, M. (). Numeric processing of Lorenz plots
of R-R intervals from long-term ECGs: Comparison with time-domainmeasures of heart rate
variability for risk stratiﬁcation aer myocardial infarction. Journal of Electrocardiology, ,
Supplement (): – .

Bibliography
Houben, A., Canoy, M., Paling, H., Derhaag, P., and de Leeuw, P. (). antitative
analysis of retinal vascular changes in essential and renovascular hypertension. J Hypertens,
():–.
Hubbard, L., Ehrhardt, B., and Klein, R. (). e association between generalized arteriolar
narrowing and blood pressure. Investigative Ophthalmology & Visual Science, :.
Hubbard, L. D., Brothers, R. J., King, W. N., Clegg, L. X., Klein, R., Cooper, L. S., Sharre, A. R.,
Davis, M. D., and Cai, J. (). Methods for evaluation of retinal microvascular abnormalities
associated with hypertension/sclerosis in the Atherosclerosis Risk In Communities study.
Ophthalmology, (): – .
Hughes, A. D., Martinez-Perez, E., Jabbar, A. S., Hassan, A., Wi, N. W., Mistry, P. D.,
Chapman, N., Stanton, A. V., Beevers, G., Pedrinelli, R., Parker, K. H., and om, S. A.
(). antiﬁcation of topological changes in retinal vascular architecture in essential
and malignant hypertension. J Hypertens, ():–.
Jacks, A. S. and Miller, N. R. (). Spontaneous retinal venous pulsation: aetiology and
signiﬁcance. Journal of Neurology, Neurosurgery & Psychiatry, ():–.
Jean-Louis, S., Lovasik, J., and Kergoat, H. (). Systemic hyperoxia and retinal vasomotor
responses. Investigative Ophthalmology & Visual Science, ():–.
Jensen, S. P., Jeppesen, P., and Bek, T. (). Diﬀerential diameter responses in macular
and peripheral retinal arterioles may contribute to the regional distribution of diabetic
retinopathy lesions. Graefe’s Archive for Clinical and Experimental Ophthalmology, :–
.
Jeppesen, P., Sanye-Hajari, J., and Bek, T. (). Increased Blood Pressure Induces a
Diameter Response of Retinal Arterioles that Increases with Decreasing Arteriolar Diameter.
Investigative Ophthalmology & Visual Science, ():–.
Johnson, P. (). Autoregulation of blood ﬂow. Circulation research, ():–.
Kagan, A., Aurell, E., and Tibblin, G. (). Signs in the fundus oculi and arterial hypertension:
unconventional assessment and signiﬁcance. Bulletin of the World Health Organization,
():–.
Kalitzeos, A. A., Lip, G. Y., and Heitmar, R. (). Retinal vessel tortuosity measures and their
applications. Experimental Eye Research, (): – .
Kamath, M. and Fallen, E. (). Power spectral analysis of heart rate variability: a noninvasive
signature of cardiac autonomic function. Crit Rev Biomed Eng, ():–.

Bibliography
Keith, N. M. M., Wagener, H. P. M., and Barker, N. W. M. (). Some diﬀerent types of
essential hypertension: their course and prognosis. e American Journal of the Medical
Sciences, ():–.
King, L., Stanton, A., Sever, P.,om, S., andHughes, A. (). Arteriolar length-diameter (L:D)
ratio: a geometric parameter of the retinal vasculature diagnostic of hypertension. Journal
of Human Hypertension, ():–.
Kiss, B., Polska, E., Dorner, G., Polak, K., Findl, O., Mayrl, G. F., Eichler, H.-G., Wolzt, M., and
Schmeerer, L. (). Retinal Blood Flow duringHyperoxia inHumans Revisited: Concerted
Results Using Diﬀerent Measurement Techniques. Microvascular Research, (): – .
Klabunde, R. E. (). Cardiovascular physiology concepts. Wolters Kluwer Health.
Knudtson, M. D., Klein, B. E. K., Klein, R., Wong, T. Y., Hubbard, L. D., Lee, K. E., Meuer, S. M.,
and Bulla, C. P. (). Variation associated with measurement of retinal vessel diameters at
diﬀerent points in the pulse cycle. British Journal of Ophthalmology, ():–.
Knudtson, M. D., Lee, K. E., Hubbard, L. D., Wong, T. Y., Klein, R., and Klein, B. E. (). Revised
formulas for summarizing retinal vessel diameters. Current Eye Research, ():–.
Kotliar, K., Nagel, E., Vilser, W., and Lanzl, I. (). Functional in vivo assessment of retinal
artery microirregularities in glaucoma. Acta Ophthalmologica, ():–.
Kotliar, K., Nagel, E., Vilser, W., Seidova, S.-F., and Lanzl, I. M. (). Microstructural
alterations of retinal arterial blood column along the vessel axis in systemic hypertension.
Investigative Ophthalmology & Visual Science, ():–.
Kotliar, K. E., Baumann, M., Vilser, W., and Lanzl, I. M. (a). Pulse wave velocity in retinal
arteries of healthy volunteers. British Journal of Ophthalmology, :–.
Kotliar, K. E., Lanzl, I. M., Schmidt-Trucksäss, A., Sitnikova, D., Ali, M., Blume, K., Halle, M., and
Hanssen, H. (b). Dynamic retinal vessel response to ﬂicker in obesity: A methodological
approach. Microvascular Research, (): – .
Kotliar, K. E., Vilser, W., Nagel, E., and Lanzl, I. (). Retinal vessel reaction in response
to chromatic ﬂickering light. Graefe’s Archive for Clinical and Experimental Ophthalmology,
:–.
Kylstra, J., Wierzbicki, T., Wolbarsht, M., Landers, M., and Stefansson, E. (). e
relationship between retinal vessel tortuosity, diameter, and transmural pressure. Graefe’s
Archive for Clinical and Experimental Ophthalmology, :–.

Bibliography
La Rovere, M. T., Specchia, G., Mortara, A., and Schwartz, P. J. (). Baroreﬂex sensitivity,
clinical correlates, and cardiovascular mortality among patients with a ﬁrst myocardial
infarction. A prospective study. Circulation, ():–.
Langewitz, W., Rüddel, H., and Schächinger, H. (). Reduced parasympathetic cardiac
control in patients with hypertension at rest and under mental stress. American Heart
Journal, (): – .
Lanigan, L., Clark, C., and Hill, D. (). Retinal circulation responses to systemic autonomic
nerve stimulation. Eye (London, England), :–.
Lanzl, I., Seidova, S., Maier, M., Lohmann, C., Schmidt-Trucksäss, A., Halle, M., and Kotliar,
K. (). Dynamic retinal vessel response to ﬂicker in age-related macular degeneration
patients before and aer vascular endothelial growth factor inhibitor injection. Acta
Ophthalmologica, :–.
Lasta, M., Palkovits, S., Boltz, A., Schmidl, D., Kaya, S., Cherecheanu, A. P., Garhöfer, G., and
Schmeerer, L. (). Reproducibility of retinal vessel oxygen saturation measurements in
healthy young subjects. Acta Ophthalmologica, :e–e.
Lasta, M., Pemp, B., Schmidl, D., Boltz, A., Kaya, S., Palkovits, S., Werkmeister, R., Howorka, K.,
Popa-Cherecheanu, A., Garhöfer, G., and Schmeerer, L. (). Neurovascular Dysfunction
Precedes Neural Dysfunction in the Retina of Patients with Type  Diabetes. Investigative
Ophthalmology & Visual Science, ():–.
Leatham, A. (). e retinal vessels in hypertension. QJM, ():–.
Lee, B. B., Pokorny, J., Smith, V. C., Martin, P. R., and Valberg, A. (). Luminance and
chromatic modulation sensitivity of macaque ganglion cells and human observers. JOSA A,
():–.
Li, Y., Wang, J.-G., Dolan, E., Gao, P.-J., Guo, H.-F., Nawrot, T., Stanton, A. V., Zhu, D.-L.,
O’Brien, E., and Staessen, J. A. (). Ambulatory Arterial Stiﬀness Index Derived From
-Hour Ambulatory Blood Pressure Monitoring. Hypertension, ():–.
Lombardi, F., Malliani, A., Pagani, M., and Cerui, S. (). Heart rate variability and its
sympatho-vagal modulation. Cardiovascular research, ():–.
Lotmar, W., Freiburghaus, A., and Bracher, D. (). Measurement of vessel tortuosity on
fundus photographs. Graefe’s Archive for Clinical and Experimental Ophthalmology, :–
.
Lo, M. E. J., Slocomb, J. E., Shivkumar, V., Smith, B., Gabbay, R. A.,illen, D., Gardner, T. W.,
and Beermann, K. (). Comparison of retinal vasodilator and constrictor responses in

Bibliography
type  diabetes. Acta Ophthalmologica, ():e–e.
Lucini, D., Mela, G. S., Malliani, A., and Pagani, M. (). Impairment in cardiac autonomic
regulation preceding arterial hypertension in humans: Insights from spectral analysis of
beat-by-beat cardiovascular variability. Circulation, ():–.
Luscher, T. F. (). e Endothelium and Cardiovascular Disease – A Complex Relation. N
Engl J Med, ():–.
Mahler, F., Saner, H., Boss, C., and Annaheim, M. (). Local cold exposure test for
capillaroscopic examination of patients with Raynaud’s syndrome. Microvascular research,
():–.
Malik, M., Bigger, J. T., Camm, A. J., Kleiger, R. E., Malliani, A., Moss, A. J., and Schwartz, P. J.
(). Heart rate variability: Standards of measurement, physiological interpretation, and
clinical use. European Heart Journal, ():–.
Malliani, A. (). Heart rate variability: from bench to bedside . European Journal of Internal
Medicine, (): – .
Man, R. E. K., Kawasaki, R., Wu, Z., Luu, C. D., Wang, J. J., Wong, T. Y., and Lamoureux, E. L.
(). Reliability and Reproducibility of Retinal Oxygen Saturation Measurements using a
Predeﬁned Peri-papillary Annulus. Acta Ophthalmologica, :e–e.
Mancia, G., De Backer, G., Dominiczak, A., Ciova, R., Fagard, R., Germano, G., Grassi,
G., Heagerty, A. M., Kjeldse n, S. E., Laurent, S., Narkiewicz, K., Ruilope, L., Rynkiewicz,
A., Schmieder, R. E., Struijker Boudier, H. A., Zanchei, A. t., Vahanian, A., Camm, J.,
De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I.,
Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano,
J. L., Kjeldsen, S. E., Erdine, S., Narkiewicz, K., Kiowski, W., Agabiti-Rosei, E., Ambrosioni,
E., Ciova, R., Dominiczak, A., Fagard, R., Heagerty, A. h. M., Laurent, S., Lindholm, L. H.,
Mancia, G., Manolis, A., Nilsson, P. M., Redon, J., Schmieder, R. E., Struijker-Boudier, H. A.,
Viigimaa, M., Filippatos, G., Adamopoulos, S., Agabiti-Rosei, E., Ambrosioni, E., Bertomeu,
V., Clement, D., Er dine, S., Farsang, C., Gaita, D., Kiowski, W., Lip, G., Mallion, J.-M.,
Manolis, A. J., Nilsson, P. M., O’Brien, E., P onikowski, P., Redon, J., Ruschitzka, F., Tamargo,
J., van Zwieten, P., Viigimaa, M., Waeber, B., Williams, B., and Zamorano, J. L. ().
 Guidelines for the management of arterial hypertension. European Heart Journal,
():–.
Mandecka, A., Dawczynski, J., Blum, M., Müller, N., Kloos, C., Wolf, G., Vilser, W., Hoyer, H.,
and Müller, U. A. (). Inﬂuence of Flickering Light on the Retinal Vessels in Diabetic
Patients. Diabetes Care, ():–.

Bibliography
Mandecka, A., Dawczynski, J., Vilser, W., Blum, M., Müller, N., Kloos, C., Wolf, G., and Müller,
U. A. (). Abnormal retinal autoregulation is detected by provoked stimulation with
ﬂicker light in well-controlled patients with type  diabetes without retinopathy. Diabetes
Research and Clinical Practice, (): – .
Mehlsen, J., Jeppesen, P., Erlandsen, M., Poulsen, P. L., and Bek, T. (). Lack of eﬀect of short-
term treatment with Amlodipine and Lisinopril on retinal autoregulation in normotensive
patients with type  diabetes and mild diabetic retinopathy. Acta Ophthalmologica, :–
.
Millar-Craig, M., Bishop, C., and Raery, E. (). Circadian variation of blood pressure. e
Lancet, (): – .
Moore, R. F. (). e Retinitis of Arterio-Sclerosis, and Its Relation to Renal Retinitis and to
Cerebral Vascular Disease. QJM, os-(-):–.
Muench, K., Vilser, W., and Senﬀ, I. (). Adaptive Algorithms for the Automatic
Measurement of Retinal Vessel Diameters. Biomedizinische Technik, ():–.
Murray, C. (). e physiological principle of minimum work applied to the angle of
branching of arteries. Proc Natl Acad Sci U S A, ():–.
Nadar, S., Blann, A. D., and Lip, G. Y. (). Endothelial Dysfunction: Methods of Assessment
and Application to Hypertension. Current Pharmaceutical Design, ():–.
Nagel, E. and Vilser, W. (). Autoregulative behavior of retinal arteries and veins during
changes of perfusion pressure: a clinical study. Graefe’s Archive for Clinical and Experimental
Ophthalmology, :–.
Nagel, E., Vilser, W., Fink, A., and Riemer, T. (a). Varianz der Netzhautgeäßreaktion auf
Flickerlicht. Der Ophthalmologe, ():–.
Nagel, E., Vilser, W., Fink, A., Riemer, T., and Lanzl, I. (b). Blood pressure eﬀects on
retinal vessel diameter and ﬂicker response: A .-year follow-up. European Journal of
Ophthalmology, ():–.
Nagel, E., Vilser, W., and Lanzl, I. (). Age, Blood Pressure, and Vessel Diameter as Factors
Inﬂuencing the Arterial Retinal Flicker Response. Investigative Ophthalmology & Visual
Science, ():–.
Nagel, E., Vilser, W., and Lanzl, I. (). Vergleich der Durchmesserreaktion retinaler Arterien
und Venen auf Flickerlicht. Der Ophthalmologe, ():–.

Bibliography
Nguyen, T. T., Kreis, A. J., Kawasaki, R., Wang, J. J., Seifert, B.-U., Vilser, W., Nagel, E., and
Wong, T. Y. (). Reproducibility of the Retinal Vascular Response to Flicker Light in
Asians. Current Eye Research, ():–.
Nickla, D. L. and Wallman, J. (). e multifunctional choroid. Progress in Retinal and Eye
Research, (): – .
Noon, J. P., Walker, B. R., Webb, D. J., Shore, A. C., Holton, D.W., Edwards, H. V., andWa, G. C.
(). Impaired microvascular dilatation and capillary rarefaction in young adults with a
predisposition to high blood pressure. J Clin Invest, ():–.
Ogbuehi, K. C. and Almubrad, T. M. (). Accuracy and Reliability of the Keeler Pulsair
EasyEye Non-Contact Tonometer. Optometry & Vision Science, ():–.
Pache, M., Nagel, E., and Flammer, J. (). Reproduzierbarkeit derMessungenmit demRetinal
Vessel Analyzer unter Optimalbedingungen Reproducibility of measurements with the
retinal vessel analyzer under optimal conditions. KlinischeMonatsbläer ür Augenheilkunde,
:–.
Pagani, M., Lombardi, F., Guzzei, S., Rimoldi, O., Furlan, R., Pizzinelli, P., Sandrone, G.,
Malfao, G., Dell’Orto, S., and Piccaluga, E. (). Power spectral analysis of heart rate
and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and
conscious dog. Circulation Research, ():–.
Panza, J. A., yyumi, A. A., Brush, J. E., and Epstein, S. E. (). Abnormal Endothelium-
Dependent Vascular Relaxation in Patients with Essential Hypertension. New England
Journal of Medicine, ():–.
Parr, J. (). Hypertensive generalised narrowing of retinal arteries. Transactions of the
Ophthalmological Society of New Zealand, ():–.
Parr, J. and Spears, G. (a). General caliber of the retinal arteries expressed as the equivalent
width of the central retinal artery. American journal of ophthalmology, ():–.
Parr, J. and Spears, G. (b). Mathematic relationships between the width of a retinal artery
and the widths of its branches. American journal of ophthalmology, ():–.
Patel, S. R., Bellary, S., Qin, L., Gill, P., Taheri, S., Heitmar, R., Gibson, J. M., and Gherghel, D.
(). Abnormal retinal vascular function and lipid levels in a sample of healthy UK South
Asians. British Journal of Ophthalmology, :–.
Paon, N., Aslam, T., MacGillivray, T., Dhillon, B., and Constable, I. (). Asymmetry of
Retinal Arteriolar Branch Widths at Junctions Aﬀects Ability of Formulæ to Predict Trunk
Arteriolar Widths. Investigative Ophthalmology & Visual Science, ():–.

Bibliography
Paon, N., Maini, R., MacGillivary, T., Aslam, T. M., Deary, I. J., and Dhillon, B. (). Eﬀect of
Axial Length on Retinal Vascular Network Geometry. American Journal of Ophthalmology,
():.e – .e.
Pemp, B., Weigert, G., Karl, K., Petzl, U., Wolzt, M., Schmeerer, L., and Garhöfer, G.
(). Correlation of Flicker-Induced and Flow-Mediated Vasodilatation in Patients With
Endothelial Dysfunction and Healthy Volunteers. Diabetes Care, ():–.
Pickering, T. G., Gerin, W., and Schwartz, A. R. (). What is the white-coat eﬀect and how
should it be measured? Blood pressure monitoring, ():–.
Polak, K., Dorner, G., Kiss, B., Polska, E., Findl, O., Rainer, G., Eichler, H.-G., and Schmeerer,
L. (). Evaluation of the Zeiss retinal vessel analyser. British Journal of Ophthalmology,
():–.
Polak, K., Schmeerer, L., and Riva, C. E. (). Inﬂuence of Flicker Frequency on Flicker-
Induced Changes of Retinal Vessel Diameter. Investigative Ophthalmology & Visual Science,
():–.
Pournaras, C. J., Rungger-Brändle, E., Riva, C. E., Hardarson, S. H., and Stefansson, E. ().
Regulation of retinal blood ﬂow in health and disease. Progress in Retinal and Eye Research,
(): – .
yyumi, A. A., Crake, T., Mockus, L. J., Wright, C. A., Rickards, A. F., and Fox, K. M. ().
Value of the bipolar lead CM in electrocardiography. British Heart Journal, ():–.
Reimann, M., Prieur, S., Lippold, B., Bornstein, S. R., Reichmann, H., Julius, U., and
Ziemssen, T. (). Retinal vessel analysis in hypercholesterolemic patients before and
aer LDL apheresis. Atherosclerosis Supplements, (): – . Proceedings from the st
Dresden International Symposium onerapeutic Apheresis: Recent progress inerapeutic
Apheresis.
Resch, H., Zawinka, C., Weigert, G., Schmeerer, L., and Garhöfer, G. (). Inhaled Carbon
Monoxide Increases Retinal and Choroidal Blood Flow in Healthy Humans. Investigative
Ophthalmology & Visual Science, ():–.
Rickenbacher, I., Gugleta, K., Zawinka, C., Schötzau, A., Katamay, R., Flammer, J., and
Orgül, S. (). Flickerlichtprovokation bei Vasospastikern verglichen mit gesunden
Kontrollpersonen. Klinische Monatsbläer ür Augenheilkunde, :–.
Riva, C. E., Logean, E., and Falsini, B. (). Visually evoked hemodynamical response and
assessment of neurovascular coupling in the optic nerve and retina. Progress in Retinal and
Eye Research, (): – .

Bibliography
Rogers, K. (). Blood: Physiology and Circulation. e Rosen Publishing Group.
Rogoza, A. N., Pavlova, T. S., and Sergeeva, M. V. (). Validation of A&D UA- device for
the self-measurement of blood pressure. Blood Pressure Monitoring, ():–.
Rueddel, T., Kneser, M., and Tost, F. (). Impact of exercise on retinal microvascular
regulation measured by dynamic vessel analysis in healthy individuals. Clinical Physiology
and Functional Imaging, ():–.
Scheie, H. (). Evaluation of Ophthalmoscopic changes of Hypertension and Arteriolar
Sclerosis. AMA Arch Ophthalmol, ():–.
Seifertl, B. U. and Vilser, W. (). Retinal Vessel Analyzer (RVA)–design and function. Biomed
Tech,  Suppl  Pt :–.
Serne, E. H., Gans, R. O., ter Maaten, J. C., Tangelder, G.-J., Donker, A. J., and Stehouwer, C. D.
(). Impaired Skin Capillary Recruitment in Essential Hypertension Is Caused by Both
Functional and Structural Capillary Rarefaction. Hypertension, ():–.
Shantsila, A., Shantsila, E., and YH Lip, G. (). Malignant Hypertension: A Rare Problem or
is it Underdiagnosed? Current Vascular Pharmacology, ():–.
Shrout, P. and Fleiss, J. (). Intraclass correlations: uses in assessing rater reliability.
Psychological bulletin, ():–.
Staessen, J. A., Wang, J., Bianchi, G., and Birkenhäger, W. H. (). Essential hypertension.
e Lancet, (): – .
Stanton, A., Wasan, B., Cerui, A., Ford, S., Marsh, R., Sever, P., om, S., and Hughes, A.
(). Vascular network changes in the retina with age and hypertension. J Hypertens,
( Pt ):–.
Stokoe, N. and Turner, R. (). Normal retinal vascular paern. Arteriovenous ratio as a
measure of arterial calibre. British Medical Journal, ():–.
Stücker, M., Baier, V., Reuther, T., Hoﬀmann, K., Kellam, K., and Altmeyer, P. (). Capillary
blood cell velocity in human skin capillaries located perpendicularly to the skin surface:
measured by a new laser Doppler anemometer. Microvascular research, :–.
Taarnhøj, N. C. B. B., Larsen, M., Sander, B., Kyvik, K. O., Kessel, L., Hougaard, J. L., and
Sorensen, T. I. A. (). Heritability of Retinal Vessel Diameters and Blood Pressure: A
Twin Study. Investigative Ophthalmology & Visual Science, ():–.
Taarnhøj, N. C. B. B., Munch, I. C., Sander, B., Kessel, L., Hougaard, J. L., Kyvik, K., Sørensen,
T. I. A., and Larsen, M. (). Straight versus tortuous retinal arteries in relation to blood

Bibliography
pressure and genetics. British Journal of Ophthalmology, ():–.
Taylor, J. A., Carr, D. L., Myers, C. W., and Eckberg, D. L. (). Mechanisms Underlying
Very-Low-Frequency RR-Interval Oscillations in Humans. Circulation, ():–.
Verberk, W., Kroon, A., Jongen-Vancraybex, H., and De Leeuw, P. (). e applicability
of home blood pressure measurement in clinical practice: A review of literature. Vascular
Health and Risk Management, ():–.
Verdecchia, P. (). Prognostic Value of Ambulatory Blood Pressure: Current Evidence and
Clinical Implications. Hypertension, ():–.
Waeber, B., Genoud, M., Feihl, F., Hayoz, D., andWaeber, G. (). Ambulatory blood pressure
monitoring: a mean to stratify cardiovascular risk. Blood Pressure Monitoring, ():–.
Wallace, D. (). Computer-assisted quantiﬁcation of vascular tortuosity in retinopathy of
prematurity (an American Ophthalmological Society thesis). Transactions of the American
Ophthalmological Society, :–.
Walsh, J. (). Hypertensive retinopathy. Description, classiﬁcation, and prognosis.
Ophthalmology, ():–.
White, W. B., Berson, A. S., Robbins, C., Jamieson, M. J., Prisant, L. M., Roccella, E., and Sheps,
S. G. (). National standard for measurement of resting and ambulatory blood pressures
with automated sphygmomanometers. Hypertension, ():–.
Whitworth, J. ().  World Health Organization (WHO)/International Society of
Hypertension (ISH) statement on management of hypertension. Journal of hypertension,
():–.
Williams, B., Poulter, N., Brown, M., Davis, M., McInnes, G., Poer, J., Sever, P., and om, S.
(). Guidelines for management of hypertension: report of the fourth working party of
the British Hypertension Society, —BHS IV. Journal of Human Hypertension, ():–
.
Williams, T. (). antiﬁcation of arteriolar tortuosity in two normotensive age groups.
American journal of optometry and physiological optics, ():–.
Wimpissinger, B., Resch, H., Berisha, F., Weigert, G., Schmeerer, L., and Polak, K. ().
Response of choroidal blood ﬂow to carbogen breathing in smokers and non-smokers. British
Journal of Ophthalmology, ():–.
Wi, N.W., Chapman, N.,om, S. A. M., Stanton, A. V., Parker, K. H., and Hughes, A. D. ().
A novel measure to characterise optimality of diameter relationships at retinal vascular

Bibliography
bifurcations. Artery Research, (): – .
Wong, T. Y., Wang, J. J., Rochtchina, E., Klein, R., and Mitchell, P. (). Does refractive error
inﬂuence the association of blood pressure and retinal vessel diameters? e BlueMountains
Eye Study. American Journal of Ophthalmology, (): – .
Yu, P. K., Yu, D.-Y., Alder, V. A., Seydel, U., Su, E.-N., and Cringle, S. J. (). Heterogeneous
Endothelial Cell Structure Along the Porcine Retinal Microvasculature. Experimental Eye
Research, (): – .
Yvonne-Tee, G. B., Rasool, A. H. G., Halim, A. S., and Rahman, A. R. A. (). Noninvasive
assessment of cutaneous vascular function in vivo using capillaroscopy, plethysmography
and laser-Doppler instruments: Its strengths and weaknesses. Clinical Hemorheology and
Microcirculation, ():–.
Zamir, M., Medeiros, J. A., and Cunningham, T. K. (). Arterial bifurcations in the human
retina. e Journal of General Physiology, ():–.

Acronyms
AASI Ambulatory Arterial Stiﬀness Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
ABPM Ambulatory Blood Pressure Monitoring . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
ACE Angiotensin Converting Enzyme . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
AECG Ambulatory Electrocardiography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
ANOVA Analysis of Variance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
ANS Autonomic Nervous System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
APR Average Peak Ratio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
ARIC Atherosclerosis Risk In Communities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
AV Atrioventricular . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
AVR Arterio-Venous Ratio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
BDF Baseline Diameter Fluctuation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
bFR Baseline-Corrected Flicker Response . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
BP Blood Pressure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
CCD Charged-Coupled Device . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
CO Cardiac Output . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
CRA Central Retinal Artery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
CRAE Central Retinal Artery Equivalent . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
CRV Central Retinal Vein . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
CRVE Central Retinal Vein Equivalent . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
CSV Comma-separated Values . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
CT Constriction Time . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
CV Coeﬃcient of Variation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
CVD Cardio-Vascular Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
DA Dilation Amplitude . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
DBP Diastolic Blood Pressure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
DD Disk Diameter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
ECG Electrocardiogram. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
FMD Flow-Mediated Dilation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

Acronyms
HRV Heart Rate Variability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
HF High Frequency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
HR Heart Rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
HT Hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
ICC Intraclass Correlation Coeﬃcient . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
IOP Intraocular Pressure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
IQR Inter-artile Range . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
LDR Length-to-Diameter Ratio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
LED Light-emiing Diode . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
LF Low Frequency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
MABP Mean Arterial Blood Pressure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
MC Maximum Constriction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
MD Maximum Dilation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
MU Measuring Units . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
NN Normal-to-Normal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
NO Nitric Oxide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
OD Optical Density . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
ODR Optical Density Ratio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
ONH Optic Nerve Head . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
OPP Ocular Perfusion Pressure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
PNS Parasympathetic Nervous System. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
PP Pulse Pressure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
PSD Power Spectral Density . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
RT Reaction Time . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
RVA Retinal Vessel Analyser . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
SA Sinoatrial . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
SBP Systolic Blood Pressure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
SD Standard Deviation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
SITA Swedish Interactive resholding Algorithm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
SNS Sympathetic Nervous System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
OSat Oxygen Saturation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
SV Stroke Volume . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
SVR Systemic Vascular Resistance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
TIFF Tagged Image File Format . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
VF Visual Field . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
VLF Very Low Frequency . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

  
 
 Page removed for copyright restrictions. 
  
